ZA200302168B - Herbicide resistant plants. - Google Patents
Herbicide resistant plants. Download PDFInfo
- Publication number
- ZA200302168B ZA200302168B ZA200302168A ZA200302168A ZA200302168B ZA 200302168 B ZA200302168 B ZA 200302168B ZA 200302168 A ZA200302168 A ZA 200302168A ZA 200302168 A ZA200302168 A ZA 200302168A ZA 200302168 B ZA200302168 B ZA 200302168B
- Authority
- ZA
- South Africa
- Prior art keywords
- sequence
- polynucleotide
- epsps
- enhancer
- transcriptional
- Prior art date
Links
- 239000004009 herbicide Substances 0.000 title claims description 41
- 230000002363 herbicidal effect Effects 0.000 title claims description 34
- 241000196324 Embryophyta Species 0.000 claims description 140
- 108091033319 polynucleotide Proteins 0.000 claims description 122
- 102000040430 polynucleotide Human genes 0.000 claims description 122
- 239000002157 polynucleotide Substances 0.000 claims description 122
- 239000003623 enhancer Substances 0.000 claims description 96
- 108090000623 proteins and genes Proteins 0.000 claims description 93
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 claims description 65
- 239000005562 Glyphosate Substances 0.000 claims description 63
- 229940097068 glyphosate Drugs 0.000 claims description 63
- 230000002103 transcriptional effect Effects 0.000 claims description 63
- 235000010469 Glycine max Nutrition 0.000 claims description 56
- 244000068988 Glycine max Species 0.000 claims description 56
- 238000011144 upstream manufacturing Methods 0.000 claims description 54
- 102000004190 Enzymes Human genes 0.000 claims description 53
- 108090000790 Enzymes Proteins 0.000 claims description 53
- 102000004169 proteins and genes Human genes 0.000 claims description 51
- 239000000463 material Substances 0.000 claims description 50
- 238000000034 method Methods 0.000 claims description 48
- 210000001519 tissue Anatomy 0.000 claims description 43
- 108020004414 DNA Proteins 0.000 claims description 42
- 239000002773 nucleotide Substances 0.000 claims description 38
- 125000003729 nucleotide group Chemical group 0.000 claims description 37
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 claims description 34
- 240000002791 Brassica napus Species 0.000 claims description 32
- 230000002708 enhancing effect Effects 0.000 claims description 32
- 230000014509 gene expression Effects 0.000 claims description 32
- 230000035772 mutation Effects 0.000 claims description 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 22
- 235000011293 Brassica napus Nutrition 0.000 claims description 21
- 101150111720 EPSPS gene Proteins 0.000 claims description 21
- 108020004705 Codon Proteins 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 18
- 230000009466 transformation Effects 0.000 claims description 18
- 108091026890 Coding region Proteins 0.000 claims description 17
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 claims description 17
- 210000002257 embryonic structure Anatomy 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 17
- 241000700605 Viruses Species 0.000 claims description 16
- 108010031100 chloroplast transit peptides Proteins 0.000 claims description 16
- 239000002245 particle Substances 0.000 claims description 14
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 claims description 13
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 11
- 108010062110 water dikinase pyruvate Proteins 0.000 claims description 11
- 244000020551 Helianthus annuus Species 0.000 claims description 10
- 108020001991 Protoporphyrinogen Oxidase Proteins 0.000 claims description 10
- 102000005135 Protoporphyrinogen oxidase Human genes 0.000 claims description 10
- 230000009261 transgenic effect Effects 0.000 claims description 10
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 9
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 9
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 8
- 229920000742 Cotton Polymers 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 8
- 244000299507 Gossypium hirsutum Species 0.000 claims description 8
- 241000238631 Hexapoda Species 0.000 claims description 8
- 235000021536 Sugar beet Nutrition 0.000 claims description 8
- 241000589158 Agrobacterium Species 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 7
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 7
- 210000003763 chloroplast Anatomy 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000008929 regeneration Effects 0.000 claims description 7
- 238000011069 regeneration method Methods 0.000 claims description 7
- 241000244206 Nematoda Species 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 230000000408 embryogenic effect Effects 0.000 claims description 6
- 241001233957 eudicotyledons Species 0.000 claims description 6
- 108010085238 Actins Proteins 0.000 claims description 5
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 5
- 240000000385 Brassica napus var. napus Species 0.000 claims description 5
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 5
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 5
- 244000061176 Nicotiana tabacum Species 0.000 claims description 5
- 235000010582 Pisum sativum Nutrition 0.000 claims description 5
- 240000004713 Pisum sativum Species 0.000 claims description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 5
- 244000061456 Solanum tuberosum Species 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 239000003112 inhibitor Substances 0.000 claims description 5
- 235000009973 maize Nutrition 0.000 claims description 5
- MWMOPIVLTLEUJO-UHFFFAOYSA-N 2-oxopropanoic acid;phosphoric acid Chemical compound OP(O)(O)=O.CC(=O)C(O)=O MWMOPIVLTLEUJO-UHFFFAOYSA-N 0.000 claims description 4
- 235000011331 Brassica Nutrition 0.000 claims description 4
- 241000219198 Brassica Species 0.000 claims description 4
- 108010033040 Histones Proteins 0.000 claims description 4
- 108090000704 Tubulin Proteins 0.000 claims description 4
- 101150063097 ppdK gene Proteins 0.000 claims description 4
- 230000001172 regenerating effect Effects 0.000 claims description 4
- 239000003053 toxin Substances 0.000 claims description 4
- 231100000765 toxin Toxicity 0.000 claims description 4
- 108700012359 toxins Proteins 0.000 claims description 4
- 238000013518 transcription Methods 0.000 claims description 4
- 230000035897 transcription Effects 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 101710132601 Capsid protein Proteins 0.000 claims description 3
- 101710094648 Coat protein Proteins 0.000 claims description 3
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 3
- 101710125418 Major capsid protein Proteins 0.000 claims description 3
- 101710141454 Nucleoprotein Proteins 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 101710083689 Probable capsid protein Proteins 0.000 claims description 3
- 239000012620 biological material Substances 0.000 claims description 3
- 108020004999 messenger RNA Proteins 0.000 claims description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 3
- 229930029653 phosphoenolpyruvate Natural products 0.000 claims description 3
- 235000012015 potatoes Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 230000009452 underexpressoin Effects 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- 102000007469 Actins Human genes 0.000 claims description 2
- 244000291564 Allium cepa Species 0.000 claims description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 2
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims description 2
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 244000075850 Avena orientalis Species 0.000 claims description 2
- 235000007319 Avena orientalis Nutrition 0.000 claims description 2
- 108700003918 Bacillus Thuringiensis insecticidal crystal Proteins 0.000 claims description 2
- 240000007124 Brassica oleracea Species 0.000 claims description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 2
- 235000004936 Bromus mango Nutrition 0.000 claims description 2
- 108090000994 Catalytic RNA Proteins 0.000 claims description 2
- 102000053642 Catalytic RNA Human genes 0.000 claims description 2
- 108050004290 Cecropin Proteins 0.000 claims description 2
- 102000012286 Chitinases Human genes 0.000 claims description 2
- 108010022172 Chitinases Proteins 0.000 claims description 2
- 241000207199 Citrus Species 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 108010002069 Defensins Proteins 0.000 claims description 2
- 102000000541 Defensins Human genes 0.000 claims description 2
- 238000009007 Diagnostic Kit Methods 0.000 claims description 2
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 2
- 108010070675 Glutathione transferase Proteins 0.000 claims description 2
- 102000005720 Glutathione transferase Human genes 0.000 claims description 2
- 240000005979 Hordeum vulgare Species 0.000 claims description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 2
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 2
- 101710123134 Ice-binding protein Proteins 0.000 claims description 2
- 101710082837 Ice-structuring protein Proteins 0.000 claims description 2
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 2
- 240000008415 Lactuca sativa Species 0.000 claims description 2
- 108090001090 Lectins Proteins 0.000 claims description 2
- 102000004856 Lectins Human genes 0.000 claims description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 2
- 240000006240 Linum usitatissimum Species 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- 101710189714 Major cell-binding factor Proteins 0.000 claims description 2
- 235000011430 Malus pumila Nutrition 0.000 claims description 2
- 244000070406 Malus silvestris Species 0.000 claims description 2
- 235000015103 Malus silvestris Nutrition 0.000 claims description 2
- 235000014826 Mangifera indica Nutrition 0.000 claims description 2
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 240000004658 Medicago sativa Species 0.000 claims description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 2
- 240000005561 Musa balbisiana Species 0.000 claims description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 2
- 206010034133 Pathogen resistance Diseases 0.000 claims description 2
- 241001148062 Photorhabdus Species 0.000 claims description 2
- 241000209504 Poaceae Species 0.000 claims description 2
- 108010068086 Polyubiquitin Proteins 0.000 claims description 2
- 102100037935 Polyubiquitin-C Human genes 0.000 claims description 2
- 241000219000 Populus Species 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 235000014443 Pyrus communis Nutrition 0.000 claims description 2
- 240000001987 Pyrus communis Species 0.000 claims description 2
- 102100030000 Recombining binding protein suppressor of hairless Human genes 0.000 claims description 2
- 240000000111 Saccharum officinarum Species 0.000 claims description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 2
- 235000007238 Secale cereale Nutrition 0.000 claims description 2
- 244000082988 Secale cereale Species 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- 240000003829 Sorghum propinquum Species 0.000 claims description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 2
- 235000009184 Spondias indica Nutrition 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims description 2
- 102000004243 Tubulin Human genes 0.000 claims description 2
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims description 2
- 235000002096 Vicia faba var. equina Nutrition 0.000 claims description 2
- 108700002693 Viral Replicase Complex Proteins Proteins 0.000 claims description 2
- 108050006628 Viral movement proteins Proteins 0.000 claims description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 2
- 238000009825 accumulation Methods 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 230000000692 anti-sense effect Effects 0.000 claims description 2
- 230000000840 anti-viral effect Effects 0.000 claims description 2
- 239000003899 bactericide agent Substances 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 230000001276 controlling effect Effects 0.000 claims description 2
- 101150102059 cry3Aa gene Proteins 0.000 claims description 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims description 2
- 235000005489 dwarf bean Nutrition 0.000 claims description 2
- 244000013123 dwarf bean Species 0.000 claims description 2
- 244000037666 field crops Species 0.000 claims description 2
- 108010060641 flavanone synthetase Proteins 0.000 claims description 2
- 239000004459 forage Substances 0.000 claims description 2
- 235000012055 fruits and vegetables Nutrition 0.000 claims description 2
- 230000000855 fungicidal effect Effects 0.000 claims description 2
- 239000000417 fungicide Substances 0.000 claims description 2
- 108010079916 homocysteinase Proteins 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 239000002917 insecticide Substances 0.000 claims description 2
- 239000002523 lectin Substances 0.000 claims description 2
- 239000005645 nematicide Substances 0.000 claims description 2
- 235000014571 nuts Nutrition 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 108091092562 ribozyme Proteins 0.000 claims description 2
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 claims description 2
- 229910010271 silicon carbide Inorganic materials 0.000 claims description 2
- 108010076805 snowdrop lectin Proteins 0.000 claims description 2
- 230000000392 somatic effect Effects 0.000 claims description 2
- 101100409013 Mesembryanthemum crystallinum PPD gene Proteins 0.000 claims 3
- 235000005637 Brassica campestris Nutrition 0.000 claims 2
- 244000060924 Brassica campestris Species 0.000 claims 2
- 230000004927 fusion Effects 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 102000006587 Glutathione peroxidase Human genes 0.000 claims 1
- 108700016172 Glutathione peroxidases Proteins 0.000 claims 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 239000013615 primer Substances 0.000 description 69
- 235000018102 proteins Nutrition 0.000 description 40
- 239000000047 product Substances 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 239000000872 buffer Substances 0.000 description 19
- 239000002609 medium Substances 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 13
- 239000000284 extract Substances 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 10
- 102100033138 Tyrosine-protein phosphatase non-receptor type 22 Human genes 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 10
- 238000003556 assay Methods 0.000 description 9
- 238000010367 cloning Methods 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 7
- 240000007377 Petunia x hybrida Species 0.000 description 6
- 108700019146 Transgenes Proteins 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 239000012505 Superdex™ Substances 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- QUTYKIXIUDQOLK-PRJMDXOYSA-N 5-O-(1-carboxyvinyl)-3-phosphoshikimic acid Chemical compound O[C@H]1[C@H](OC(=C)C(O)=O)CC(C(O)=O)=C[C@H]1OP(O)(O)=O QUTYKIXIUDQOLK-PRJMDXOYSA-N 0.000 description 4
- 241000208125 Nicotiana Species 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000003155 DNA primer Substances 0.000 description 3
- 229920002148 Gellan gum Polymers 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 239000001166 ammonium sulphate Substances 0.000 description 3
- -1 fluormetron Chemical compound 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 2
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 2
- WRDABNWSWOHGMS-UHFFFAOYSA-N AEBSF hydrochloride Chemical compound Cl.NCCC1=CC=C(S(F)(=O)=O)C=C1 WRDABNWSWOHGMS-UHFFFAOYSA-N 0.000 description 2
- 108010000700 Acetolactate synthase Proteins 0.000 description 2
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 2
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010018763 Biotin carboxylase Proteins 0.000 description 2
- 108010018956 CTP synthetase Proteins 0.000 description 2
- 101100148606 Caenorhabditis elegans pst-1 gene Proteins 0.000 description 2
- 108030006517 Glyphosate oxidoreductases Proteins 0.000 description 2
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 229940122055 Serine protease inhibitor Drugs 0.000 description 2
- 101710102218 Serine protease inhibitor Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001952 enzyme assay Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000000749 insecticidal effect Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 2
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000003001 serine protease inhibitor Substances 0.000 description 2
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 2
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 238000003260 vortexing Methods 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- WNWOTMKHOLCHRJ-UHFFFAOYSA-N 1,4-dihydrotriazol-5-one Chemical compound O=C1CN=NN1 WNWOTMKHOLCHRJ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QMNWYGTWTXOQTP-UHFFFAOYSA-N 1h-triazin-6-one Chemical compound O=C1C=CN=NN1 QMNWYGTWTXOQTP-UHFFFAOYSA-N 0.000 description 1
- NUPJIGQFXCQJBK-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid Chemical compound OC(=O)C1=CC(COC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 NUPJIGQFXCQJBK-UHFFFAOYSA-N 0.000 description 1
- MPPOHAUSNPTFAJ-UHFFFAOYSA-N 2-[4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC2=CC=C(Cl)C=C2O1 MPPOHAUSNPTFAJ-UHFFFAOYSA-N 0.000 description 1
- CABMTIJINOIHOD-UHFFFAOYSA-N 2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]quinoline-3-carboxylic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC2=CC=CC=C2C=C1C(O)=O CABMTIJINOIHOD-UHFFFAOYSA-N 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- YHKBGVDUSSWOAB-UHFFFAOYSA-N 2-chloro-3-{2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-4-fluorophenyl}propanoic acid Chemical compound O=C1N(C(F)F)C(C)=NN1C1=CC(CC(Cl)C(O)=O)=C(Cl)C=C1F YHKBGVDUSSWOAB-UHFFFAOYSA-N 0.000 description 1
- ABOOPXYCKNFDNJ-UHFFFAOYSA-N 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 ABOOPXYCKNFDNJ-UHFFFAOYSA-N 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- CTSLUCNDVMMDHG-UHFFFAOYSA-N 5-bromo-3-(butan-2-yl)-6-methylpyrimidine-2,4(1H,3H)-dione Chemical compound CCC(C)N1C(=O)NC(C)=C(Br)C1=O CTSLUCNDVMMDHG-UHFFFAOYSA-N 0.000 description 1
- 101000768857 Arabidopsis thaliana 3-phosphoshikimate 1-carboxyvinyltransferase, chloroplastic Proteins 0.000 description 1
- 101100519160 Arabidopsis thaliana PCR4 gene Proteins 0.000 description 1
- 241001422755 Atys Species 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- 108010000755 Bromoxynil nitrilase Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- 241000233838 Commelina Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241000252867 Cupriavidus metallidurans Species 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 102000003849 Cytochrome P450 Human genes 0.000 description 1
- LMKYZBGVKHTLTN-NKWVEPMBSA-N D-nopaline Chemical compound NC(=N)NCCC[C@@H](C(O)=O)N[C@@H](C(O)=O)CCC(O)=O LMKYZBGVKHTLTN-NKWVEPMBSA-N 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- 239000005504 Dicamba Substances 0.000 description 1
- 108700016256 Dihydropteroate synthases Proteins 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 239000005630 Diquat Substances 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000208812 Flaveria bidentis Species 0.000 description 1
- 241001465354 Flaveria brownii Species 0.000 description 1
- RXCPQSJAVKGONC-UHFFFAOYSA-N Flumetsulam Chemical compound N1=C2N=C(C)C=CN2N=C1S(=O)(=O)NC1=C(F)C=CC=C1F RXCPQSJAVKGONC-UHFFFAOYSA-N 0.000 description 1
- AOQMRUTZEYVDIL-UHFFFAOYSA-N Flupoxam Chemical compound C=1C=C(Cl)C(COCC(F)(F)C(F)(F)F)=CC=1N1N=C(C(=O)N)N=C1C1=CC=CC=C1 AOQMRUTZEYVDIL-UHFFFAOYSA-N 0.000 description 1
- 239000005535 Flurochloridone Substances 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- LXKOADMMGWXPJQ-UHFFFAOYSA-N Halosulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2N(N=C(Cl)C=2C(O)=O)C)=N1 LXKOADMMGWXPJQ-UHFFFAOYSA-N 0.000 description 1
- 101000617808 Homo sapiens Synphilin-1 Proteins 0.000 description 1
- 239000005566 Imazamox Substances 0.000 description 1
- 239000005981 Imazaquin Substances 0.000 description 1
- XVOKUMIPKHGGTN-UHFFFAOYSA-N Imazethapyr Chemical compound OC(=O)C1=CC(CC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 XVOKUMIPKHGGTN-UHFFFAOYSA-N 0.000 description 1
- 239000005570 Isoxaben Substances 0.000 description 1
- 239000005571 Isoxaflutole Substances 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- VPRLICVDSGMIKO-UHFFFAOYSA-N Mannopine Natural products NC(=O)CCC(C(O)=O)NCC(O)C(O)C(O)C(O)CO VPRLICVDSGMIKO-UHFFFAOYSA-N 0.000 description 1
- 239000005578 Mesotrione Substances 0.000 description 1
- 239000005582 Metosulam Substances 0.000 description 1
- VGHPMIFEKOFHHQ-UHFFFAOYSA-N Metosulam Chemical compound N1=C2N=C(OC)C=C(OC)N2N=C1S(=O)(=O)NC1=C(Cl)C=CC(C)=C1Cl VGHPMIFEKOFHHQ-UHFFFAOYSA-N 0.000 description 1
- 239000005583 Metribuzin Substances 0.000 description 1
- 239000005586 Nicosulfuron Substances 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- 239000005595 Picloram Substances 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 108090000051 Plastocyanin Proteins 0.000 description 1
- 241000709992 Potato virus X Species 0.000 description 1
- 241000723762 Potato virus Y Species 0.000 description 1
- AFWBWPCXSWUCLB-WDSKDSINSA-N Pro-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 AFWBWPCXSWUCLB-WDSKDSINSA-N 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 239000012614 Q-Sepharose Substances 0.000 description 1
- 102000001218 Rec A Recombinases Human genes 0.000 description 1
- 108010055016 Rec A Recombinases Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 239000005616 Rimsulfuron Substances 0.000 description 1
- 108010070346 Salmine Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- CSPPKDPQLUUTND-NBVRZTHBSA-N Sethoxydim Chemical compound CCO\N=C(/CCC)C1=C(O)CC(CC(C)SCC)CC1=O CSPPKDPQLUUTND-NBVRZTHBSA-N 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 239000005618 Sulcotrione Substances 0.000 description 1
- 102100021997 Synphilin-1 Human genes 0.000 description 1
- LUMXICQAOKVQOB-YWIQKCBGSA-N Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)[C@@H](C)O LUMXICQAOKVQOB-YWIQKCBGSA-N 0.000 description 1
- 241000723792 Tobacco etch virus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 229960001413 acetanilide Drugs 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 150000003931 anilides Chemical class 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- VGPYEHKOIGNJKV-UHFFFAOYSA-N asulam Chemical compound COC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VGPYEHKOIGNJKV-UHFFFAOYSA-N 0.000 description 1
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 1
- OTSAMNSACVKIOJ-UHFFFAOYSA-N azane;carbamoyl(ethoxy)phosphinic acid Chemical compound [NH4+].CCOP([O-])(=O)C(N)=O OTSAMNSACVKIOJ-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- PPWBRCCBKOWDNB-UHFFFAOYSA-N bensulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)CC=2C(=CC=CC=2)C(O)=O)=N1 PPWBRCCBKOWDNB-UHFFFAOYSA-N 0.000 description 1
- ZOMSMJKLGFBRBS-UHFFFAOYSA-N bentazone Chemical compound C1=CC=C2NS(=O)(=O)N(C(C)C)C(=O)C2=C1 ZOMSMJKLGFBRBS-UHFFFAOYSA-N 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- RIUXZHMCCFLRBI-UHFFFAOYSA-N chlorimuron Chemical compound COC1=CC(Cl)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(O)=O)=N1 RIUXZHMCCFLRBI-UHFFFAOYSA-N 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- OILAIQUEIWYQPH-UHFFFAOYSA-N cyclohexane-1,2-dione Chemical compound O=C1CCCCC1=O OILAIQUEIWYQPH-UHFFFAOYSA-N 0.000 description 1
- PAFZNILMFXTMIY-UHFFFAOYSA-O cyclohexylammonium Chemical compound [NH3+]C1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-O 0.000 description 1
- 239000002852 cysteine proteinase inhibitor Substances 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- 101150024923 da gene Proteins 0.000 description 1
- IWEDIXLBFLAXBO-UHFFFAOYSA-N dicamba Chemical compound COC1=C(Cl)C=CC(Cl)=C1C(O)=O IWEDIXLBFLAXBO-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- SYJFEGQWDCRVNX-UHFFFAOYSA-N diquat Chemical compound C1=CC=[N+]2CC[N+]3=CC=CC=C3C2=C1 SYJFEGQWDCRVNX-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005437 etoperidone Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 230000004883 flower formation Effects 0.000 description 1
- OQZCSNDVOWYALR-UHFFFAOYSA-N flurochloridone Chemical compound FC(F)(F)C1=CC=CC(N2C(C(Cl)C(CCl)C2)=O)=C1 OQZCSNDVOWYALR-UHFFFAOYSA-N 0.000 description 1
- BGZZWXTVIYUUEY-UHFFFAOYSA-N fomesafen Chemical compound C1=C([N+]([O-])=O)C(C(=O)NS(=O)(=O)C)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 BGZZWXTVIYUUEY-UHFFFAOYSA-N 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- PMHURSZHKKJGBM-UHFFFAOYSA-N isoxaben Chemical compound O1N=C(C(C)(CC)CC)C=C1NC(=O)C1=C(OC)C=CC=C1OC PMHURSZHKKJGBM-UHFFFAOYSA-N 0.000 description 1
- OYIKARCXOQLFHF-UHFFFAOYSA-N isoxaflutole Chemical compound CS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1=C(C2CC2)ON=C1 OYIKARCXOQLFHF-UHFFFAOYSA-N 0.000 description 1
- 229940088649 isoxaflutole Drugs 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VPRLICVDSGMIKO-SZWOQXJISA-N mannopine Chemical compound NC(=O)CC[C@@H](C(O)=O)NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO VPRLICVDSGMIKO-SZWOQXJISA-N 0.000 description 1
- 108010083942 mannopine synthase Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- KPUREKXXPHOJQT-UHFFFAOYSA-N mesotrione Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O KPUREKXXPHOJQT-UHFFFAOYSA-N 0.000 description 1
- FOXFZRUHNHCZPX-UHFFFAOYSA-N metribuzin Chemical compound CSC1=NN=C(C(C)(C)C)C(=O)N1N FOXFZRUHNHCZPX-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- LZGUHMNOBNWABZ-UHFFFAOYSA-N n-nitro-n-phenylnitramide Chemical compound [O-][N+](=O)N([N+]([O-])=O)C1=CC=CC=C1 LZGUHMNOBNWABZ-UHFFFAOYSA-N 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- RTCOGUMHFFWOJV-UHFFFAOYSA-N nicosulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CN=2)C(=O)N(C)C)=N1 RTCOGUMHFFWOJV-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- NVGOPFQZYCNLDU-UHFFFAOYSA-N norflurazon Chemical compound O=C1C(Cl)=C(NC)C=NN1C1=CC=CC(C(F)(F)F)=C1 NVGOPFQZYCNLDU-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- LQRJAEQXMSMEDP-XCHBZYMASA-N peptide a Chemical group N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)NCCCC[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)C(\NC(=O)[C@@H](CCCCN)NC(=O)CNC(C)=O)=C/C=1C=CC=CC=1)C(N)=O)C(=O)C(\NC(=O)[C@@H](CCCCN)NC(=O)CNC(C)=O)=C\C1=CC=CC=C1 LQRJAEQXMSMEDP-XCHBZYMASA-N 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WROZTZHKRRNHBS-UHFFFAOYSA-N phenyl propaneperoxoate Chemical compound CCC(=O)OOC1=CC=CC=C1 WROZTZHKRRNHBS-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- NQQVFXUMIDALNH-UHFFFAOYSA-N picloram Chemical compound NC1=C(Cl)C(Cl)=NC(C(O)=O)=C1Cl NQQVFXUMIDALNH-UHFFFAOYSA-N 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000013492 plasmid preparation Methods 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- LIOPHZNMBKHGAV-UHFFFAOYSA-M potassium;2-(phosphonomethylamino)acetate Chemical compound [K+].OC(=O)CNCP(O)([O-])=O LIOPHZNMBKHGAV-UHFFFAOYSA-M 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- MEFOUWRMVYJCQC-UHFFFAOYSA-N rimsulfuron Chemical compound CCS(=O)(=O)C1=CC=CN=C1S(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 MEFOUWRMVYJCQC-UHFFFAOYSA-N 0.000 description 1
- 101150100282 rplK gene Proteins 0.000 description 1
- 229920006298 saran Polymers 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108020001482 shikimate kinase Proteins 0.000 description 1
- QYOJSKGCWNAKGW-HCWXCVPCSA-N shikimate-3-phosphate Chemical compound O[C@H]1CC(C(O)=O)=C[C@H](OP(O)(O)=O)[C@@H]1O QYOJSKGCWNAKGW-HCWXCVPCSA-N 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- PQTBTIFWAXVEPB-UHFFFAOYSA-N sulcotrione Chemical compound ClC1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O PQTBTIFWAXVEPB-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Description
HERBICIDE RESISTANT PLANTS
The present invention relates to recombinant DNA technology, and in particular to the production of transgenic plants which exhibit substantial resistance or substantial tolerance to herbicides when compared with non transgenic like plants. The invention also relates, inter alia, to the nucleotide sequences (and expression products thereof), which are used in the production of, or are produced by, the said transgenic plants.
Plants which are substantially “tolerant” to a herbicide when they are subjected to it - provide a dose/response curve which is shifted to the right when compared with that provided by similarly subjected non tolerant like plants. Such dose/response curves have “dose” plotted on the x-axis and “percentage kill”,“herbicidal effect” etc. plotted on the y- axis. Tolerant plants will typically require at least twice as much herbicide as non tolerant like plants in order to produce a given herbicidal effect. Plants which are substantially “resistant” to the herbicide exhibit few, if any, necrotic, lytic, chlorotic or other lesions when subjected to the herbicide at concentrations and rates which are typically employed by the agricultural community to kill weeds in the field in which crops are to be grown for commercial purposes.
It is particularly preferred that the plants are substantially resistant or substantially : tolerant to herbicides (hereinafter "glyphosate" which have 5-enol pyruvyl shikimate phosphate synthetase (hereinafter "EPSPS") as their site of action, of which N- phosphonomethylglycine (and its various salts) is the pre-eminent example.
The herbicide may be applied either pre- or post emergence in accordance with usual techniques for herbicide application to fields comprising crops which have been rendered resistant to the herbicide. The present invention provides, inter alia, nucleotide sequences useful in the production of such herbicide tolerant or resistant plants.
According to the present invention there is provided a glyphosate resistant EPSPS enzyme wherein in comparison with the wild type EPSPS the protein sequence is modified in that a first position is mutated so that the residue at this position is Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into EPSPS sequences which comprise the conserved region
GNAGTAMRPL in the wild type enzyme such that the modified sequence reads
GNAGIAMRSL, wherein the enzyme does not comprise the sequence
K(A/V)AKRAVVVGCGGKFPVE, characterised in that the enzyme is stable and possesses at least one of the following sequence motifs (i) to (viii) in which X is any amino acid and Z,
Z, and Z, are any amino acid other than those specified:- (1) ALLMZAPLA, wherein Z is not S or T; (i) EIEIZDKL, wherein Z is not V; : (ii) FG(V/M)(K/S)ZEH, wherein Z isnot V; : (iv) ALK/R)ZLGL, wherein Z is not R;
Ww) GLXVEZ,DXZ,XXXA(/V)V, wherein Z, is not T and/or Z, is not E; (vi) ITPPZ,K(L/V)(K/N)Z, wherein Z, is not K and/or Z, is not T; : (vii) TIZ(D/N)PGCT, wherein Z isnot N or L; (viii) (D/N)YFXVLXZXX(K/R)H, wherein Z is not R.
A preferred embodiment of the enzyme comprises at least two of the motifs (i), (ii), (iii), (v) and (vi). In specific embodiments of the present inventive enzyme in motif (i) Z is
A; in motif (ii) Z is I; in motif (iii) Z is A; in motif (iv) Zis K, T or A; in motif (v) Z, isR or
A or less preferably D or E and Z, is preferably V or A or less preferably T; in sequence motif (vi) Z, is E or A and Z, is P, I or V; in motif (vii) Z is R or K; and in motif (viii) Z is T or S or less preferably Q. Particularly preferred embodiments of the said enzyme comprise one or more sequences selected from the group consiting of: )) (I/V)VEGCGGI/L/Q)FP(V/A/T)S/G)
Gi) @V)VVGCGGI/L/Q)FP(V/A/T)E; (iii) (/VYVVGCGG(I/L/IQ)FP(V/A/T)(S/G); (ivy (/V)VVGCGGKFP(V/A/T)(S/G); v) ({/V)VEGCGGKFP(V/A/T)E; vi) ({/V)VEGCGGI/L/Q)FP(V/A/T)E; (vii) (A/V)VEGCGGKFP(V/A/T)(S/G).
The present invention also comprises an isolated polynucleotide comprising a region which encodes the present inventive enzyme, particular such polynucleotides comprising , for example, a sequence depicted in SEQ ID Nos. 4 or 5, or a sequence obtained by hybridising an intron located in the SEQ ID 4 or 5 sequences with polynucleotides comprised in plant genomic libraries. The invention also includes an isolated polynucleotide comprising a region encoding a chloroplast transit peptide and a glyphosate resistant dicotyledenous 5-enolpyruvylshikimate phosphate synthase (EPSPS) 3' of the peptide, the said region being under expression control of a plant operable promoter, with the provisos that the said promoter is not heterologous with respect to the said region, and the chloroplast transit peptide is not heterologous with respect to the said synthase.
By "heterologous" is meant from a different source, and correspondingly "non- heterologous" means derived from the same source - but at a gene rather than organism or tissue level. For example the CaMV35S promoter is clearly heterologous with respect to a petunia EPSPS coding sequence insofar as the promoter is derived from a virus and the sequence - the expression of which it controls - from a plant. The term "heterologous" according to the present invention has a still narrower meaning, however. For example "heterologous" as it relates to the present invention means that the petunia EPSPS coding sequence is "heterologous" with respect to, for example, a promoter also derived from petunia - other than that which controls expression of the EPSPS gene. In this sense the petunia promoter derived from the petunia EPSPS gene then used to control expression of an
EPSPS coding sequence likewise-derived from petunia is "non-heterologous” with respect to the said coding sequence. "Non-heterologous” does not mean, however, that the promoter and coding sequence must necessarily have been obtained. from one and the same (original or progenitor) polynucleotide. Likewise with respect to transit peptides. For example, a rubisco chloroplast transit peptide derived from sunflower is "heterologous" with respect to the coding sequence of an EPSPS gene likewise derived from sunflower (the same plant, tissue or cell). A rubisco transit peptide encoding sequence derived from sunflower is "non- heterologous" with respect to a rubisco enzyme encoding-sequence also derived from sunflower even if the origins of both sequences are different polynucleotides which may have been present in different cells, tissues or sunflower plants.
Most particularly preferred forms of the said polynucleotide include a construct which comprises the following components in the 5' to 3' direction of transcription: either (1):- @) At least one transcriptional enhancer being that enhancing region which is upstream from the transcriptional start of the sequence from which the enhancer is obtained and which enhancer per se does not function as a promoter either in the sequence in which it is endogenously comprised or when present heterologously as part of a construct;
(ii) The promoter from the soybean EPSPS gene; (iii) The soybean genomic sequence which encodes the soybean EPSPS chloroplast transit peptide; (iv) The genomic sequence which encodes the soybean EPSPS; (v) A transcriptional terminator; wherein the soybean EPSPS coding sequence is modified in comparison with a wild type sequence in that a first position is mutated so that the residue at this position is Ile rather than
Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into EPSPS sequences which comprise the conserved region
GNAGTAMRPLTAAYV in the wild type enzyme such that modified sequence reads
GNAGIAMRSLTAAV; or (2) @) At least one transcriptional enhancer being that enhancing region which is upstream from the transcriptional start of the sequence from which the enhancer is obtained and which enhancer per se does not function as a promoter either in the sequence in which it is endogenously comprised or when present heterologously as part of a construct; (ii) The promoter from the Brasicca napus EPSPS gene; (iii) The Brasicca napus genomic sequence which encodes the Brasicca napus
EPSPS chloroplast transit peptide; (iv) The genomic sequence which encodes the Brasicca napus EPSPS; (v) A transcriptional terminator; wherein the Brasicca napus EPSPS coding sequence is modified in comparison with a wild type sequence in that a first position is mutated so that the residue at this position is Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than
Pro, the mutations being introduced into EPSPS sequences which comprise the conserved region GNAGTAMRPLTAAYV in the wild type enzyme such that the modified sequence reads GNAGIAMRSLTAAYV.
The present inventive polynucleotide, particularly the two disclosed in the immediately preceding paragraphs, may further comprise a sequence which encodes a chloroplast transit peptide/phosphoenolpyruvate synthase (CTP/PPS) or a chloroplast transit peptide/pyruvate orthophosphate di-kinase (CTP/PPDK), which sequence is under expression control of a plant operable promoter. It is particularly preferred that the PPDK protein sequence is directed to the chloroplast in planta via its autologous transit peptide, and accordingly the polynucleotide of the immediately preceding sentence encodes such a non- heterologous combination. The PPDK encoding sequence can be derived from either a monocot or a dicot and the protein thus encoded is optionally not cold-labile. By “not cold labile” is meant that the enzyme retains at least 50% of its activity when incubated at 0 degrees Celsius for 5 minutes under experimental conditions similar to those referred to in
Usami ef al (1995) Plant Mol. Biol., 27, 969-980. Such a ‘cold stable’ enzyme is at least two-fold more stable than the like enzyme isolated from F. bidentis. The PPS or PPDK enzymes provide for elevated levels of PEP in the chloroplast which is the site of action of glyphosate and which contains the EPSPS enzyme.
The enhancing region of the polynucleotide preferably constitutes a sequence the 3 end of which is at least 40 nucleotides upstream of the closest transcriptional start of the sequence from which the enhancer is obtained. In a further embodiment of the polynucleotide, the enhancing region constitutes a region the 3' end of which is at least 60 nucleotides upstream of the said closest start, and in a still further embodiment of the polynucleotide the said enhancing region constitutes a sequence the 3’ of which is at least 10 nucleotides upstream from the first nucleotide of the TATA consensus of the sequence from which the enhancer is obtained.
The polynucleotide according to the invention may comprise two or more transcriptional enhancers, which in a particular embodiment of the polynucleotide may be tandemly present.
In the present inventive polynucleotide the 3’ end of the enhancer, or first enhancer if there is more than one present, may be between about 100 to about 1000 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide or the first nucleotide of an intron or other untranslated leader sequence in the 5' untranslated region in the case that the said region contains an intron or other untranslated sequence. Ina more preferred embodiment of the polynucleotide, the 3’ end of the enhancer, or first enhancer, is between about 150 to about 1000 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide or the first nucleotide of in the 5' untranslated region, and in a still more preferred embodiment the 3’ end of the enhancer, or first nhancer, may be between about 300 to about 950 nucleotides upstream of oo the codon corresp nding to the translational start of the EPSPS transit peptide or the first - nucleotide of an i tron or other untranslated leader sequence in the 5' untranslated region. In a yet more preferr d embodiment, the 3’ end of the enhancer, or first enhancer, may be located between a out 770 and about 790 nucleotides upstream of the codon corresponding to the translationa start of the EPSPS transit peptide or the first nucleotide of an intron or other untranslated adr sequence in the 5' untranslated region.
In an alterjative inventive polynucleotide, the 3’ end of the enhancer, or first enhancer, may be beated between about 300 to about 380 nucleotides upstream of the codon corresponding to t A translational start of the EPSPS transit peptide or the first nucleotide of an intron or other translated leader sequence in the 5' untranslated region, and in a preferred embodi ent of this alternative polynucleotide the 3’ end of the enhancer, or first enhancer, is locat | between about 320 to about 350 nucleotides upstream of the codon corresponding to t 1 translational start of the EPSPS transit peptide, or the first nucleotide of an intron or other translated leader sequence in the 5' untranslated region.
In the poly cleotide according to the invention, the region upstream of the promoter from the EPSPS g ne may comprise at least one enhancer derived from a sequence which is upstream from the transoriptiona start of a promoter selected from the group consisting of those of the actin, folDFd, S-adenosyl homocysteinase, histone, tubulin, polyubiquitin and plastocyanin gene land the CaMV35S and FMV35S genes.
According \ the present inventive polynucleotide may comprise in the 5' to 3' direction a first en ancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of either the CaMV35S or
FMV 35S promote] 5, and a second enhancer comprising a transcriptional enhancing region derived from a se uence which is upstream from the transcriptional start of an actin gene.
Alternativ ly, the polynucleotide may comprise in the 5' to 3' direction a first enhancer comprisi g a transcriptional enhancing region derived from a sequence which is upstream from th transcriptional start of either the CaMV 35S or FMV35S promoters, and a second enhancer comprising a transcriptional enhancing region derived from a sequence 30° which is upstream from the transcriptional start of the rolDfd gene.
Alternatively, the polynucleotide may comprise in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of either the CaMV35S or FMV35S promoters, and a ‘second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of a histone gene.
Alternatively, the polynucleotide may comprise in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of either the CaMV35S or FMV35S promoters, and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of a tubulin gene.
Alternatively, the polynucleotide may comprise in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is “upstream from the transcriptional start of the FMV 35S promoter and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the CaMV35S promoter. :
Alternatively, the polynucleotide may comprise in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the CaMV35S promoter and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the FMV35S promoter.
Whatever the identity and juxtaposition of the various enhancers present in the polynucleotide, the nucleotides 5' of the codon which constitutes the translational start of the
EPSPS chloroplast transit peptide may be Kozack preferred. What is meant by this is well known to the skilled man and will be further apparent from the examples below.
Particularly preferred embodiments of the present inventive polynucleotide comprise up stream of the sequence encoding the EPSPS chloroplast transit peptide a sequence encoding a non-translated 5' leader sequence derived from a relatively highly expressed gene, such as that of the glucanase, chalcone synthase and Rubisco genes.
The polynucleotide of the invention may also comprise a virally derived translational enhancer located within the non translated region 5' of the genomic sequence which encodes the EPSPS chloroplast transit peptide. The man skilled in the art is aware of the identity of such suitable translational enhancers - such as the Omega and Omega prime sequences derived from TMV and that derived from the tobacco etch virus, and how such translational enhancers can be introduced into the polynucleotide so as to provide for the desired result of increased protein expression.
The polynucleotide according to the invention may further comprise regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, dessication, and herbicides. Whilst such a polynucleotide contemplates the herbicide resistance conferring gene being other than an EPSPS, such as glyphosate oxido-reductase (GOX) for example, the herbicide may be other than glyphosate in which case the resistance conferring genes may be selected from the group encoding the following proteins: phosphinothricin acetyl transferase (PAT), hydroxyphenyl pyruvate dioxygenase (HPPD), ‘glutathione S transferase (GST), cytochrome P450, Acetyl-COA carboxylase (ACCase),
Acetolactate synthase (ALS), protoporphyrinogen oxidase (PPO), dihydropteroate synthase, polyamine transport proteins, superoxide dismutase (SOD), bromoxynil nitrilase, phytoene desaturase (PDS), the product of the #/dA gene obtainable from Alcaligenes eutrophus, and known mutagenised or otherwise modified variants of the said proteins. In the case that the polynucleotide provides for multiple herbicide resistance such herbicides may be selected from the group consisting of a dinitroaniline herbicide, triazolo-pyrimidines, a uracil, a phenylurea, a triketone, an isoxazole, an acetanilide, an oxadiazole, a triazinone, a sulfonanilide, an amide, an anilide, an isoxaflutole, a flurochloridone, a norflurazon, and a triazolinone type herbicide and the post-emergence herbicide is selected from the group consisting of glyphosate and salts thereof, glufosinate, asulam, bentazon, bialaphos, bromacil, sethoxydim or another cyclohexanedione, dicamba, fosamine, flupoxam, phenoxy propionate, quizalofop or another aryloxy-phenoxypropanoate, picloram, fluormetron, atrazine or another triazine, metribuzin, chlorimuron, chlorsulfuron, flumetsulam, halosulfuron, sulfometron, imazaquin, imazethapyr, isoxaben, imazamox, metosulam, pyrithrobac, rimsulfuron, bensulfuron, nicosulfuron, fomesafen, fluroglycofen, KIH9201, ET751, carfentrazone, mesotrione, sulcotrione, paraquat, diquat, bromoxynil and fenoxaprop.
A particular embodiment of the polynucleotide according to the invention provides for resistance to both glyphosate and a protoporphyrinogen oxidase (PPGO) inhibitor, in
© WO 02/26995 PCT/GB01/04131 particular butafenicil, for which the corresponding resistance protein is a PPGO or an inhibitor resistant variant thereof. A particularly preferred construct encoding such a herbicide resistance conferring combination comprises the EPSPS encoding sequence of the invention in combination with a sequence which encodes a PPDK or PPS in combination with a PPGO inhibitor resistant PPGO enzyme encoding sequence — such sequences being directed to the chloroplast — if desirable — by their autologous transit peptides and being under the expression control of non-heterologous promoters if the protein encoding sequences are of plant as opposed to bacterial origin.
In the case that the polynucleotide comprises sequences encoding insecticidal proteins, these proteins may be selected from the group consisting of crystal toxins derived from Bt, including secreted Bt toxins; protease inhibitors, lectins,
Xenhorabdus/Photorhabdus toxins. The fungus resistance conferring genes may be selected from the group consisting of those encoding known AFPs, defensins, chitinases, glucanases, and Avr-Cf9. Particularly preferred insecticidal proteins are crylAc, crylAb, cry3A, Vip 1A,Vip 1B, Vip3A, Vip3B, cysteine protease inhibitors, and snowdrop lectin. In the case that the polynucleotide comprises bacterial resistance conferring genes these may be selected from the group consisting of those encoding cecropins and techyplesin and analogues thereof. Virus resistance conferring genes may be selected from the group consisting of those encoding virus coat proteins, movement proteins, viral replicases, and anti-sense and ribozyme sequences which are known to provide for virus resistance; whereas the stress, salt, and drought resistance conferring genes may be selected from those that encode Glutathione-
S-transferase and peroxidase, the sequence which constitutes the known CBF1 regulatory sequence and genes which are known to provide for accumulation of trehalose. :
The polynucleotide according to the invention may be modified to enhance expression of the protein encoding sequences comprised by it, in that mRNA instability motifs and/or fortuitous splice regions may be removed, or crop preferred codons may be used so that expression of the thus modified polynucleotide in a plant yields substantially similar protein having a substantially similar activity/function to that obtained by expression of the protein encoding regions of the unmodified polynucleotide in the organism in which such regions of the unmodified polynucleotide are endogenous. The degree of identity between the modified polynucleotide and a polynucleotide endogenously contained within the said plant and encoding substantially the same protein may be such as to prevent co- ~~ suppression between the modified and endogenous sequences. In this case the degree of identity between the sequences should preferably be less than about 70%.
The invention still further includes a biological or transformation vector comprising the present inventive polynucleotide. Accordingly, by "vector" is meant, infer alia, one of the following: a plasmid, virus, cosmid or a bacterium transformed or transfected so as to contain the polynucleotide.
The invention still further includes plant material which has been transformed with the said polynucleotide or vector, as well as such transformed plant material which has been, or is, further transformed with a polynucleotide comprising regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, dessication, and herbicides.
The invention still further includes morphologically normal fertile whole plants which result from the crossing of plants which have been regenerated from material which has been transformed with the polynucleotide of the invention and plants which result from regeneration of material transformed with a polyncleotide which comprises a sequence which encodes a protein, such as a phosphoenolpyruvate synthase (PPS) or pyruvate orthophosphate di-kinase (PPDK) which proteins are capable of providing for elevated levels of phosphoenolpyruvate in the chloroplast. Such proteins are directed to the chloroplast by a suitable transit peptide — in the case of the PPDK enzyme preferably by the autologous peptide.
The invention still further includes morphologically normal fertile whole plants which contain the present inventive polynucleotide and which result from the crossing of plants which have been regenerated from material transformed with the present inventive polynucleotide or vector, and plants which have been transformed with a polynucleotide comprising regions encoding a CTP/PPS or CTP/PPDK, and/or regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, dessication, and herbicides. The invention also includes progeny of the resultant plants, their seeds and parts.
-11- oo
Plants of the invention may be selected from the group consisting of field crops, . fruits and vegetables such as canola, sunflower, tobacco, sugar beet, cotton, maize, wheat, - Co barley, rice, sorghum, mangel worzels, tomato, mango, peach, apple, pear, strawberry, banana, melon, potato, carrot, lettuce, cabbage, onion, soya spp, sugar cane, pea, field beans, poplar, grape, citrus, alfalfa, rye, oats, turf and forage grasses, flax and oilseed rape, and nut producing plants insofar as they are not already specifically mentioned, their progeny, seeds and parts.
Particularly preferred such plants include soybean, canola, brassica, cotton, sugar beet, sunflower, peas, potatoes and mangel worzels. Lo
The invention still further comprises a method of selectively controlling weeds in a field, the field comprising weeds and plants of the invention or the herbicide resistant progeny thereof, the method comprising application to the field of a glyphosate type herbicide in an amount sufficient to control the weeds without substantially affecting the ‘plants. According to this method, one or more of a herbicide, insecticide, fungicide, nematicide, bacteriocide and an anti-viral may be applied to the field (and thus the plants contained within it) either before or after application of the glyphosate herbicide.
The invention still further provides a method of producing plants which are substantially tolerant or substantially resistant to glyphosate herbicide, comprising the steps of: @ transforming plant material with the polynucleotide or vector of the invention; (ii) selecting the thus transformed material; and (iii) regenerating the thus selected material into morphologically normal fertile whole plants.
The transformation may involve the introduction of the polynucleotide into the material by any known means, but in particular by: (i) biolistic bombardment of the material with particles coated with the polynucleotide; (ii) by impalement of the material on silicon carbide fibres which are coated with a solution comprising the polynucleotide; or (iii) by introduction of the polynucleotide or vector into Agrobacterium and co-cultivation of the thus transformed Agrobacterium with plant material which is thereby transformed and is subsequently regenerated. Plant transformation, selection and regeneration techniques, which may require routine modification in respect of a particular plant species, are well known to the skilled man. The thus transformed plant material may be selected by its resistance to glyphosate. ‘ The invention still further provides the use of the present inventive polynucleotide or vector in the production of plant tissues and/or morphologically normal fertile whole plants which are substantially tolerant or substantially resistant to glyphosate herbicide.
The invention still further includes a method of selecting biological material © transformed so as to express a gene of interest, wherein the transformed material comprises the polynucleotide or vector of the invention, and wherein the selection comprises exposing the transformed material to glyphosate or a salt thereof, and selecting surviving material.
The said material may be of plant origin, and may in particular be derived from a dicot selected from the group consisting of soybean, sugar beet, cotton and the Brassicas.
The invention still further includes a method for regenerating a fertile transformed plant to contain foreign DNA comprising the steps of: (a producing regenerable tissue from said plant to be transformed; )} transforming said regenerable tissue with said foreign DNA, wherein said foreign DNA comprises a selectable DNA sequence, wherein said sequence functions in a regenerable tissue as a selection device; (c) between about one day to about 60 days after step (b), placing said regenerable tissue from step (b) in a medium capable of producing shoots from said tissue, wherein said medium may further contain a compound used to select regenerable tissue containing said selectable DNA sequence to allow identification or selection of the transformed regenerated tissue; (d) after at least one shoot has formed from the selected tissue of step (c) transferring said shoot to a second medium capable of producing roots from said shoot to produce a plantlet, wherein the second medium optionally contains the said compound; and (e) growing said plantlet into a fertile transgenic plant wherein the foreign DNA is transmitted to progeny plants in Mendelian fashion, characterised in that the foreign DNA is, or the selectable DNA sequence comprised by the foreign DNA comprises, the polynucleotide according to the invention, and the said compound is glyphosate or a salt thereof. The plant may be a dicot as indicated above - more preferably selected from soybean, canola, brassica, cotton, sugar beet, sunflower, peas, potatoes and mangel worzel, . and the said regenerable tissue may consist of embryogenic calli, somatic embryos, immature embryos etc. ’ The present invention also includes a diagnostic kit comprising means for detecting the present inventive enzyme or polynucleotide or enzymes encoded by it, and therefore suitable for identifying tissues or samples which contain these. The polynucleotides can be detected by PCR amplification as is known to the skilled man - based on primers which he can easily derive from the enzyme encoding sequences which are disclosed in this application. The enzymes per se can be detected by, for example, the use of antibodies which have been raised against them for diagnostically distinguishing the antigenic regions which they contain.
The present invention will be further apparent from the following description taken in conjunction with the associated drawings and sequence listings.
Of the Sequences:
SEQ ID No.1 depicts Brassicia napus genomic DNA. 2 Bn EPSPS5 (PCR primer) 3 Bn EPSPS3 (PCR primer) 4 BnF1 (PCR primer) 5 BnF2 (PCR primer) 6 BnF3 (PCR primer) 7 BnF4 (PCR primer) 8 BnFS (PCR primer) 9 BnF6 (PCR primer) 10 BnF7 (PCR primer) 11 BnF8 (PCR primer) . 12 BnF9 (PCR primer) 13 BnF10 (PCR primer) ’ 14 BnFl11 (PCR primer) 15 BnF12 (PCR primer) 16 BnXho (PCR primer) 17 BnMUTBot (PCR primer)
18 BaMUTTop (PCR primer) 19 BnNde (PRC primer) : 20 BnRBSEP (PCR primer) 21 Brasr 12 (PCR primer) 22 Brasr 11 (PCR Primer)
23 Bnapus start rev 24 Genome walker 1 25 Genome walker 2 26 CaMV343 (PCR primer)
27 CaMV46C (PCR primer) 28 BnGUSXMa (PCR primer) 29 FMV enhancer 30 CaMV35S enhancer 31 Soybean Genomic EPSPS Sequence clone 1/14
32 Soybean Genomic EPSPS Sequence clone 1/12 33 EPSPS 10 reverse ~~ (PCR primer) 34 EPSPS 4 forward (PCR primer) 35 SEQ ID No. 31 containing double mutation 36 SEQ ID No. 32 containing double mutation
37 FMV35S90 enhancer 38 FMV35546 enhancer 39 Gm Term Bam (PCR primer) 40 Gm Term Eco (PCR primer) 41 BnMUT2PST (PCR primer)
42 BnMUTKPN (PCR primer) 43 GmRubPac (PCR primer) 44 GmRubbot (PCR primer) 45 GmRubtop (PCR primer) 46 GmRubKpn (PCR primer)
47 ZMPPDK 1 (PCR primer) 48 ZMPPDK2 (PCR primer)
49 ECPPS! (PCR primer) 0 50 ECPPS2 (PCR primer) : 51 -65 Motifs present in the stable EPSPS proteins of the invention > .
Methods useful for cloning, expressing and characterising the stable glyphosate- resistant EPSP synthases of the current invention are described herein
Stable glyphosate- resistant EPSPSs of the current invention are characterised as being stable (retaining > ~ 80% of their catalytic activity) after being incubated in a suitable buffer at 37 C for at least 4 hours. As exemplified below, enzyme stability experiments can suitably be carried out using substantially purified, part purified or crude preparations of enzyme extracts (for example the latter are readily obtained as extracts of transgenic plants engineered to express the glyphosate-resistant EPSPS or, similarly, extracts of microbes engineered to express a transgene encoding the glyphosate-resistant EPSPS). Ideally, glyphosate-resistant enzymes are tested for stability both in a purified form and thenas purified protein spiked back into a crude plant extract so as to test them under more realistic in planta -like conditions. In such extracts, the enzyme activity due to glyphosate-resistant
EPSPS can easily be discriminated from background susceptible endogenous EPSPS by testing activity over a range of glyphosate concentrations. At a discriminating concentration of glyphosate (e.g 0.1 mM glyphosate in the presence of 0.1 mM PEP) virtually all of the measured activity will originate from the resistant enzyme
Example. 1 Method for identification of stable glyphosate-resistant EPSP synthases
In order to test the stability of a glyphosate-resistant EPSPS, a test solution of the enzyme (prepared as described below in buffer at pH ~ 7.0-7.5 and in purified or part purified form) is heated to 37 C for 4-5h. The glyphosate-resistant activity of the heated enzyme is then compared with the activity of a) a sample similarly prepared but kept at ice temperature and b) a similar sample but freshly prepared.
Stable glyphosate resistant enzymes of the current invention are characterised by the fact that, following incubation for 5 h at 37 C, they lose little, if any, of their original glyphosate-resistant catalytic activity (<20% , preferably < 15% and more preferably < 10%)
-16- | } relative to suitable controls when assayed as described below. Preferably the stability oo - experiment is carried out using substantially pure enzyme although a very similar result will normally be obtained using crude preparations, or when pure protein is spiked back into crude extract. Methods suitably used for assay and preparation of enzyme extracts are further detailed below. The stability of the glyphosate-resistant EPSPS can suitably be assessed in a variety of other, essentially equivalent ways (for example by heating the E enzyme at a slightly higher temperature for a shorter time or a lower temperature for a longer period...e.g at 25 C for 3 d).
Example 2. Method for assaying EPSPS activity and determination of kinetic constants.
Assays are carried out generally according to the radiochemical method of Padgette et al 1987 (Archives of Biochemistry and Biophysics, 258(2) 564-573) with K+ ions as the major species of cationic counterion. Assays in a total volume of 50ul, in 50mM Hepes(KOH) pH 7.0 at 25°C, contain purified enzyme or plant extract (see below) diluted appropriately in
Hepes pH 7.0 containing 10% glycerol, and SmM DTT, 4C PEP either as variable substrate( for kinetic determinations) or fixed at 100 or 250 pM and shikimate 3 Phosphate (K+ salt) at 0.75 or 2 mM as indicated. Optionally, for assays of crude plant extracts, assays also contain 5 mM KF and/or 0.1 mM ammonium molybdate. Assays are started with the addition of *C phosphoenolpyruvate (cyclohexylammonium+ salt) and stopped after 2-10 minutes (2 minutes is preferable) with the addition of 50pl of a solution of 1 part 1M acetic acid and 9 parts ethanol. After stopping, 20pl is loaded onto a synchropak AX100 (25cm x 4.6mm ) column and chromatographed using isocratic elution with a 0.28M potassium phosphate pH 6.5 mobile phase flowing at 0.5 ml/min over 35 minutes. Under these conditions the retention times for PEP and EPSP are, depending on the individual columns, ~ 19 and 25 minutes respectively. A CP 525TR scintillation counter is connected to the end of the AX 100 column. It is fitted with a 0.5ml flow cell, and the flow rate of scintillant ( Ultima Flo
AP) is set at 1ml/min. Relative peak areas of PEP and EPSP are integrated to determine the percentage conversion of labelled PEP to EPSP. Apparent K| and Vmax values are determined by least squares fit to a hyperbola with simple weighting using the Grafit 3.09b from Erithacus Software Ltd. Km values are generally ascertained using 8-9 concentrations of variable substrate ranging from K_, / 2 - 10 K,, and triplicate points. Except where
-17- | oo specifically noted, data points are only included in the analysis where there is < 30% conversion of substrate to EPSP.
Shikimate-3-Pi (S3P) is prepared as follows, To 7mls of 0.3M TAPS pH 8.5 containing 0.05M Shikimate, 0.0665M ATP ( Na salt ), 10mM KF, 5mM DTT, and 0.05M
MgClL,.6H,0, 75ul of a 77 unit ( tmol min" ) ml" solution of shikimate kinase is added. After 24hrs at room temperature, the reaction is stopped by brief heating to 95°C. The reaction solution is diluted 50 fold in 0.01M Tris HCI pH 9, and chromatographed by anion exchange on Dowex 1 X 8 - 400, using a 0 - 0.34M LiCl, gradient. The S3P fractions are combined, : freeze dried, and then redissolved in 7mls distilled H,0. 28mls of 0.1M Ba(CH,COOH), and 189mls of absolute ethanol are then added. This solution is left to stir overnight at 4°C. The resulting precipitate of tri-Barium S3P is collected and washed in 30mls of 67% ethanol. The washed precipitate is then dissolved in ~ 30mls distilled H,0. By adding K,SO, the K” salt of
S3P is produced as required. Great care is taken to add a minimal excess of sulphate. The
BaSO, precipitate is removed and the supernatant containing the required salt of S3P freeze dried. Each salt is weighed and analysed by proton NMR. S3P preparations so-prcpared arc > 90% pure according to proton NMR and, according to their weights and integration of 31P
NMR, contain only low residues of potassium sulphate.
Example 3. Preparation of extracts of plant material suitable for EPSPS assay
Callus or plantlet material (0.5 -1.0 g) is ground to a fine frozen powder in a liquid nitrogen-chilled mortar and pestle. This powder is taken up in an equal volume of a suitable chilled extraction buffer (for example, 50 mM Hepes/ KOH buffer at pH 7.5 containing 1 mM EDTA, 3 mM DTT, 1.7 mM ‘pefabloc’ (serine protease inhibitor), 1.5 mM leupeptin, 1.5 mM pepstatin A, 10% v/v glycerol and 1% polyvinylpyrolidone), resuspended, mixed and centrifuged in a chilled centrifuge to bring down debris. The supernatant is exchanged down a chilled PD10 column of Sephadex G25 into 25 mM Hepes/ KOH buffer at pH 7.5 containing 1 mM EDTA, 3 mM DTT and 10% v/v glycerol. Protein is estimated by the
Bradford method standardised using bovine serum albumen. A portion of the extract is frozen in liquid nitrogen; a portion is assayed immediately. :
Example 4. Method for assaying EPSPS activities in crude plant materials and discriminating the proportion of the total which is resistant to glyphosate.
EPSPS assays of plant extracts are carried out, as described above, with 0.1 mM "“C-
PEP and 0.75 mM shikimate-3-Pi either in the absence or the presence of 0.1 mM N- (phosphonomethyl)glycine. Under these assay conditions, the resistant forms of EPSPS of the current invention are estimated to be inhibited by < 8.5% whilst the sensitive w/t form is essentially fully inhibited (> 98%). Thus, the level of activity observed in the presence of glyphosate (A) is taken to represent ~ 92% of the level of resistant enzyme derived from expression of the transgene whilst the level of susceptible w/t EPSPS is taken to be the total level of EPSPS activity observed in the absence of glyphosate minus the value of A x ~ 1.08.
Because the Vmax of the mutant enzymes of the current invention are estimated to be, for example, only about a third of the Vmax of the w/t enzyme (and because the Km values for
PEP of both w/t and mutant forms are estimated to be about 20 uM or less), the level of expression of the mutant enzyme polypeptide relative to the level of expression of the endogenous w/t EPSPS is taken, to be about three fold higher than the ratio calculated on the basis of the ratio of their relative observed activities. The total level of EPSPS polypeptide expression (mutant + w/t) is also estimated by Western blotting.
Example 5. Cloning and expression of w/t cDNA encoding mature Brassica napus
EPSPS in E.coli
Brassica napus EPSPS cDNA is amplified using RT-PCR from RNA isolated from glass-house grown Brassica napus plants using Superscript RT from BRL according to the recommendation supplied by the manufacturer. PCR is performed using Pfu turbo polymerase from Stratagene according to the methods supplied by the manufacturer.
Suitably designed oligonucleotide primers based on the known nucleotide sequence (EMBL accession X51475) are used in the amplification reaction and the reverse transcription steps.
The PCR product is cloned into pCRBlunt II using Invitrogens Zero Blunt TOPO kit. The sequence of the insert is confirmed by sequencing and it is verified that the predicted open reading frame corresponds to that of the predicted mature chloroplastic Brassica napus
EPSPS protein with the exception of the presence of an initiating Met. The cloned and verified EPSPS sequence is excised using suitable restriction enzymes as known in the art and the purified fragment is cloned into pET24a (Novagen) digested similarly. The recombinant clones are introduced into BL21 (DE3) a codon-optimised RP strain of E.coli supplied by Stratagene. The EPSPS protein is expressed in this strain following addition of 1 mM IPTG to the fermenter medium (LB supplemented with 100ug/ml Kanamycin). The recombinant protein of the correct predicted mass is identified (i) on the basis of Coomassie staining of SDS gels of cell extracts and side by side comparison with Coomassie-stained gels of extracts of similar E.coli cells transformed with an empty pET24a vector and ii) by western analysis using a polyclonal antibody raised to previously-purified plant EPSPS protein.
Example 6. Cloning and expression in E.coli of glyphosate-resistant mutant Brassica napus EPSPS
The Brassica napus EPSPS ¢cDNA in pCRBlunt is used as a template for two further
PCR using primer pairs designed to introduce specific changes such that the resulting reaction product encodes a modified EPSPS protein wherein a first position is mutated so that the residue at this position is Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into EPSPS sequences which comprise the conserved region GNAGTAMRPLTAAYV in the wild type enzyme such that the modified sequence reads GNAGIAMRSLTAAYV. The sequence of
Brassica napus EPSPS gene is known and methods for designing primers to effect this mutagenesis are well-known in the art.
The resultant PCR product is gel purified and cloned into pCRBIlunt II using Invitrogens
Zero Blunt TOPO kit. It is confirmed that the DNA sequence of the insert and its predicted open reading frame correspond to that of the predicted mature chloroplastic Brassica napus
EPSPS protein (with the exception of the presence of an initiating Met) and also that the desired changes (the specific mutation of TtoIand P to S at specific positions in the EPSPS sequence) are encoded . The thus cloned and verified B.napus EPSPS sequence is excised using suitable restriction enzymes and the purified fragment cloned into pET24a (Novagen) digested similarly. The recombinant clones are introduced into BL21 (DE3), a codon optimised RP strain of E.coli supplied by Stratagene. The EPSPS protein is expressed in this strain following addition of 1 mM IPTG to the fermenter medium (LB supplemented with 100ug/ml Kanamycin). The recombinant protein of the correct predicted mass is identified i) on the basis of Coomassie staining of SDS gels of cell extracts and side by side comparison with Coomassie-stained gels of extracts of similar E.coli cells transformed with an empty pET24a vector and ii) by Western analysis using a polyclonal antibody raised to previously-
purified plant EPSPS protein. This mutant form of Brassica napus EPSPS is purified and characterised as described herein.
Example 7. Purification and characterisation of mutant Brassica napus EPSPS
The mature mutant Brassica napus EPSPS protein is purified at ~ 4 C as follows. 25 g wet weight of cells are washed in 50 ml of 0.1M Hepes/ KOH buffer at pH 7.5 containing 5 mM DTT, 2 mM EDTA and 20% v/v glycerol. Following low-speed centrifugation, the cell pellet is resuspended in 50 ml of the same buffer but also containing 2 mM of ‘Pefabloc’ a serine protease inhibitor. Cells are evenly suspended using a glass homogenizer and then disrupted at 10000 psi using a Constant Systems (Budbrooke Rd, Warwick, U.K.) Basic Z cell disrupter. The crude extract is centrifuged at ~ 30,000 g for 1 h and the pellet discarded.
Protamine sulphate (salmine) is added to a final concentration of 0.2% , mixed and the solution left to stand for 30 min. Precipitated material is removed by centrifugation for 30 min at ~ 30,000 g. Aristar grade ammonium sulfate is added to a final concentration of 40% of saturation, stirred for 30 min and then centrifuged at ~ 27,000 g for 30 min. The pellet is resuspended in ~ 10 ml of the same buffer as used for cell disruption, further ammonium sulfate is added to bring the solution to ~ 70% of saturation, the solution is stirred for 30 min and centrifuged again to yield a pellet which is resuspended in ~ 15 ml of S200 buffer (10 mM Hepes/ KOH (pH 7.8) containing 1 mM DTT, 1 mM EDTA and 20% v/v glycerol).
This is filtered (0.45 micron) loaded and chromatographed down a K26/ 60 column containing Superdex 200 equilibrated with S200 buffer. EPSPS-containing fractions detected on the basis of EPSPS enzyme activity are combined and loaded onto an xk16 column containing 20 ml of HP Q-Sepharose equilibrated with S200 buffer. The column is washed with S200 buffer and then EPSPS eluted within a linear gradient developed from 0.0M to 0.2M KCl in the same buffer. EPSPS elutes within a single peak corresponding to a salt concentration at or below approximately 0.1 M. EPSPS-containing fractions detected on the basis of EPSPS enzyme activity are combined and loaded onto a HiL.oad xk26/60 column of Superdex 75 equilibrated with Superdex 75 buffer (25 mM Hepes/ KOH (pH 7.5) containing 2 mM DTT, 1 mM EDTA and 10% v/v glycerol. EPSPS-containing fractions identified on the basis of enzyme activity are combined and loaded onto a 1m! column of MonoQ equilibrated with the same, Superdex 75 buffer. The column is washed with starting buffer and EPSPS eluted as a single peak over the course of a 15 ml linear gradient
-21- | : developed between 0.0 and 0.2M KCI. EPSPS is obtained near (>90%) pure at this stage in the purification. Optionally, EPSPS is further purified by exchange into Superdex 75 buffer containing 1.0 M (Aristar) ammonium sulphate and loading onto a 10 ml column of phenyl sepharose equilibrated in the same buffer. EPSPS is eluted as a single peak early during the course of a linear gradient of declining ammonium sulphate developed between 1.0 and 0.0
M ammonium sulphate.
The purified mutant form of Brassica napus EPSPS, obtained by these or by similar methods and assayed as described above in the presence of 2 mM shikimate-3-Pi, has an apparent Vmax of ~ 5 pmol/ min/ mg and a Km for PEP of ~ 25 uM. At40 uM PEP, the
IC50 value for the potassium salt of glyphosate is ~ 0.6 mM. The estimated Ki value for potassium glyphosate of the mutant EPSPS is ~ 0.45 mM.
Example 8. Cloning of genomic DNA encoding Brassica napus EPSPS
A Brassica napus genomic DNA fragment (SEQ ID No.1), encoding EPSPS is known in the art (Gasser and Klee, 1990). PCR primers BnEPSPS5 (SEQ ID No.2) and
BnEPSPS3 (SEQ ID No.3) are used to amplify the EPSPS gene from genomic DNA isolated from Brassica napus var. Westar.
Pfu polymerase is used to perform the PCR using the following conditions: 94 °C 5 min 94 °C min 55°C30s 72 °C 12 min
The resulting 3.8 Kb product is cloned into pCR4Blunt-Topo and sequenced using the following primers: M13Forward, M13Reverse (Invitrogen), BnF1 (SEQ ID No.4), BnF2 (SEQ ID No.5), BaF3 (SEQ ID No.6), BnF4 (SEQ ID No.7), BnF5 (SEQ ID No.8), BnF6 (SEQ ID No.9), BnF7 (SEQ ID No.10), BnF8 (SEQ ID No.11), BnF9 (SEQ ID No.12),
BnF10 (SEQ ID No.13), BnF11 (SEQ ID No.14) and BnF12 (SEQ ID No.15).
Example 9. Introduction of mutations into genomic DNA encoding BnEPSPS.
The desired Thr-Ile and Pro-Ser mutations are introduced into the B. napus EPSPS gene by PCR using oligonucleotide primers containing codon changes so as to introduce the desired amino acid changes. Primers BnXho (SEQ ID No.16) and BoMUTBot (SEQ ID
No.17) are used to amplify a desired region of EPSPS from Westar genomic DNA. Likewise,
primers BnMutTop (SEQ ID No.18) and BnNde (SEQ ID No.19) are used to amplify an additional region from Westar genomic DNA. 1 ul of each of the PCR products is mixed and overlapping complementary sequences allowed to anneal. The products are then joined by
PCR using primers BnXho and BnNde. The resulting PCR product is cloned and sequenced : to check for the inclusion of the double mutation. The Xho1/Ndel fragment in the BhEPSPS clone is excised and replace with the cloned Xhol/Ndel fragment containing the double mutant.
Example 10. Construct for expression of mutant B.napus EPSPS in plants having the
Rubisco leader sequence upstream of the gene encoding mutant Brassica napus EPSPS.
The tobacco rubisco leader is introduced into the construct by PCR. Primers
BnRBSEP (SEQ ID No.20) and Brasr12 (SEQ ID No.21) are used to amplify a product from 50 ng wildtype B. napus genomic DNA as template using Pfu-Turbo polymerase. The resulting PCR product is cloned into pCR4 blunt TOPO and clones are identified by restrictions digest that are otientated such as it may be excised as Notl (from vector) and Xhol. The rubisco leader is then introduced into the mutated BnEPSPS clone as Not1/Xhol.
Example 11. Identification of the Brassica napus EPSPS promoter (useful for expression of EPSPS in plants) by genome walking
Increased lengths of upstream or downstream sequence of any plant gene may be obtained using the genome walking kit as supplied and directed by Clontech.
The primers depicted in SEQ ID Nos 22 and 23 (Bras r11 and Bnapus start rev) are used to obtain upstream sequence of the Brasicca napus EPSPS gene using Brasicca napus genomic
DNA according to the methods described in the protocol accompanying the genome walker kit.
The Bras r11 (SEQ ID No. 22) primer is used in conjunction with the AP1 primer supplied in the genome walker kit and the Bnapus start rev primer is used with the AP2 primer supplied with the genome walker kit. Products are cloned into pCR- TOPO using a
TOPO TA Cloning kit from Invitrogen according to the manufacturers instructions. PCR using M13 forward and reverse primers is performed using Ready to Go Beads from
Pharmacia to ascertain which clones. contain inserts of the correct size. A number of these clones are used to make DNA preps and these DNAs are then used to determine the nucleotide sequence of the inserts.
A second set of primers (SEQ ID Nos.24 and 25 respectively) is used for a further walk as shown below:
Genome walker 1 (SEQ ID No.24) with the AP1 primer
Genome walker 2 (SEQ ID No.25) with the AP2 primer
Additional genomic digests are performed in addition to those recommended by
Clontech’s protocols. These digests include Alu I, Hae III, Hinc II and Rsa I. These digested
DNAs are then treated identically to the other digests performed as described by the protocols accompanying the Genome walking kit. This is done to increase the chance of getting a correct and long PCR product. Again the PCR products are cloned into pCR-
TOPO using a TOPO TA Cloning kit from Invitrogen according to the manufactures instructions and sequence determination is performed on random clones obtained from each cloned product that contain inserts of the correct size. The sequence of the inserts are determined. Approximately 1kb of sequence upstream form the translational start site of the
Brasicca napus EPSPS is obtained that is contiguous with the published sequence.
Example 12. Constructs for expression of mutant Brassica napus EPSPS in plants
The 35S enhancer is amplified from vector pMIB1 (Figure 1) by PCR using primers
CaMV343 and CaMV46C (SEQ ID Nos.26 and 27 respectively)
The PCR product is cloned into vector pPCR4Blunt-TOPO and sequenced. The desired promoter, obtained as described in the previous example is amplified from B. napus
Westar genomic DNA using a 5’ primer containing a Sphl site and BnGUSXma (SEQ ID
No.28)
The PCR product is digested directly with Sphl and Xmal and ligated into the pCR4Blunt-T OPO vector containing the 35S enhancer as Sph1/Xmal (partial digest with
Sph 1). The CaMV 35S enhancer fused to the BnEPSPS promoter is then excised from pCR4-
Blunt using Not1 (from vector) and Xma 1 and cloned into the PCR4Blunt vector containing the tobacco rubisco leader and mutated B. napus EPSPS gene. The FMV enhancer (SEQ ID
No.29) or the CaMV35S enhancer (SEQ ID No.30) is synthesised chemically and subcloned into vector pCR4 Blunt TOPO. The FMV enhancer is excised from PCR4-Blunt as
Not1/Sacl and ligated into the CaMV 35S enhancer/B. napus promoter / rubisco leader / B. napus EPSPS as Notl/Sacl. The final construct is shown in Figure 2. The whole expression cassette may be excised using EcoRI and ligated into a suitable vector for plant transformation.
Example 13. Plant Transformation and Regeneration.
The expression cassette is excised from the pFCBnEPSPS vector using EcoR/ and ligated into, for example, a binary vector pBin19 at the unique EcoR 1 restriction site. The binary vector, containing the desired expression cassette transformed into Agrobacterium tumefaciens strain LBA 4404 using the freeze thaw method of transformation provided by
Holsters et al., 1978. Tobacco transformation and whole plant regeneration is performed using Nicotiana tabacum var. Samsun according to protocols in Draper ef al (Plant Genetic
Transformation, Blackwell Sci. Pub. 1989). Transformation events are selected on MS-media containing kanamycin. Alternatively pFCBnEPSPS, or other constructs capable of delivering glyphosate resistance in plants by the expression of a glyphosate resistant EPSPS - gene from soybean may be introduced into plants directly without using Agrobacterium mediated techniques as described for Soybean.
Constructs are transformed into regenerable embryogenic soyabean tissues using either biolistic type approaches (e.g Santarem ER, Finer, J.J (1999) ‘Transformation of soyabean (Glycine max (L.) Merrill) using proliferative embryogenic tissue maintained on a semi-solid medium’ In vitro Cellular and Developmental Biology-Plant 35, 451-455; USP- 5,503,998, USP 5830728 )or via infection with Agrobacterium (e.g. USP-5,024,944, USP- 5,959,179). Regenerable embryogenic soyabean tissues are derived, for example, from the cotyledons of immature embryos or other suitable tissues.
Proliferative embryogenic tissue can, for example, be maintained on a semi-solid medium. Such tissue, is, for example obtained in the following way. Immature zygotic embryos which are 3- 4 mm long are isolated from pods of, for example, Glycine max (L.)
Merrill, 2-3 weeks after flower formation. Pods can be checked for the presence of embryos of the correct length and maturity by ‘backlighting’. Pods are then sterilized. Immature embryos are removed and the axis removed from each. Immature embryos are then plated on ‘D40-Lite’ semi-solid (0.2% gelrite) MS salts medium at pH 7.0 containing BS vitamins, 3% sucrose and 40 mg/l 2,4-D for 3-4 weeks. For proliferation of embryos the material is then transferred to ‘D20’” MS salts medium at pH 5.7 containing BS vitamins, 3% sucrose, 20 mg/1 2,4-D and 0.2% Gelrite. Material with bright green globular proliferative embryos is selected and subcultured every 2-3 weeks.
For bombardment, 20-25 clumps/ plate of tissue are selected (subcultured 4-5 days prior to bombardment) and arranged in the centre of the dish containing D20 medium. The tissue is dried for 15 min by uncovering for 15 minutes under a sterile hood. Gold particles coated in DNA construct (coated, for example, using methods described in the references above) are twice bombarded into the tissue on D20 medium using any one of a large number of commercially available guns. By way of further example a PDS1000 particle gun is used.
Particles may be prepared and coated with DNA in a similar manner to that described by
Klein ef al 1987, Nature, 327, 70-73. Alternatively, for example, 60 mg of gold or tungsten particles (~ 1.0 um) in a microcentrifuge tube are washed repeatedly in HPLC-grade ethanol and then, repeatedly, in sterile water. The particles are resuspended in 1 ml of sterile water and dispensed into 50 pl aliquots in microcentrifuge tubes. Gold particles are stored at 4 C, tungsten particles at - 20 C. 3 mg of DNA are added to each aliquot of (defrosted) particles and the tubes are vortexed at top speed. Whilst maintaining near continuous vortexing, 50 ul of 2.5M CaCl, and 20 pl of 0.1M spermidine is added. After 10 minutes of further vortexing, samples are centrifuged for 5 seconds in an eppendorf microcentrifuge, the supernatant is drawn off and the particles washed in successive additions of HPLC-grade ethanol. The particles are thoroughly resuspended in 60 pl of ethanol and then dispensed in 10 pl aliquots onto the surface of each macrocarrier to be used in the PDS1000 particle gun.
Components of the PDS1000 particle gun are surface sterilised by immersion in 70% ethanol and air-drying. Target plates prepared, as described above, with tissue arranged into an ~ 2.5 cm disc are placed 6 cm from the stopping screen. Suitably chosen rupture discs are then used for bombardment.
One week after bombardment, all tissue clumps are transferred onto D20 medium, buffered to pH 5.7, containing a suitable selective concentration of glyphosate between 0.05 and 5 mM. After an additional 3-4 weeks all tissue is transferred to fresh D20 medium containing an increased concentration of glyphosate within this concentration range. After a further 3-4 weeks, living tissue is selected and subcultured on every 3-4 weeks in similar
D20 medium containing glyphosate. Alternatively, in the case that some other selectable. marker than glyphosate is also present then selections may be made as appropriate (e.g using
. =26- . increasing concentrations of hygromycin). Growing sections are thus maintained and, given enough tissue, may be analysed by PCR to confirm that they are transgenic for the desired
DNA.
In order to develop and mature embryos, tissue clumps are placed onto M6 medium | which comprises MS salts at pH 5.7 containing BS vitamins, 6% maltose and 0.2% gelrite.. 6-9 clumps are placed in a tall dish at 23°C. After 3-4 weeks, embryos elongate and can be separated and transferred to another round of incubation on M6 medium. After 4-6 weeks, embryos are cream-coloured and ready for desiccation. 9 such cream-coloured embryos are placed in a dry Petri dish, sealed with parafilm and placed onto a shelf for 2-3 days.
Embryos should be somewhat flaccid and not “crispy-crunchy”.
Dessicated embryos can be germinated by plating onto OMS (growth regulator-free
MS medium). Following germination which normally occurs within a week plants are transferred to larger boxes and, once there is sufficient root and shoot formation, thence to soil. To prevent fungal contamination it is advisable to wash OMS from the roots with distilled water. Plants may be kept and grown under high humidity and, initially, under 24 - hour lighting. Plants may be grown until about 2 feet tall under 24 hour lighting and then encouraged to flower and form pods through a shift to a 16 hour lighting regime. Seeds are collected and progeny grown on, crossed and backcrossed into order to move the transgenes into the desired plant background using the normal methods of plant breeding. Plants are routinely analysed for the presence and expression of transgenes using the normal methods of molecular biology including analysis by PCR, Southern, Western, ELISA and enzyme assay techniques.
Example 14. Methods of obtaining genes encoding stable glyphosate resistant EPSPs
In one embodiment of the current invention, glyphosate resistant EPSPS genes suitable for expression in E.coli are constructed, as for example, described herein where, in the coding sequence a first position is mutated so that the residue at this position is
Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into EPSPS sequences which comprise the following conserved region GNAGTAMRPL in the wild type enzyme such that the modified sequence reads GNAGIAMRSL.
7. oo
Stable glyphosate-resistant EPSP synthases of the current invention and genes encoding these are then obtained by generating a wide range of variants by a process of random or partially random mutagenesis (for example using chemical or UV mutagenesis, by using a non-proof reading DNA polymerase (e.g. in a strain such as XL1 red) or by using any "5 one of a number of ‘directed evolution’ approaches (e.g as reviewed by Kuchner and Arnold, 1997 in TIBTECH, 15, 523-530 or described by Stemmer (1994) in PNAS, 91, 10747- 10751) and selecting genes expressing EPSPSs which are stable and which remain glyphosate resistant. Suitable means of selection include, for example, expression of mutated genes (e.g from a weak constitutive promoter) in an Aro A- strain of E.coli grown at elevated temperatures (e.g 37-42 C) and selecting those transformants most capable of growth in minimal medium (optionally also containing glyphosate). Alternatively, a non-aro
A host strain might be used (preferably e.g. rec A) provided that the medium contains a selective concentration of glyphosate. The skilled man will recognise that many methods of mutagenesis and selection could be used within the ambit of the current invention.
Example 15. Stable glyphosate-resistant EPSPSs and genes encoding them
The stable double mutant form of Brassica napus EPSPS is one example of the current invention. The skilled man will recognise that other examples of such EPSPSs of the current invention and genes encoding them can be cloned, isolated and characterised using methods the same or similar to those described above.
In EPSPSs and the EPSPS gene sequences of the current invention, the coding sequence at a first position is mutated so that the residue at this position is Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into EPSPS sequences which comprise the following conserved region GNAGTAMRPL in the wild type enzyme such that the modified sequence reads
GNAGIAMRSL.
EPSPS protein sequences of the current invention are further characterised in that they DO NOT comprise a region having the sequence K(A/V)AKRAVVVGCGGKFPVE
EPSPS protein sequences of the current invention are further characterised in that they comprise at least one of the amino acid sequence motifs listed below in (i)-> (viii). (i) ALLMZAPLA where ZisNOT Sor T (ii) EIEIZDKL where Z is NOT V
(iii) FG(V/M)(K/S)ZEH where Z is NOT V (Iv) AL(K/R)ZLGL where Z is NOT R (v) GLXVEZ DXZ,XXXA(I/V)V ~~ where Z, is NOT T and/or Z, is NOT E (vi) ITPPZ,K(L/V)(X/N)Z, where Z, is NOT K and/or Z, is NOT T s (vil) TIZ(D/N)PGCT where Zis NOT Nor L (viii) (D/N)YFXVLXZXX(X/R)H where Z is NOTR wherein X is any amino acid and Z,7Z1, and Z2 are any amino acid other than those : indicated.
Furthermore it is preferred, for EPSPS genes and proteins of the current invention, that the protein sequence comprise at least one of the sequence motifs i), ii) iii), v) and vi), preferably, at least two of these.
Furthermore, in amino acid sequence motif i) Z is preferably A, in sequence motif ii)
Z is preferably I, in sequence motif iii) Z is preferably A, in sequence motif iv) Z is preferably K, T or A, in sequence v) Z, is preferably R or A and less preferably D or E whilst
Z, is preferably V or A and less preferably T, in sequence motif vi) Z, is preferably E or A whilst Z, is preferably P, 1 or V, in sequence motif vii) Z is preferably R or K and in sequence motif viii) Z is preferably T or S and less preferably is Q.
Furthermore, some of the EPSPS protein sequences of the current invention are characterised in that they comprise at least one of the following sequences: (I/V)VEGCGGI/L/Q)FP(V/A/T)S/G) or
I/VYVVGCGGI/L/Q)FP(V/A/T)E or
I/VYIVVGCGGI/L/Q)FP(V/A/T)(S/G) or
I/VY)VV GCGGKFP(V/A/T)S/G)or _ (WV)VEGCGGKFP(V/A/T)E or (I/V)VEGCGG/L/Q)FP(V/A/T)E or (I/VYVEGCGGKFP(V/A/T)(S/G)
Furthermore EPSPS sequences of the current invention are preferably derived from : dicotyledenous plants
Example 16. Stable glyphosate-resistant EPSPSs derived from soyabean
Preferred examples of the current invention are the EPSPS protein sequences and the
DNA sequences which encode these which are derived from soyabean ( see for example
~ WO0226995 PCT/GB01/04131
EPSPS gene SEQ ID Nos 33 and 34) and which are then optionally modified according to
Example 15 to yield a stable glyphosate resistant EPSP synthase.
Particularly preferred examples are EPSP synthase genes derived from soyabean in which:- (a) the coding sequence at a first position is mutated so that the residue at this position is Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into EPSPS sequences which comprise the following conserved region GNAGTAMRPL in the wild type enzyme such that the modified sequence reads GNAGIAMRSL,
And : (b) the DNA coding sequence may be further modified in accord with Example so that the encoded protein comprises at least one and preferably two or more of the amino acid sequence motifs ii), iii), v) and viii) .
Example 17 Cloning of a soybean partial length cDNA encoding EPSPS. 15 Soybean RNA is isolated using Trizol™ reagent as described by Gibco BRL and first- strand cDNA synthesised using Superscript II (Gibco BRL) using protocols provided by the manufacturer with the degenerate primer EPSPS 10 reverse (SEQ ID No.35). PCR is performed using ready to go PCR beads supplied by AmershamPharmacia™ according to the protocol supplied by the manufacturer using the reverse transcribed soybean first-strand cDNA product as a template and the primers EPSPS 4 forward (SEQ ID No.34) and EPSPS 10 reverse (SEQ ID No.33).
The following PCR conditions are used:- 1. 94°C 3 minutes for 1 cycle 2. 94°C 45 seconds 50°C 30 seconds 72°C 1 minute for 25 cycles 3. 72°C 10 minutes for 1 cycle.
The product obtained of approximately 1 kb is cloned into pCR2.1 using a TOPO TA cloning Kit (Invitrogen) according to the manufacturer’s recommendations. Colonies are picked at random and are selected for further work via plasmid preparation with the QI Aprep
Mini-Prep Kit (Qiagen), followed by digestion with Eco RI to show the size of the insert in these clones. Clones containing the expected 1kb insert are progressed. The polynucleotide sequence of selected clones is determined using an ABI 377 automated sequencer. Database searching is performed using the Blast algorithm (Altschul ef al., 1990) and indicates that the majority of sequenced clones contain partial length cDNAs exhibiting high homology toward known plant EPSPS sequences.
Example 18 Isolation of a genomic polynucleotide sequence encoding soybean EPSPS.
A soybean genomic library constructed in Lambda Fix II is purchased from
Stratagene and 1,000,000 clones are plated out according to the suppliers protocols. Hybond
N+ filters are used to make lifts from the library plates and these were processed according to the protocols supplied by AmershamPharmacia and Molecular Cloning - a laboratory manual (Sambrook et al., 1989). UV cross linking of the DNA to the membrane is carried out using a UV Stratalinker (Stratagene). The soybean EPSPS cDNA probe is prepared by digesting the clone containing the soybean EPSPS partial length cDNA sequence with Eco
RI and purifying the 1 kb product by agarose gel electrophoresis. The probe is labelled with *P dCTP using a Ready-To-Go™ DNA labelling kit (AmershamPharmacia). The filters are prehybridised and hybridised in Rapid-Hyb Buffer (Amersham Pharmacia). Washes are performed using 0.1 x SSPE, 0.5% SDS at 65 °C. The filters are then wrapped in Saran wrap and exposed to film in a cassette containing an intensifying screen as described in Molecular
Cloning - a laboratory manual (Sambrook et al., 1989).
Hybridising plaques are picked into SM buffer, replated at lower density and rescreened through 2 further rounds of purification. Phage DNA is recovered from plaque pure phage stocks using methods well known in the art (Sambrooke et al. 1989). The recovered phage DNA is digested with Not 1, and the genomic DNA subcloned into pBluescript. The resulting vector is transformed into TOP 10 E.coli. The resulting clones are sequenced using the Genome Priming System (NEB) using protocols provided by the manufacturer. Briefly, sufficient batches of 96 GPS events are selected and DNA prepared using a Qiagen™ Biorobot. The DNA was sequenced with the GPS-S and GPS-N primers as supplied by NEB using an ABI 377 automated sequencer. Sequence data are analysed using
Seqman (DNASTAR Inc). The gene encoding EPSPS is identified by homology to known
EPSPS genes using the Blast algorithm. The sequence of two contigs containing sequences showing high homology to known EPSPS are given in SEQ ID No.37 and SEQ ID No.38
NE -31- and are termed GmEPSPS1/14 and GmEPSPS12 respectively. A schematic representation of : these genes is given in Figure 3 and Figure 4.
The person skilled in the art will know that there could be other EPSPS genes present in soybean and that these may be isolated and the nucleotide sequence determined using similar methodologies as described in this example.
Example 19 Production of plant transformation vector harbouring the soybean EPSPS
The two enhancer combinations FMV35S90 (SEQ ID No.37 and FMV35546 (SEQ
ID No.38) are synthesised chemically and subcloned into vector pTCV1001 (Figure 5) using
Hind I / Pac 1. The soybean EPSPS terminator, and a small region of the coding sequence, are obtained by PCR using the primers GmTermBam (SEQ ID No.39) and GmTermEco (SEQ ID No.40) using clone GmEPSPS 1/14 as template. The PCR product is cloned into pCR4-Blunt-TOPO, sequenced, and excised using Pst1 and EcoR1 and ligated into the pTCV1001 vector containing the FMV/CaMV35S enhancers. Finally, the Pacl:BamH]
DNA fragment containing the majority of the soybean EPSPS gene in either GmEPSPS 1/14 is excised and cloned into the pTCV1001 vector comprising both the enhancers and terminator.
Example 20 Introduction of mutation into EPSPS gene.
The desired Thr to Ile and Pro to Ser mutations required to increase tolerance to glyphosate are inserted into the construct in the following manner. Primer BaMUT2PST (SEQ ID No.41), which contains the nucleotide changes that give rise to the desired amino- acid mutation, is used in conjunction with primer BaMUTKPN (SEQ ID No.42) in PCR with pfu-TURBO polymerase (Stratagene) with GmEPSPS 1/14 as template. The PCR product, now containing the desired mutation, is cloned into pCR4-Blunt-TOPO and sequenced. It is then excised as Kpn 1 Pst 1 and used to replace the corresponding fragment in the construct in pTCV1001 containing WT sequence. The final vector is termed pTCVGMEPSPS (Figure 6).
Example 21 Introduction of 5° UTL.
An additional 5° UTL, such as that from the small subunit of ribulose biphosphate carboxylase/oxygenase (Rubisco) or tobacco glucanase can be inserted into the construct by
PCR. In addition the context surrounding the AUG translation initiation codon is optimised to give the consensus Kozak sequence ACCAUGG. With regard the SSU rubisco leader, primers GmRubPac (SEQ ID No.43) and GmRubbot (SEQ ID No.44) are used to introduce the soybean rubisco 5” UTL into 5° UTL of the soybean EPSPS gene. GmRubTop (SEQ ID
No.45) and GmRubKpn (SEQ ID No.46) are then used to introduce the soybean rubisco 5’
UTL into the first exon of the soybean EPSPS gene. The two PCR products are then joined, by PCR using primers GmRubPac and GmRubKpn and the resulting product cloned into pCR4Blunt-TOPO and sequenced. Once the authenticity of the PCR product is confirmed it is excised from the PCR4 vector as Pacl:Kpnl and used to replace the Pacl/Kpnl restriction fragment in vector pTCVGMEPSPS.
These examples outline the construction of a DNA sequence comprising two enhancers fused to a soybean EPSPS gene containing specific mutations in the coding sequence that is capable of producing a glyphosate resistant EPSPS enzyme in plants. The person skilled in the art will know that enhancers may be introduced at various distances up stream from the promoter and transcriptional start site to act to enhance the rate and/or amount of transcription of the double mutant EPSPS soybean gene in plant cells. The distance may have to be determined empirically for each individual gene. This involves making a number of constructs where the enhancers are fused at different distances from the transcriptional start of the double mutant EPSPS soybean gene and introducing these constructs into plant material and assaying the material for resistance to selecting concentrations of glyphosate. The person skilled in the art will also know that enhancer choices are not restricted to CaMV 35S and FMV enhancers, but may also include enhancers from any gene that is highly expressed in plants including inter alia, enhancers from actin genes, ubiquitin genes, mannopine, nopaline and octopine synthase genes, genes from commelina yellow virus and other plant viruses expressed in plants such as potato virus Y and X coat proteins. The choice of 5’ UTR may not be restricted to soybean small subunit rubisco and leader from other genes may be used.
Example 22 Plant Transformation and Regeneration.
The expression cassette is excised from the pTCVGMEPSPS vector using Xma 1 and ligated into a binary vector pBin19 at the unique Xma 1 restriction site. The binary vector, containing the desired expression cassette transformed into Agrobacterium tumefaciens strain
LBA 4404 using the freeze thaw method of transformation provided by Holsters et al., 1978.
Tobacco transformation and whole plant regeneration are performed using Nicotiana tabacum var. Samusun according to protocols in Draper et al (Plant Genetic Transformation,
Blackwell Sci. Pub. 1989). Transformation events are selected on MS-media containing kanamycin.
Alternatively PTCGMEPSPS, or other constructs capable of delivering glyphosate resistance in plants by the expression of a glyphosate resistant EPSPS gene from soybean may be introduced into plants directly without using Agrobacterium mediated techniques as described for Soybean in a number of references including the following: Physiol. Plant. (1990), 79(1), 210-12; USP-5,968,830; WO-0042207; and USP-5,959,179 and as described in Example 13.
Example 23 Analysis of Transgenic Plants
PCR analysis of transformants
Leaf samples were taken from transformed lines and DNA extracted according to known methods. Oligonucleotide primers are designed to specific regions within the transgene to enable its detection in the plant material tested.
RNA analysis :
The presence of mRNA encoding the transgene is detected within the plant using Northern
Blot hybridisation. Total RNA is extracted from leaf tissue using Tri-reagent and protocols provided by the manufacturer (Sigma™). Blots are prepared using existing procedures and probed using radio-labelled soybean EPSPS cDNA.
Protein Analysis
The presence of recombinant protein in the transgenic plant is determined using Western blotting procedures with antibodies raised to recombinant soybean EPSPS using standard protocols.
Enzyme assays
Resistant EPSPS activity is detected in plants using "“C radiolabelled substrates and detection of products by HPLC.
Herbicide tolerance tests
Following tissue culture, transgenic plants are transferred to 5 inch pots containing John
Innes potting compost no. 3. The plants are allowed to acclimatise (approx. 2 weeks) in the greenhouse and formulated glyphosate applied at various concentrations to the aerial tissue using a track spayer. Visual assessment of the transformed plants to identify those that are resistant to glyphosate is performed 21 days post application.
Example 24 Introduction of plastid targeted pyruvate orthophosphate di-kinase (PPDK) or phosphoenolpyruvate synthase (PPS) constructs.
The cDNA encoding PPDK from maize (EMBL Accession J03901), containing its autologous transit peptide sequence, is amplified by RT-PCR from maize tissue using primers ZMPPDK 1 (SEQ ID No. 47) and ZMPPDK2 (SEQ ID no. 48). The RT-PCR product is cloned into the vector pPCR2:1 TOPO and sequenced to check for authenticity. The maize
PPDK gene is excised from the pCR2.1 vector, as a Nco 1/Kpn 1 fragment and ligated into similarly digested pMJB1 (Figure 1). The plant expression cassetee is then subcloned into the pTCVGMEPSPS cassette (Figure 6) prior to further plant transformation. Other PPDK genes, such as that encoding a cold-stable PPDK from Flaveria brownii (EMBL accession AAQ94645) or form rice can be engineered using a similar strategy. Likewise, the gene encoding PPS in E. coli (EMBL Accession X59381) is amplified by PCR using oligos
ECPPS1 (SEQ Id No. 49) and ECPPS2 (SEQ ID No. 50). The PCR product is cloned into plant expression cassette containing a plant operable promoter (such as the cauliflower mosaic virus 35S promoter), a chloroplast transit signal sequence (such as that from the small subunit of rubisco) and a terminator (such as NOS).
Brassica napus genomic DNA encoding an EPSPS (SEQ ID No.1) geatgcagatcttaaaggctcttticcagtctcacctaccaaaactataagaaaatccactigetgtetgaaatageegacgtggataaag tacttaagacgtggcacattattatigactactagaaaaaaaactcatacaccatcgtaggagttgggatiggtgaagaatttgatgpste cctetecceeccecactcaccaaactcatgttetttgtaaagecgtcactacaacaacaaaggagacgacagttctatagaaaagettte aaattcaatcaatggcgcaatctagcagaatctgecatggegtgcagaacccatgtgttatcatcteeaatetetccaaatccaaccaaa acaaatcacctttctccgtctecttgaagacgeatcagectegagettcttegtggggattgaagaagagtggaacgatgetaaacggtt ctgtaattcgeceggttaaggtaacagettctgtticcacgtccgagaaagettcagagattgtgcticaaccaatcagagaaatctegg gtotcattaagetacecggatecaaatctetctecaateggatectecttctigecgetetatctgaggtacatatacttgettagtgttagge ctitgctgtgagattttgggaactatagacaatttagtaagaatttatatataatttttttaaaaaaaatcagaagcctatatatatttaaatttttc caaaatttttggaggttataggcttatgttacaccattctagtctgeatctttcggtttgagactgaagaattttatttittaaaaaattattatag ggaactactgtagtggacaacttgtigaacagtgatgacatcaactacatgcttgatgegttgaagaagetggggcettaacgtggaacg tgacagtgtaaacaaccgtgcggttgttgaaggatgeggtggaataticccagettcecttagaticcaagagtgatattgagttgtacctt gggaatgcaggaacagccatgegtecactcaccgetgeagttacagetgeaggtggcaacgegaggtaaggttaacgagttttitgtt attgtcaagaaattgatcttgtgtttgatgcttttagtttggtttgtttictagttatgtacttgatggggtocctagaatgagggaaagacctat aggagatttggttettggtcttaageagcettggtgctgatgtigagtgtactetiggcactaactgtectectgttegtgteaatgetaatggt ggccttcecggtggaaaggtgateticacatttactctatgaattgtitgeageagtctttgticatcacagectttgetteacattatttcatcet tttagtttgttgttatattacttgatggatctttanaaaggaattgggtctggtgtgaaagtgattageaatetttctcgattecttgecagggee gtgggcattactaagtgaaacattagectattaacccccaaaatttttgaaaaaaatttagtatatggecccaaaatagtttttaaaaaatta gaaaaacttttaataaatcgtctacagtcccaaaaatcitagagecggecctgcettgtatggtitctegatigatatattagactatgttttga attttcaggtpaagetitctggatcgatcagtagtcagtactigactgeccteetcatggeagetectitagetetiggagacgtggagatt gagatcattgataaactgatatctgticcatatgttgaaatgacattgaagttgatggagcegtittggigttagtgccgageatagtgatag ctgggatcgtttctitgtcaagggcggtcagaaatacaagtaatgagttctittaagttgagagttagattgaagaatgaatgactgattaa ccaaatggcaaaactgattcaggtcgcectggtaatgcttatgtagaaggtgatgettetagtgetagetacttcttggetggtgetgecatt actggtgaaactgttactgtcgaaggtigtggaacaactagectccaggtagtitatccactctgaatcatcaaatattatactcectecgtt ttatgttaagtgtcattagcttttaaatittgtitcattaaaagtgtcattttacattttcaatgcatatattaaataaattttccagtttttactaattc attaattagcaaaatcaaacaaaaattatattaaataatgtaaaattcgtaatitgtgtgcaaataccttaaaccttatgaaacggaaacctta tgaaacagagggagtactaattttataataaaatttgattagttcanagtigtgtataacatgttttgtaagaatetaagetcattetctttitatt ttttgtgatgaatcccaaagggagatgtgaaattcgeagaggticttgagaaaatgggatgtaaagtgtcatggacagagaacagtgty actgtgactggaccatcaagagatgcttitggaatgaggcacttgegtgctgtigatgtcaacatgaacaaaatgectgatgtagecatg actctagcegttgttgetctettigecgatggtccaaccaccatcagagatggtaaagceaaaaccetetctttgaatcagegtgttttaaaa gattcatggttgcttaaactctatitggtcaatgtagtggcetagetggagagttaaggagacagagaggatgattgecattigeacagag cttagaaaggtaagtttccttttctetcatgeictctcattcgaagttaategtigeataactititgeggttitittittgegttcagettggage tacagtggaagaaggttcagattattgtgtgataactccaccagcaaaggtgaaaccggeggagattgatacgtatgatgatcatagaa tggcgatggegttctegetigeagettgtgctgatgticeagtcaccatcaaggatectggetgeaccaggaagactticeetgactactt ccaagtccttgaaagtatcacaaageattaaaagaccctttcetctgatccaaatgtgagaatetgttgetttetettigttgecactgtaaca tttattagaagaacaaagtgtgtgtgttaagagtgtgtttgctigtaatgaactgagtgagatgcaatcgtigaatcagttitgggccttaat aaaggptttaggaagctgcagegagatgattgtitttggtegatcatetttgaaaatgtgtttgtttgagtaattttictagggttgagtigatt acactaagaaacactttttgattttctattacacctatagacacttcttacatgtgacacactttgttgtiggcaagcaacagattgtggacaa tittgectttaatgganaggacacagtigtegatggateatttgtggacgaticatgtetegtiaggteatitgtggacg gatgatgtgtag atgagtgatgagtaatgtgtgaatatgtgatgttaatgtgtttatagtagataagtggacaaactctetgttttgattccataaaactatacaa caatacgtggacatggactcatgttactaaaattataccgtaaaacgtggacacggactctgtatctccaatacaaacacttggcttctica gctcaattgataaattatctgeagttaaacticaatcaagatgagaaagagatgatattgtgaatatgarscggagagagaaatcgaaga agcgtttaccttttgtcggagagtaatgaattc
BnEPSPSS5 (SEQ ID No.2) gcatgcagatcttaaaggctcttttccagtce :
BnEPSPS3 (SEQ'ID No.3) gaattcattactctccgacaaaaggtaaacge
BnF1 (SEQ ID No.4) gcgcaatctagcagaatctg
BnF2 (SEQ ID No.5) tccttcttgecgcetctatet
BnF3 (SEQ ID No.6) gegttgaagaagetggggct
BnF4 (SEQ ID No.7) acctataggagatttggtto
BnF5 (SEQ ID No.8) actaagtgaaacattagcct
BnF6 (SEQ ID No.9) gttccatatgttgaaatgac
BnF7 (SEQ ID No.10) tccactctgaatcatcaaat
BnF8 (SEQ ID No.11) gtaagaatctaagctcattc
BnF9 (SEQ ID No.12) tcatggttgcttaaactcta
BnF10 (SEQ ID No.13) cagcttgtgctgatgticca
BnF11 (SEQ ID No.14) cgatcatctttgaaaatgtg
BnF12 (SEQ ID No.15) ctctctgttitgattccata BnXho (SEQ ID No.16) cgcatcagcctcgagcttettegtg :
BnMUTBot (SEQ ID No.17) ggtgagtgaacgcatggcetatteetgeat
BnMutTop (SEQ ID No.18) atgcaggaatagccatgcgttcactcace
BnNde (SEQ ID No.19) catttcaacatatggaacagatatc
BnRBSEP (SEQ ID No.20) ccegggatattggangttanaggaraagagagaaagagaaatctitctgtotaagtgtaattaaccatggegeaatctageagaatctg c
Brasr12 (SEQ ID No.21) : ggacgtggaaacagaagctg
Bras rl11 (SEQ ID No.22) : {ctcaaaccgaaagatgcag Bnapus start rev (SEQ ID No.23) ggttgaagcacaatctctgaagcticcatgg
Genome walker 1 (SEQ ID No.24) gatcttgggtcattttaatggpcctictaac with the AP1 primer
Genome walker 2 (SEQ ID No.25) aaataaacccattaaccactaatgaaaaagggat with the AP2 primer
CaMV343 (SEQ ID No.26) ocggagctogagactiticaacasgeg
CaMV46C (SEQ ID No.27) atcccgggaagcatgegaaggatagigggattgtg
BnGUSXma (SEQ ID No.28) cgeecegggattgaatttbaaage
FMV enhancer (SEQ ID No.29) tctagagcagetggetigtegggaccagacaaaaaaggaatggtecagaatigttaggegeacctaccaaaageatetttgectttatt 3 geaaagataaagcagattcctctagtacaagtggggaacaaaataacgtggaaaagagetgtectgacageecactcactaatgegta tgacgaacgcagtgacgaccacaaaagagetc
CaMV35S enhancer (SEQ ID No.30) tgagacttttcaacaaagggtaatatccggaaacctccteggaticcattgcecagcetatetgteactttatigtgaagatagtggaaaag gaaggtggctcctacaaatgccatcattgegataaaggaaaggccatcgttgaagatgectetgeegacagtggteccaaagatgga cccccacccacgaggagceatcgtggaaaaagaagacgttccaaccacgtcticaaagcaagtggattgatgtgatatctecactgacg taagggatgacgcacaatcccactatccttcgecaagacccttc
Soyabean genomic DNA encoding an EPSPS (SEQ ID No. 31) aaaaaataccttttagtaaaataagagcgtragatcaatcagacgttttctcttigggacttctcaticttaattgaattgacaataactaaagt gaaactaaggctaaaatcaactcgectagtcaagcetcgtccacaaaaataggtttitgaaagtttaccatgtcagtttcttactaagtaaaa aaggatcatttgtaaggtccaacgccttaaaatgatcaccettcaaagtaaaagaatcacttgtttcacgcataagtaagaactacgtagg tctgatttcctctccaaaggagggtacgtaggagcaaaagecccegcettttgtcgaccttaaaaaataaaaagaaacaaaagttaaggta acacaatttccacaattctagaaataaggttgttgtctttcgagacaaacgtaagaggtgctaataccttcctcaaacgtaaatacaactce cgaacttagaattttcattttgaccggtticcticggttticccgacgttttccacaaataaacgttggtggcgactecgegcatctticcteet ttggaaagcgcacccatgagectcgecctegetegecegegaagggeacgttgegacactaggttaataagaagtttagtcecacatat ctatggacctcttaaggtgattatcaaagtggaagtggtgacctacatgttggeectaccagcettattcgtatatttacccecatcaaccat gtatctcagctgaaacatgctatcaatccaaatgttatcagaggaacatgagctgcatgticaaccagaagtagttctagtcttaatacaa atgtcaaatggcacaagtgagattttgaattictgatgttgtaaaaatctcaggacatgaatactattgggaagcaattattcatacttcace aatccaaactgacccaaaattctcaaatcacatgaaagcaaaaatgcatataacacgaagaataagaagaagaggaactaacctggg gtttcgatgattaaagegttgtigtigatgatgaaaacgatgattatggagagaaatigiigtigaatggigaaatigttatagaaagagaa cgaagatagagaaaaagatatatagatttticaaggctcaaaccctaaaatcaccatgagagagaacaaagattgagaaacctacaac cactatgagagagaatgagcagaacagaagcgtgagatagagaacgagagttaaggtgcgagaggacacgaagaacaaaaggtg tgagaganagaacaaaggagcetacggtgtgagatgagagaatitganatictiaccatitaggtggaatticaattctacaatitatict attaaaattattttaaaaaatgatgtcattitaaaticttiaaaatctcatatccaacaactgaattatgatagaggtatttcaaaticacttaaaa aaattatcttatttaaataccccatccaaacatagcgaaatgticatgagaaggatcaagtggtttggaaacatagtactaatggtotttata cagttcatggaatcctigatagataatttaaaggttgctggaaatiggatgaaggtgtggagattaaataticticcaaaaataaagegtttt atttggagagtgttgtgtggtigictccectgtaggcaaaageticgatgtaaaggagttcaatgtccaataacctatgctitctateccteg attattgaaaatgaatgacacattttatttggttgaaatcaagaaataagcatgtggcaagcaacgggtatttgacaaticatagaacaaaa ggtgaatgcagcaaaagaattaatgaactcctittcgatctacttggatcactacatggagatattatcaacaaatttgatgttactttatgg agcagttggaattcttggaatgacaagatatgaaatgaacataccaaccctectettgttictgtttcggtttctatgcagtatittgttgaatg gcaaagtgcaaggtaatatgctectcaacatcaattaacaaatgttcatgacatctettaccagctceaacttggggacgtttgacaaaca ccaccgtcaagittecttaaatgeaacattaatgtigeteatiicaaggagpagaatagtittggtetcggcatgatactccatcaaggaag attcgtcaaagctcactcacgttticgacatgggtcgacatgggttacctgacccaaaggetgaggcttaggettgggtttocttcaagta ttgatctgggcccagactattggtttacataatatcattittgaaaacctaacaictaaaactcaaggtigtttagaggtgegecattccaaa ataagattatcctatttgtgcatgaatgcgaccaactatctectgtttcageattataaagtataaacaacaaactictttaatcaagggacta aaagatattggacatacaagctaaaagtgatagaatttgagaaaacaaatattgacaacaatattcaagaggacactaaaacataattct caaattitttttgtttatttaaaataaagtggttcattaggtagctcttgaaaaaaaaaagtgattaacatgctagtacatgttaaaaaaagtga ataatattctattataagtaaagaggaataatttatcgatgtctcatttttgagatagttcaccgaagccaatttttttacttttttctcttcaatca attttattttgttaatagttgtcattgtggatggattataataattitgaaatgattiaaaatgagatatatattaataaatttaattaattcataaata tettactaaatataaatticatggtatactcaggacggitatancggaaatcaaataaataataaaatagaataatatiaattigeagtaaaa agaataatattaatttattctgtttacactatgtataacgaaattaaatatattcatttaatatgattitattttictitaatitaaaaacatgaattattt gtttcttattttattaccatttigttcacttctcaattaataaaataaaaatatattctacaattatagtaaaaaggtttaattitatataatgttagca tacagatttttctctattaactaattaattaaaaattatccttatittaaggaaattaaaaattatcatatatatataagttttaaattaattatcttata tatgtaccaaaaagttttaaagcaattattataaaaattaataaatttatcatataaaataatttataattaaattitaaattatcaattcattaaatt aaattatttaaaatititgaatgataatataataattttatectctactaagteccaacgtitcetatittattccactittageaataaatittgtcat aaacacttataacaaaaaaagtaagtaaaaaataaaaaaaagtitttcaataaagtataaactaatttgtataaacttttagaaaaaataaag ttatacattgataatataaattttttacataattatccgatcaactcattatatatgataaatttattgatittttaaaataattatcttaaaataattta aacaatgatttgcaattagatgataatataaaattattttacacactacatgtattaaactcaaacttttatatattagtttttctaaaaactaatttt taactcaaaaaaaatgttacttataattttcttatcticttttittataagtattttttaagaaatttattgaaacatgaccatgcttgggtcaataat actactctcttagacaccaaacaacccttcccaaactataatctaatccaaaagecatcattcattttccttggtaggtaaagttccaagace ttcaccaactttttcactcaattgttttggtgtaagcaattcgacatgtgttagtgttagttggcaaccaaaaatecctttatgtgactcaatee aacaaccactcacaccaccaaccccceataaccatttctcacaataccettcatttacacattatcatcaccaaaaataaataaaaaaaace tctcatitcagagagagagagagagacttcacagaccaaagtgcagagaacaacdnagticacaactttaaggaaaatigaaatggeo cangigagcagagtgeacaatctigetearageactcaaatttitggecaticticcaactocaacaaactcanatoggtgaatteggtite attgaggccacgcctttgggggpcctcaaaatctcgeatcecgatgeataaaaatggaagcettiatgggaaattitaatgtggpoaagg gaaattccggegtgttiaaggtttctgcatcggtegecgecgeagagaagecgteaacgtegeeggagategtgttggaacecatcaa agacttctcgggtaccatcacattgccagggtecaagtcetetgtccaategaattttgettctigetgetetctetgaggtgaagtttatttatt tatttatttgttigtttgtigttgggtotgpgaataggagtttgatgtgtagagtggattitgaatatttgattttitittgtattatictgtpaaaatg aagcatcatgtcccatgaaagaaatggacacgaaattaagtggcttatgatgtgaaatgaggatagaaatgtgtgtagggttitttaatgg " gtagcaataagcatattcaatatctggattgatttggacgtttctgtataaaggagtatgctageaatgtgttaatgtatggettgetaaaata ctcctaaaaatcaagtgggagtagtatacatatctacagcaaatgtattaggtgaggeatttggettctetattgtaaggaacaaataatat cagttaatgtgaaaatcaatggttgataticcaatacattcatgatgtgttatttatatgtacctaatattgactgttgtttttctccgcaatgace aagattatttattttatcctctaaagtgactaattgagttgcttactttagagaagttggacceattaggtgagagegtggggggaactaatc ttgaatatacaatctgagtcttgattatccaagtatggttgtatgaacaatgttagcetctagaagataaacectcccccaaaacacaaatta gaatgacatttcaagttccatgtatgtcactttcattctattatttttacaacttttagttacttaacagatgtcttgttcagcataaattataatttat tctgttittttttagggaacaactgtigtagacaacttgtigtatagtgaggatattcattacatgettggtgcattaaggacccttggactge gtgtggaagatgacaaaacaaccaaacaagcaatigttgaaggetgtgggggattgtiicecactagtaaggaatctaaagatgaaate aatttattccttggaaatgetggtactgcaatgegtectttgacageagetgtggttgctgcaggtggaaatgeaaggtetgttttttttittit gttcagcataatcttigaattgttceicgtataactaatcacaacagagtacgtgticticttcctgttataatctaaaaatctcatccagattag tcatcctticticttaaaaggaaccittaattatcaatgtatttatttaatatitaaattagctigtcaaagtctageatatacatatittgattatatt ctgagaaatgcacctgagggtgttcetcatgatctacttcaacctctgttattattagatittctatcatgattactggtitgagictctaagtag accatcttgatgitcaaaatatttcagctacgtacttgatggggtgcccegaatgagagagaggecaattggggatttggtigetggtett aagcaacttggtgcagatgttgatigctitctiggeacaaactgtccacctgttegtgtaaatgggaagggaggacticctggeggaaag gtatggtitggatttcatttagaataaggtggagtaactttcctggatcaaaattctaatttaagaagecteectgttticetcictitagaataa gactaagggtaggtttaggagttoggitttggagagaaatggaagggagagcaattttttictictictaataaatatictttaatitgataca tttittaagtaaaagaatataaagatagattagcataacttaatgttttaatcttitatttatttitataaatattatatacctgtctatttaaaaatca aatatttgtcctecatteccttteccticaaaacctcagttceaaatatacegtagttgaattatattitggaaggectattggttggagactttt ccttttcagagattatccetcacctitattatagectttetatttttaaacticatatagacgcceattettgttttaaaaaacactaagttttctitta gttataccttccectecttattctctecaaagtaaatattgtageaagtgitggttgatecattgigaatcttattatectatttaacatgeaggt gaaactgtctggatcagttagcagtcaatacttgactgcetttgettatggeagetcectitagetctiggtgatgtggaaattgagatigttgat aaactgatttctgttccatatgttgaaatgactctgaagitgatggagegttttggagttictgtggaacacagtggtaattgggataggttc ttggtccatggaggtcaaaagtacaagtaggtitctatgitttagtgttacatcacttitagtatccaaaatgcaatgaaattaaaacteatgtt tectattaggtetectggeaatgcetittgttgaaggtgatgcettcaagtgecagttatitactagetggtgeageaattactggtgggactat ’ cactgttaatggctgtggeacaageagtttacaggtattcatgaatgacactatcttctattatcttttatittatagettacactatcattectaa ttcaacccccttettttctetttccecteactcecaaaatagagettateattgtatecttaatagetettttatgtgetgtitcatetettgageag attctacatgattatcctttttagtgaacttttitgtcttitaaataattgatatcatcatttgaacttgcacatcatctctatecttecteattttattat atttcattaagagtgataaaattacattgicaagtaaagcaagttagcgtatcagataatgatgettcgatigeagaattggtgaaagettg cacaattcattagcttagtgacaattgtgatgtagatagccataatcttccatgeaacttattatgetttttgtctaaaacttcttttgeacttaaa catgaattagagagttaggatgaacaatagtaacagacacaaagcttatttctagaccacccagiggtgaagacgaagcageatgagt gagattaatggcagcatctgattgaagcttetttiggtattattggagatgaaatcttgagccaaattagggcttttgectectcaatageca ttggttcaaaattgctttcaataaaatgattacagaatcaaattcttaagaaagaccticaagaacaacatcaagatgtttcctgtgcaaaac aggctcacctacaaaagagtgtctacaageacctttacacttgcaaaaaattccttaactgaacaattgecaagagtcatgttgcaaactt gagattggagttgattagattiggtgotgtetgagatictggaaatgagcatgaagttttttgcaaagctcataaaatgaatgcagecaaga atcctagataggattgaatttgagagagaggctigaagtcaagataaccgcaactgatettgetgticecatgetgeataggaciegtig attctaccaagataacaatcttctgtggtgagaatatgagtgggaattgicaggcaacaaagaaaatgaaggctatgagectttgttaag gtgcagagagaaaacagaaaatgaagaacttgtgtattgaaggaattgaaaagccaattacaattgtgttgcagagagatatttatagtt ctgaagtgtataactaactaaacagaatgctaccaacctagaggeagttgagaattgcteccttattacaatactctcacagecttgatgat aggcttgatttgctgeccaccgaagaagaacattattgttggagagtttticagtgattgcatcagagaaagttacaagtgtgattggagat gaaggacttgcggtegtcgaaggttaagtgttaagtggtggaatgtgtatcggaggtogtigectageecaagaagetggttgeagty gaagcggatgcggcagaagcecatgggttcagatcagaactatgttctagataccatattagggttagetttcaagagaaaacttatgaa actgaactgtaaactgttgtattattgattagctgatctagtagtgatggaagcttgcttgegaagettetatggaggetggateattgaget } tcaatgaggtccticaatggtgatttttcaccatggagatgcagcggaagataaatgaagaggtgagaggaggegtcatccactagga aataaactatggaagaaggagcttcaccaccaagagagtgtcttggataagaagcttagagaggaagcttcaatggaggaatagaaa gagagagggggaacaaaaaattgaaggaggaaaagagggagagaagttpaactitgaagtgtgtctcacaagactcatteattaaag ttacaacaagtgttacacatgcttctatttatagtctaggtaacttccttgagaagctagaacttaactacacacacctctctaataactaaga taacctccttgagaaatttccttgagaagettcettaagaagattcctagagaagcetaaagcettagttacacacacctctctaataactaagt tcacctcctigagatgagaagctagagecttagetacacacacccttataatagetaaactcactctattccaaaatacatgaaaatacaa aaaagttcctactacaaagattactcaaaatgtcctgaaatacaagactaaaactctatactactagaatggtcaaaatacaaggtccaaa agaaggaaaaacctattctaatatttacaaagagagtggacccaaccttagtccatgggetcagaaatctacectgaggticatgggaat cctagggtctictitagtagctctagtccaattitcttggagicttctatccaatatecttgggggtaggattgeatcatgtagtacaagagag gggaatatatatacagttgtaagtigtaactacctaatcaaacccaactgactcaccatacacagaaaaacaatgtacaaaggataatag aaaaactgaaactgagatatactcattacatagaagaattacatgatgaatctgaaaattttaattgggaaactgaggacaataacaagg ctttcagagttcatittgacaataggtaaattatggacttcaacttagacctcaagggtatgettgggagtegggtittagaggaaaagge panggaggganattititaatictagtaaatattcictatittgatiaatttttaaaatasaacasataaactiatagatiageaticactiaatgt cctgatcttttatttgtttcatgaagttittiatagccttictgttictgttaaaagaaattggagggtgticataatctatatgcccatatatatgta ttgtectgttgtetgtgtitetgtttictitetttagtgtetegectttecttaattccttatcaacaccttgtitatittigaaaacttaaatgtecteat tttttttacctgtactataactttccaaacaaatagtagaaaatgtttcaaataticcccagaactgtttcagtgaacaaagttcaagecagaa aaaaagcaagcagaggctaaagaagtatatcttattgtgaagagtaatcteaattggttaattatcgaattgtatcattttacaatagaaaat tagaagtgggttgattagtttatacgaacaattatttaaatagggttgatggtgtggttaattactgatcatatgtiaagactatgagtcgatg accagcctcagtgcagtcattttaagttceattattttitaattgtgcttatgtttaactttgtcctictittaaagggagatgtaaaatttgetgaa gttcttgaaaagatgggagctaaggttacatggtcagagaacagtgteactgtttctggaccaccacgagatttitctggtcgaaaagtet tgcgaggcattgatgtcaatatgaacaagatgcecagatgttgecatgacactigetgttgttgeactatttgetaatggteccactgetata agagatggtatggtitagctgtitgtitttgctcaagagctigttticacatatitgtggtcaagageggtitagetgtttttttttttaaatigtgg ttaatgaaattattataattatactaatattgaaattggatcactaaccatgtgaaatgcttgaatttttagettgaaaacttctitigtggatgatt tttcttttatctatgtagtgtggggcatctatgtigttectttaagetitgtgtcatagtigtacaacctggtetgtgggetggtecagttettact catgactgtcttttgcagcaaactggttaaacttgggtgacctgttgacccacccagattggectgttcttitttaaataaaactccaaaagg ctacttataagatttcaacatgatacttgaatgaccacccttactttaaaggtcatiatgecatcagaccectigatictetgttcagttatgtic : ttattcttattattttttaatttatattattatccaacgatctgatctttgtacatgatgetggacaatcatcaaagetagtttggttacatcatataa taccttttttttcataaattattttttcccataatatatttatatgtatttttitaatacaatattctggggaaatttittttttctgttttctittitctggtitg aatactatttcaatgactgggccttattattttctggtttgggttatacaactgtectttgatgtacttitgaatgeticaatagtatttttcataate atggaaggcactagagtgcagtgcatattgcacaaggttctitaatggcatctigaatitgitagaacatggagttatgatatacaaccatt cctatgtcttcatctaatagctaaagcettitggegtagttggttaacatggtattggaatcttattttaaaggtccatcttattcgcaagtacaa ggcaggtggacctgegcattattcacgtgecaggetcaaagggattitgtatgagpgggaatttttggaatataatatatagaatcattca tgtggttcacctatcatgtgtcaactcaagttittgtcctagttgtattattgeagtgtctaaactaggeatgatettetgtggaaggaaatita acctaaggaacttgaatgcttcttgtictgagatctttattitttttctccaatctttitaatacttgaaaggttttagtigtatctataaagggtge aganttaggggptcagcittictgtigtaagegteaattaagtgeatittatgttgticeotattttatacatitpaactatcaaccatateattta gcaaacttctitgttgctcagattcecatttatictigtticetctatittttagtggcaagtiggagagitaaagagactgagaggatgatage aatctgcacagaactcagaaaggtcttgctaattcetitatggtttctatattactggactttttacatctcactgacctactactgtcttggtat ttcagctaggagcaacagttgaagaaggtcctgattactgtgtgattactccacctgagaaattgaatgtcacagctatagacacatatga tgaccacagaatggccatggcattetetcttgetgetigtggggatgttceagtaaccatcaaggatectggttgeaccaggaagacatt tcctgactactttgaagtccttgagaggttaacaaageactaagceattttgtacattgagtagggaagagagagagatatatataaatact cacaaagcagtgagtatatggcttgcttttgttictaaacattectttataaggacttgagataattigtattgtitaaaagagcecattggttct gitgtatcaaagtaatttaattttcagtaccgactiggetctactcatatgtggtggtatacattgeatettigeatttgaticeatatctattgg gatgggaccatacattttttgtttattatttaagtcaaacatatcagataatatgtggtgaccagaaaagtgictagcaatcaaatgggtetgt gattgcatgtttgagttcaggacatttattaatgagtgacagaattitaaaaagcetcgecaataggagtigecacatetgategagtettetg taaacactaactgtaacttgagtttgataatcagattccccccgttggtaggtaatatgtaaatttcactatagattcttactgaggatgatgg tcttgacttcgaagtggtgagtgtaaticictaatctaaactttatatatatataaaaaaagaatgttaaaaacttgagtgacatacagcaaat agcaatgaaagcatgaccatggectiggggggccaaatggecatgtaccacttttccacctacttgagagecatggtectgaatgag gt ccttttgtttcattttttitacaataaagaaagttcatattctiggcaatagcaaggcaaatcatttgtggaagtcacatgaaattcaccatagg cttcattgttcaaatectttagtcactaaggcagggcectatgtaagaattttgactactcttgtaaatgetgtgeggtaaagactacgggaa aatataaattattgcatatctagaggtgaggttcattictccgatccatttctccaagtaataaaaatatatataaattattaatatggtatgata oo -43 - tggttatttgtcctttaaatatgcgatiataggttcaatcttiggttaatctatcaaatgcatctcaatatttigagagaatagtitttagetctiga ctgagagatactttgagttaaaaaaatgtatttataaactattgtctattgaatttttattttttttgtaacaccacatgtgagtattttactaaatcc atgttacaatgtactgaatgttttacaatacagtctggtitgataataaaatatgcacaaagtecagettatgtaactcittcaaticatggaaa atgatgatatgcgaattgaaagaaagaaaaccataatgtaagtgtattttttttttcttictctictitaatattactcaatatcagatigcacatg ggaagggtactggctcatgtgggatattaatttttatcccttacctaaaaagagagaaagagaaaataactatttaaaaagagtaccacc accacctttttcgcttttaagttttgttctgttttcactactctttcatgegttgtttgttgacticcgatagtgacgaatatgataatgattitacgt tgagaaaaaaaatgtgccatgtaaattccagagattgaaattitagcticaaattaatatttattttattatcttticaaattggttgeatgtgaa agaatttgaagttcttcaacaaggaaataaacacttcaatgctcaatccttagagtcagtcactagatcccaaaagaatgtgatgtitacac acattagtatatatatatatataaacacagcttatattatattaatgagtgatgecgegaggacggtggtgacactacatggccaaaacaag aaatgtaatttaatttitttttctitaagtattactctatccttgaatattagtcttaaatcticaaagaccttgcgaacgaagcaatcttgtectga tectgtgattgttctacactagtecttacgtgtacctaageacatgatactttgetgecctaacataaattgtaccataaggattcttgggga gatgcttttgecttcattttcaagtttgtttacactttcaagtcgttttttcaatgcattctetttccetitctgggaceccttgtetttaacacgege geacacaaaaactagtagacaataattagtactactigggitecattaaatigtaactacatatacatgtgtititttttottggatcaactge atatacatatgttttatgagtttcattgaatttatatitacacaaacagttattaaaacataatgtagagccttgtcattaacctgatgttaggatt ataatttcatgctttgattttgattgtacgttitttgtttttatigtaaagtgtttattttattaaaatttgtcttggagtgetgtgatctttagggtgea ccgticaaaagagagacgacaaggataatactaatactagtagattccacgcattcaaccctagttagtitagctatgacaaattaageat ggtaagaaaaggggaggagaaaagtaagaatgaaaacatataacaaattgtgattgaacttttccatgacgtaatgaaaacattaatttt aagataagcttcaactcctaagaagagatatgtcaaagaaacttaggattttttctctatttataacggtaaattactcatccttttaaatgatt aattigcettpttpaaticgtigtaaaggganaatcaagangteicticacgggaaagttatatcaaagtateatatactagactteatgget agcttttactttgattataagtaatgcatgcaattaatgggeaaataaattatttgaaaccaactaaagtacaaataattitcctccaaaacct ctcaagttcgcattgaaattaaataaaccaatgcatattaaggcgtaaatctaaaccatgtttgtttcatctigtattgtatatcatagtattaat aaggtactttgaatttagttgttatigaccgttaaatttaggggtgagtigttttactatctcitactcaatigetittattcaacgcaaattctagt aggattttcagcccaaattaaaagaagttttacggtttgaticictacaaacttgaattgagattictaatttcagaaatcaataatigeggtet taattaactctataatcaaaccttttaacccaatcttttictcaattctctgaattaagacaatcaaaatttaaactcacacgaatctcacacge cttcccacggtagagaaatatagggagtcccttaatagecaaaagectcaaaattcagaaaatctcatccattgeatttgeacattcaacaa accacccattattatgttccettaataaatctcacacttaaaaaccetectcacceataattaacccaaaaggaagiticetccacacaaaa aatatccttaaacaaagagcctctataaatctattttaaaaaaacccccaaatttaagga
Soyabean genomic DNA encoding an EPSPS (SEQ ID No. 32) aaaagtctgaatgaagtgaagttgtigtgttagggpgatgetgaatitgatittaatttaatttaaataaattaccigigtaaaggatittigta ccgccttttaatcacaaattgtegtgtategaaagtttgtigaattttatagtaactatctiggaggttatacctagtaggatticigattagtta accatgtaaatttttttaatgggtitgtotttgtittaactgatgttgtttitgatatgtacgtggtaagtgtgatgagtitgtgeatatctigatca aagactgaagtgaagttgttgtgtitgggegttgactctittaggaagaggatttgagggaatticgecaatgggggageagaactce gggacaccctgagaattttgagactccgggaattgaagttacaacaggtttgatatgagttagagttigtataatagaatagtaattcttttt attttttattittattgtitatttatccattattgctatttttgtaggtectettggteaggggattgecaatgetgtiggtttggeccttgeagagaa geacttggetgcaagatacaacaagectgacaatgagattgttgaccattacacgtaaaaataactaaatcatacacaacttgcaagact ttagttgttggtetittgctaatggegttigttitatgcaggtatgetattetgggtgatggitgtcaaatggagggaattgeaaatgaageat getcacttgetggecactggggactggggaagetgatageattttatgatgacaatcatattictattgatggtaacacagagattgegtt caccgagagtgttgatagtegttitgagggacttgggtggcatgttattigggtaaagaatggaaataatggetatgatgatattegiget gecattaaggaagcaaaagcetgtcaaagacaaacccacattaatcaaggttagtttactaattgtggeaatgatatgeatagatttetgge tgtagttaccataacaatcataatcigteatgatttatagggattctittanactaaggttataaacatgatatgttactaaagactgcattge attgtagtacctcatttgagaaactggaagttataggtgggaaatcaaaatagtaaattatgggtcagittattaagtgtagetggtitgtctt ttgctaactctatcatttcacaggtcacaacaaccattggttatggttctcetaacaaggetaactectacagtgtgeatggaagtgeactg ggtoccaaagaagttgatgccaccaggeagaacciiggatggteacatgagecattccacgtgectgaggatgteaaaaagtatggat gatgggtttagagatticttttttcetgtgacactgetgatgtitataatgatactgaataagaattgettgtctgteccecaggeattggagte gecacacccctgagggtgctgeacttgaagetgagtggaatgetaagtttgetgagtatgaaaagaaatacaaggaggaageigeag aattgaaatctattatcaatggtgaattcectgetggitgggagaaageacttecggtgagtaaattctaaactcacaggtttiicttacatgt ttgtaactittcaaggttiggattacatactatccaaagttgatcatgatttcagttigattiggtagtatggggcticaaaaagttaticcaaat attaaaacctggcttccaatttgatticagacatacactccagagagceccageggatgecaccagaaacctgtctcaaacaaaccttaat gecettgeaaaggttettceeggtetgettggtggeagtgeagatettgettcticcaacatgacctigetcaaaatgticggggacticea anaggatactccageagagegtaatgtiagattcggtgtiagagaacacggaatgggagctatetgeaacggcatigetcticacagee ctggactgattccatattgtgcaaccttcttigtaticactgactacatgagaggtgccataaggetttctgegetgtetgaggetggggtta tttatgtcatgacccatgattcaataggacttggagaagatgggecaaccecaccageetatigageacctageaageticegggeaaty ccaaacattttgatgcttcgtectgecgacggtaacsgaaacagecsgageatacaaagtggeegtgetcaacaggaaagagacect ccattcttgeectatccaggeaaaaactgecccagettcecggaacttheattgaaggagttpaaaagggtggttacaccatticggpa canctccactggcaacaagectgatgtoatitigateggaactggticggaattggaaategetgecaaagetgetgatgacctaagga aggaagggaaggctgttagagtigtticectigtitettggggaactttttgatgageaatcagaagestacaaggagagtgtittccetg ctgetgtttcagecagagttageatigaggeaggatcaacatitgggtgggagaanatigtiggageaaagggaaaagcaataggeat tgatcgttitggagctagtgetccagetggaagaatatacaaagaatttggtatcactaaggaagetgttgttgetgeagetaaagagett atctagaacttttgattitittitgcctictggtittggttgagageattccatgtcatgaataagaaaaaggtiaaatatecticgattgg gaat ttgggatictaagtgaagaagcaacatagatcaaagaattitgtgaacttgtaataactattigacaatttagititgcactgecacatggtta aattcaatgtttgatcatatcaaccatagatgctagtitatactacttgtataattigtttcacttgeagattcactcttageatitgagtgtttgg atggccgtgttttgttcattaagaaatgtigacatggatagtitgttgcatggtaaattggtgatiaatacctititaagettcititggeaagtt gttaaaaagtgttttgitttaatctctagttaatctaaaaatgectacttattitatittgactttcaaaacttgtctatatgecgagtataaaaaaa acttgtctatataagttccttatggaaaaaggacctacaaaataatttaaaaatgctgaatttgttaggaagtttgacaacttiagacattaat aattgtttttttticatatatataattgactttcaaaacttgtctatatattataaattcgttatggaaagggegaccacacgtaaaacgtaacat gccaatctctccctagtgaactgttattcteattcagttttigtaagttcaccticaaattticaatittttitttgacaaaaatatctttgatggaac acgttaggggtgtaaattcaccaticatcatiicaticattatacacaatagtetticataatccaatganaactigtitttgttgttatitititctg aaaaatctitataaaataaataaaaacatitttitgttataaatttcagttgaaatacataaccattaattctacagagtgttaatgttgatgtaaa ataaaaaaatattggatatcaaacttaatgaacagaacaaaaattacaaaattgtacaatttaaatgataaaaaaccaaattcacaaaaata aaaattaaggacgaaatttgagaaatgataattaaaaacgattaaaaatataattaaactaaaatttattatgtaatictitaatatatatatata tatatatatatatatatatatatatatatatataataaaagttttacattataattttgaaatgaagtatttgataaacgaacaacccacccttggg gitggtgagagtgaaacggagaacagtgtctcecteacttggtettctgagtegagtectattcatcaccaaccecactegtcaaaattgtt gtatgctatgtaaccattttgtittttaataaataaaagtgttitgtictgctatgcactccecatcaaataccatttacttttttittgtctictatca atttctatttagttcctagttgctacaacttccagetggtgaaaaatagtcaacagagactacaatattctaataaaatagaataacaaaatc aaatatattcatttaatatgattttatttitatttaatttaaaacatgaattatttgtitcttatttaattaccgtttcgttcactictcaattaataaaata aaanattictacaatiatagaaaaagtttagtittgtagattgtiaacataaagatttticctattaactaattaattaaaagtcatctiatatataa gitttaaagtaattatcttatatatgtacccaaaagttttaaagcaattattataaaaaagtaanattitatcatatacaataatctataattacat gaaagtataatttitaaattattaatacgttaaaattattitttiaaaatttgaatgatcatatagtaattitattitataccaagtcccaacatttcet attttattccacttttaccaataaatttcctcataaacacttataagaaaaaaagtaagtaaagaataaaataagcttttctataaactataaac aaatttgtataaactticttatattagtttttctgaaaactaattitaaattatacataaattgaatttactgataatttittatttictttttgtataagtg ttttttaaganattigticaaacatatttitatgacatgtcaatgcttgagagatataaggtgagtiaaatcataaatgattaaagaaaaataaa agaagaaaaagataattaatttaattttttattaacattctaacaaattaacattatataaataaaaataatatticaataatiggatcaataatac tattgttcttaaacaccaaaccaaccttcctaaagtcctaatctaatccaaaagccateatteattitectiggtaggtaaagticcaaaacct ttaccaaccttttcactcaattattttggtgtaagcaattcgacatgtgttagtgttagttggcaaccaaaaacccetttatgtgactcactcaa tccaacaacctctcacaccaccaacceccccataactcataaggecaaaaccatttctcacaaaaccettcattacacacattattatcatt atcacacacacaaaaaacctctcatttcaaagagagagagagatticacagaccaaattgcagaggacgacaaagttcacaacttcaa ggaaaatcgaaatggceccaagtgageagagtgeacaatettgetcaaageactcaaattity ggycaticttccaayyccaacaaacy caaatcggygaaticggtttcattgaggccacgectttggggkscetcaaaatetegeateyygrtgmayaaaamtggaageyttat gggaaattitaatgyggggaagggaaaticcggortgtttaaggttictgeatesgicgecgeegecgeagagaageegtcaacgteg ccggagatcgtgttggaacceatcaaagacttotegggtaccatcacatigecagggteyaagtetetgiceaategaattitgettettg ctgctctetctgaggtaaagtttatitatitatitatttctgtatccaaaaatgtaaattgttagttgttaatitttgttageagtgagagtegaact acttggetictitctiagteatccaaccaacctiatatetceaaaatiiatitatiggtittitttggggtiatgtegttaggaataggagtitgatg cgtggagtggattitgaatatttgattitttittttitgtattattcagtgaaaatgaagcatctigicccatgaaagaaatggacacgaaatta agtggcgtatgatttagaatgatgatagaaatgtgtataggtggtittaatgtgiagcaataageatattcaatatctggatigatitggacg “ ttictgtataaaggagtatgctagcaatgtgttaataatgtctigttaaaagtatggatggctaaaataatcataaaaatcgagtgggagta gtatacatatctacaggaaatgtattaggtgaggcatttggettctetattgcgagtaaggaacaagtaatctcagttaatgtgaaaatcaa ) tggttgatattccaatacattcatgatgtgttatttacgggaacgcaatattgactgttgattttatctgcagetgagattatatactatatectt ccaaagaaatctttgactcttgattatccaagtatggttgtattaccaattitagctctagaagataatcectcceccaaaacacaaattaga atggtgctecaagttcegtgttactttcatictattatttttataacttttaattatitaatagatgtcttgttiggcataaactataatitattetgttit tttttattcttatttagggaacaactgtigtagacaactigytgtayagygaggatattcattacatgettggtgcattaaggacccttggact gegtgtggaagay gacmaaacaaccaaacaagceaattgtkgaaggetgtgggggattgtttcccactaktaargaatctaaagatga aatcaatttattccttggaaatgctggtactgeratgegtectttgacageagetgtrgtigetgcaggtggaaatgcaaggtetgttttitgt tttgtitgttcatcatgatctctgaattgttcetegtataactaatcacatcagactatgtgticticctccatectgttataatctaaaaatctcat ccagattagtcatccttctitaaatgaacctttaattatatctatgtatttatttaacatgtaaattagcttgtcaagtcaaagtctagcatataga tatactgattacactctgaggaatgcacctgagggtcttaatcatgatctatticaacctigecactttettctittattattagatcacctatcat gattactggtttgagtcictaaatagaccatcttgatgttcaaaatatttcagetacgtacttgatggrgtgececgaatgagagagaggee aattggggatttggtigctggtcttaagcarctyggtgcagatgttgattgetticttggeacaaactgtccacctgitegtgtaaatg gga agggaggacttcctggeggaaaggtatggtttggatticcattagaataaggtggactaactttcctggagceaaaattctadtttataceet etttccocctetttagaataagacactaagggtatgtitaggagttggetittegegaganagggaagggagggcaattitititctaataa atattctttaatttgataaattitttaaacgaaggaatatgaagatagattagcataacttaatgttttaatcttttatttatttttataaatattatata cctctatttaaadacaagatatttttcctecattecctttcectttaaaacctcagticcaaatataccgtacttgaattatattttggaaggtgta ttggttggagacctttcctittcagaggttatceeteacctitattatagectttctactctettaatgagtteatigigeattgagteattgaactt cctetganaaganattgtitactitciitattigtiacetacatccttaticetgtittanaaaatactangtitictittagttatgooticecctco ttattctctccaaagaaaatataatagcgaatgtiggtttatccattgtgaatcttattatcctatttcacatgcaggtgaaactgtctggatea gttagcagtcaatacytractgctttgettatggeagetcctttagetetiggygatgtggaaattgagattgttgataaactgatttetgtic catatgttganatgactctgaagttgatggagegttitggagttictgtggaacacagiggtaattgggatargticttggtccatggaggt caaaagtacaagtaggtttctatgttttagcattacatcacttittagtatccaaaatgcaatgaaatcaaaactcatgttitctatcaggtete ctggcaatgcttitgttgaaggtgatgcticaagtgecagttayttmetagetggtgeagearttactggtgggactatcactgttaatgg ’ ctgtggeacaageagtttacaggtattcatgcttgacactattttctattatcttttattitatggtetatactgtatcattectaattcaacceect tetttictetttccccteacttccanaaaaatagagcttatcattgtattcttaatagetctigtatgtcctttttcgtetctigageagattctace gtgattatcctittiagtaaactittititigtgtgtciittaaataatigatatcatcatatgaattcacacatcatctetatcecticeteattttatta tatttcattaacagtgataaagataaaaataaattgtcaagtaaagcaagttagcatgicagataatgatgcttcaattgeaaaattggtgaa agctigcacagtacattagetttggtgacaattgtgatgtagatagceataaccteccatgeaacttattatgtigitigettaaacttcttttg cacttaaacacggattagagagagtgaggatgaacaataataacagacacaaagcettagttttataccacccggeacceagtggtgaa oo -47 - gaccaagcagtatgagtgagatcaatggcageatctgattgaagcttettgtggtatttttggagatgaaatccgaggegaattagggea tctggcteaacaatagecattggticanactigettttaatanaatigatiacagaatcaaatictigaggaagecticaagaactacateat gatgticeetgtgeanaacaggttcacegacaaaagagaacatctacaagticetitacacatgecaaaaatiectcaactgaacaatig ccaagagtcatgttgegaacttcaggtiggagtigacgaaatttggtgcatgtatgatictggaaatgageatgaagtttiticctaagete ataaaagtgaatgcagccaagaaccctagataggattgaatcggagagaggcttgaagecaagataacageaactgatcttgetgtte ccatgetgegtaggactcattgattetaccaagatcacaatettctgtggtgagaaaatgagggtgaattgtcaaccaataaagaaaatg oteaaggctgagtctigatgatagectigattigetipogetgaagangaacgtiattgtigtagagtitctagtgattgtatgagagtaa gttacaggtgcgattggagatgacggacttgtggtgggaggaggataagtgttaagtggtogaatgegtatcagaggtggtigeeca occasagaagetggttgeggteeaggagatagtegtecagtggaageeatgggtitigatgctittgagaganaacatacgaaactg aactgtaaacttttgtattattgattagctgatttggtagtacaagagaggaatatatatacagttttaatgtaactacctaaccaaacatgag gaactctccatacacagaaagacgtatacaaaggataacagacaaacagaaacttagatatactcatacagagaagaattacaggatg aatctgagaattttaattgggaaactgaggaaaatagcaagggtitcagaaticattitgacgataggcaaatcatggacttaacttagac ctcaagggtacgettgggagtgggggtttitagaggganaagggaaggagggcaaacttttaattcctaataaatattctetttitigatitt tttttaaatanaacaaataaacttatagattagcatacacttaatgtcctaatcttttatttatttgcatgagtttitttcttttatattctitcigtiict gttttctttcttcagtgtctettgtctttecttaattcettatcaatacctigtttatitttgaaaacttaattitccteattitittaacttataggetata ctatagtatgtataactattcaaataaatagtagaaaatgtttcaaatattcccecagaactgtttcagtgaacaaagticaagecagaaaaa agaagtatatcttcttgtgaagagtagtctcaagtggitaattgicaaattgtatcattttagaatacaaaattagaagtggitigattagtttat acgaacgattatttaaatagggttgatgatgtggttaattactgatcatatgtgaagactgtgagtegatgaccageecagtgeagtcatit taaattccattattttitaatttgtgcttatgttaaactttgtccttctttcaaagggagatgtaaaatttgctgaagtictigaaaagatgggage taaggttacatggtcagagaacagtgtcacygttwetggacerecacragattytictggtcraaaagtcttgeraggeatigatgtcaat atgaacaagatgccagatgttgccatgacwettgeygttgtygeactattigetaatggtemmactreyatmagagatggtatggtit agctgtitgtttgtgticaagagctigttttaacaaattgttitttttaattatggttaatgaaattattataattacactaatatigaaatiggatca ctaaccatgtgaaatgcttgaatititagctigaaaacttetittgiggacaatititctittatctatggattgtgggecatetatgtigiteettt aagcttcgtacaacctggtctgtgggctggtecagiccticttactcatgacagtcttttgeagtaaactggtiaaactigggtgaccigttg acccacccagattggectgttcttittaaataaaacttggctacttataagatttcaacatgatacttgaatgatcaccettactctaaaggee attatctgticagttatgttcticticticttattattitiaatttatattatatccaacgatetgatctttgaacatgatgcig gacaatcatcaaag ctagtttggttacatcatataataccttttitttcatatattatttttcccatagtatattittgtgttittitticatacaatattatictgaaaaaaactt gtitcgtttttticctggettgaatgetatitcaatgactgggectiatiatitictggtitaggttatacaactgtectecaattgacttitgaatg cticaatagtittcticttaatcatggaaggcactagagtgcatatigaatatgttagaacatggaaggcttaaatatctttitagtctitgeaat ttaacgtitttttgcttttagtcetigeaaaattataatitittittagtectgactaattatgtttgtttigtittigagggcgagecctggtgeage ggtaaagttgtgeettggtgactigtiggteatgggticgaatccggaaacagectctitgeatatgeaagggtaaggetgegtacaatat cecteccecataccttcgeatagegaagagectetgggeaatggggtagaaaaagaagaatgetttagataacactitittigttactgtt caaagcactatctaaagtgctttgaggactaaacacaaaacaaacataatttgcaaggactgaaaaacaaaaaaataatittgcaagga caaaaaaacaaaaaaaaaaaacaaaattgcaaggaccaaaaatatatttaaaccaacatgaaattatggtataaaaccattcatatgteit catctaatagcttaagettttgggatagttggttaacaatatggtattagagtcttatgatttitaggtggtctttgagticaatccttgetgete ccagttctagttaatttctttttggtccactticaaataaaaagttgaatttaagggtaag gcagetggacctgegeattaatcatgtgicagg ctcaaagggctittgtatggggggcatgtttggaatataatatagaatcattcatgtggtttcacctatcaaggacaactctagtttttgtcat acttgtattattacagtgictaaactagacatgatctttticcggaaggaaatttaacttaaaaggaacttagatgcttctigttctgtgatcttt atttgtttattttticcaatctttttaacaattgaaaggttttagttgtatccaatctttttatacatttggactatctaccatatcatttagcaaacttg titgetgetcagattetectitggactatetaccatateatttagcaaacctgticactgoteagattcteatttattetttgtttectetatttttca gtggcaagttggagagttaaagagactgagaggatgatagcaatctgeacagaactcagaaaggtgagtgtcttgctaattectttatg gtticgatattactggactttttacatctcactgacctactctgtcttggtatttcagctaggagcaacagttgaagaaggtcctgattactgt gtgattactccacctgagaaattgaatgtcacagetatagacacatatgatgaccacagaatggecatggeatictetettgetgetigtg gggatgttccagtaaccatcaaggatcetggttgcaccaggaagacatttceygactactttgaagtecttgagaggttmacaaagea ctaagcattttgtacattgagtaggaagagagagagagataaatactcacaaaacagtgagtatatgeatggcttgcttttgtttcttaaca ttcccttgtaagaacttgagataatttgtattgttggaaagagctattgattctgtigtatcaaagtaatttaatttccagtacagacttggetet attcctcatatgtggtggtgtacattgcatctitgeatttgatcccatttctattgggataggaccataccttttittgtttattattcaagtcaaac ttagcagataatatgtggtgaccagaaaatagtctagctagcaaatagacctgtgattgeatgtitgaattcaggacttcaggacatitaat taatgagtgacaatgttaaaaagctcgccaacaggagttgacacatctgattgagtcttctattaacactaactgtaacttgagtttgattat cagattcctectgttggtaggtaatatgtaaatticactatatatttaccgaggtiggtggtettactigacttigaagaggtgagtgtaattta aacitttatatcasaaanagatigetanaagctigagtggcatgcaacaaatageaatgaaagaatgactatggcectigggaaccaaatg gccacgtaccacttttccaccaacttgagagecctggtcetggatgatgeccctttttttitttcattictttgacaataaagaaagttcttattc ttggcaattgcaagtcgtttgtggaagtcacatgaaattcaccataggetticattgticaaatectttagtcactaactaaaggcetggaccta tgcaagaattttggctactcttataaatgctgtgeggeaaagactacggaaaaatataaattattgeatatetagaggtgaggttcattget cccatccatttttccaagaactaaaatatatataaattattaatatgatattacattgaaaaataatattiticttttaaatatgtgatcataagttta attttaagtctaticatacgaaaaaaatatitattagaaaagattaatttattaaatggatctcaatattttaagaaattaacttttagetctcaac caacagatgatttgagttaaaaaaatgtatatataaactattgcatatctgetgatttttgtttgtaacaccaataagtgggcattttactaaat ccatgtgacaatgtactgaatgtittagaatacagtctggtttgataataaaacgtgcataaagtccagettatgttaactcttaattcatgga aaatgatgatatgcgaattgaaagaaagaaaaccataatgtaagtgcagttttctctetcttitttaatattattcaatatcagattgcacatg ggaaggggtattggctcatgtgggatattagttttigtcecttacctaaaaagagagaaagagaaaaataacaatitaaaaagagtacca ccgetaccacctttttcgcttttaaatttttgtictgttttcactactetttcatgegtigttigttggetictgatagtgacgaatatgatataatga ttitatgttgggaaaaaagtgccatgtaaatictagagattgaaattttageatcaaattatttatittatcacctittaaaatttgtigeatgtga aagaatttgaagctctccaacaaggaaataacacticaatccttagagtcatcctctagatcecaaaagaatgtgatgtttatacacattag tatatatatatatatatatatatatatatatatatatatatatatatatatatatatatatatagggtttatattatattaatgagtgatgtacgaggac ggtggtgacactatatggccaaaacaagtgtaatataattattttttitctcaagtattactctatecttgaatattattagtettaaatcttcaa gcaccfttgtgaacgaagcaatcttgicc 5s EPSPS 10 reverse (SEQ ID No.33) gcacarcgigcaagigaraaigccatigccat
EPSPS 4 forward (SEQ ID No.34) gcwggaacwgematgegicerytiacige :
SEQ ID No. 31 with double mutation (SEQ ID No.35) aaaaaataccttttagtaaaataagagcgtragatcaatcagacgttttctctttgggacttctcattcttaattgaattgacaataactaaagt gaaactaaggctaaaatcaactcgectagtcaagetegtecacaaaaataggtittigaaagtttaccatgteagtttettactaagtaaaa aaggatcatttgtaaggtccaacgecttaaaatgatcacccticaaagtaaaagaatcacttgtticacgeataagtaagaactacgtagg {ctgatttcctctecanaggagggiacetaggageasaagocoogtitiptogacotioansaatasaaaganacasaagitaaggta acacaatttccacaattctagaaataaggttgttgtctttcgagacaaacgtaagaggtgctaataccttcctcaaacgtaaatacaactce cgaacttagaattttcatittgaccggtttcetteggtiticcegacgtiticcacaaataaacgttggtggegactcegegcatctitectect ttggaaagcgcacccatgagectegeectegetegeecgegaagggeacgttgegacactaggttaataagaagtttagtceacatat ctatggacctcttaaggtgattatcaaagtggaagtggtgacctacatgttggecctaccagcettattegtatatttacceecatcaaccat gtatctcagctgaaacatgetatcaatccaaatgttatcagaggaacatgagetgeatgticaaccagaagtagttctagicttaatacaa atgtcaaatggcacaagtgagatittgaatitctgatgttgtaaaaatctcaggacatgaatactattgggaagcaattattcatacttcace ‘ aatccaaactgacccaaaattctcaaatcacatgaaagcaaaaatgcatataacacgaagaataagaagaagaggaactaacctggg gtttcgatgattaaagegtigttgttgatgatgaaaacgatgattatggagagaaatigtigtigaatggteaaatigttatagaaagagaa cgaagatagagaaaaagatatatagatttttcaaggctcaaaccctaaaatcaccatgagagagaacaaagattgagaaacctacaac cactatgagagagaatgagcagaacagaagcgtgagatagagaacgagagttaaggtgcgagaggacacgaagaacaaaaggtg tgagagaaagaacaaaggagcctacggtgigagatgagagaatitgaaaticttaccatttaggtggaatitcaatictacaattttattct attaaaattattttaaaaaatgatgtcattttaaatictttaaaatctcatatccaacaactgaattatgatagaggtatttcaaattcacttaaaa aaattatcttatttaaataccccatccaaacatagcgaaatgticatgagaaggatcaagtggtttggaaacatagtactaatggtotitata cagttcatggaatcctigatagataatttaaaggttpctggaaattggatgaaggtgtggagattaaataticticcaaaaataaagegtitt atttggagagtgttgigtggtigictccectgtaggeaaaagcticgatgtaaaggagttcaatgtccaataacctatgettictateecteg attattgaaaatgaatgacacattitatttggttgaaatcaagaaataagcatgtggcaageaacgggtatitgacaaticatagaacaaaa ggtgaatgcagcaaaagaattaatgaactectittcgatetactiggatcactacatggagatattatcaacaaatttgatgitactitatgg agcagttggaattcttggaatgacaagatatgaaatgaacataccaaccctectettgtttctgtitcggttctatgeagtattitgtigaatg geanagtgcaaggtaatatgctecteaacatcaattaacaaatgttcatgacatctcttaccagetecaacttggggacgtitgacaaaca ccaccgtcaagtttccttaaatgeaacattaatgttgetcatttcaaggaggagaatagttttggtgtcggeatgatactccatcaaggaag attcgtcaaagctcactcacgttttcgacatgggtcgacatgggttacctgacccaaaggetgaggcttaggettgggttigeticaagta ttgatctgggeccagactattggtttacataatatcattittgaaaacctaacatctaaaactcaaggttgtitagaggtgegecaticcaaa ataagattatcctatttgtgcatgaatgcgaccaactatctcetgtitcagcattataaagtataaacaacaaacttctttaatcaagggacta aaagatattggacatacaagctaaaagtgatagaatttgagaaaacaaatattgacaacaataticaagaggacactaaaacataattct caaatttttittgtttatttaaaatanagtegticattaggtagctettganaananaaagtgatiaacatgetagtacatgttaaaaaaagtga ataatattctattataagtasagaggaataatttatcgatgtctcatttttgagatagticaccgaagccaatttttttacttttttctcttcaatca attttattitgttaatagttgtcattgtggatggattataataattttgaaatgatttaaaatgagatatatattaataaatttaattaattcataaata tgttactaaatataaatttcatggtatactcaggacggttataacggaaatcaaataaataataaaatagaataatattaatitgcagtaaaa agaataatattaatttattctgtttacactatgtataacgaaattaaatatattcatttaatatgattttattittctttaatttaaaaacatgaattattt gittcttattttattaccattttgttcactictcaattaataaaataaaaatatatictacaattatagtanaaaggtttaattttatataatgttagca tacagatttttctctattaactaattaattaaaaattatccitatittaaggaaattaaaaattatcatatatatataagtittaaattaatiatcitata tatgtaccaaaaagttttaaagcaattattataaaaattaataaatitatcatataaaataatitataattaaatittaaattatcaaticattaaatt aaattatttaaaatttttgaatgataatataataattttatcctctactaagtcccaacgtttectattttattceacttitagcaataaattitgtcat anacacttataacaaaaaaagtaagtanaaaataaaaaaaagtitticaataaagtatasactaatttgtataaacttitagaaaaaataaag ttatacattgataatataaattttttacataattatccgatcaactcattatatatgataaatttattgattittiaaaataattatcttaaaataattta aacaatgatttgcaattagatgataatataaaattattttacacactacatgtattaaactcaaacttitatatattagtittictaaaaactaatttt taactcaaaaaaaatgttacttataattttcttatcttctttttttataagtatttittaagaaatttattgaaacatgaccatgettgggteaataat actactctcttagacaccaaacaacccttcccaaactataatctaatccaaaagecatcattcattticettggtaggtaaagticcaagace ttcaccaactttttcactcaattgttttggtgtaagcaaticgacatgtgttagtgttagttggeaaccaaaaatecctttatgtgactcaatee aacaaccactcacaccaccaaccoccataaccattteteacaatacecttcatttacacattatcatcaccaaaaataaataaaaaaaace tcteatttcagagagagagagagagacttcacagaccaaagtgcagagaacaacaaagttcacaactttaaggaaaattgaaatggec caagtgagcagagtgcacaatcttgctcaaageactcaaatttttggecaticttccaactccaacaaactcaaatcggtgaatteggttte attgaggccacgectitggggggectcaaaatetcgeateecgatgeataaaaatggaagetttatgggaaatittaatgtgggoaagg gaaattccggegtgtitaaggtttetgcatcggtegecgeegeagagaageegtcaacgicgeeggagategtgitggaacceateaa agacttctcgggtaccatcacattgccagggtecaagtctctgtccaategaattttgettettgetgetctetetgaggtgaagtttatitatt tatttatttgttigtttottgttggptgtapgaataggagtttgatgtgtagagtggattitgaatatttgattttittitgtattatictgtgaaaatg aagcatcatgtcccatgaaagaaatggacacgaaattaagtggettatgatgtgaaatgaggatagaaatgtgtgtaggptittttaatgg gtagcaataagcatattcaatatctggattgatitggacgttictgtataaaggagtatgetagcaatgigttaatgtatggctigetaaaata ctcctanaaatcaagtgggagtagtatacatatctacagceaaatgtattaggtgaggcatttggcettetctatigtaaggaacaaataatat oo Co -.51- | oo cagttaatgtgaaaatcaatggttgatattccaatacattcatgatgtgttatttatatgtacctaatattgactgttgtttttctccgcaatgacc | _ aagattatttatittatcctctaaagtgactaattgagttgcttactttagagaagttggacceattaggtgagagegtg gggggaactaate ttgaatatacaatctgagtcttgattatccaagtatggtigtatgaacaatgttagctctagaagataaaccctceccccaaaacacaaatta gaatgacatttcaagttccatgtatgtcactttcattctattatttitacaacttttagttacttaacagatgtcttgttcagcataaattataatitat ttgtttttittaggpaacaactgttgtagacaacttgttgtatagtgaggatattcattacatgettggtgcattaaggaccetiggactge gtgtggaagatgacaaaacaaccaaacaagcaattgtigaaggcetgtgggggeattgtticccactagtaaggaatctaaagatgaaatc aatttattccttggaaatgotggtactgcaatgegtectitgacageagetgtggtioctecaggtoganatgcaggtctg ittitittttt gttcagcataatctttgaattgttcctegtataactaatcacaacagagtacgtgttcticttcctgttataatctaaaaatctcatccagattag tcatcctticticttaaaaggaacctttaattatcaatgtatitatitaatatttaaattagetigtcaaagtctagcatatacatattttgattatatt ctgagaaatgcacctgagggtgttcctcatgatctacttcaacctetgttattattagattttctatcatgattactggtttgagtctctaagtag accatcttgatgttcaaaatatttcagctacgtacttgatggggtgccccgaatgagagagaggecaattggggatttggttgetggtett aagcaacttggtgcagatgttgattgctticttggcacaaactgtccacctgttcgtgtaaatgggaagggaggacttectggeggaaag gtatggtitggatttcatttagaataaggtggagtaactttcctggatcaaaattctaatttaagaagectecctgttticctctcetttagaataa gactaagggtaggtttaggagttgggtittogagagaaatggaagggagagcaatttttticticttctaataaatattctitaatttgataca tttittaagtaaaagaatataaagatagattagcataacttaatgttttaatctittatttattttiataaatattatatacctgtctatttaaaaatca aatatttgtcctceattcectttcecticaaaacctcagttccaaatataccgtagttgaattatatttiggaaggectattggttggagactttt ccttttcagagattatccctcacctttattatagectttctatttttaaacttcatatagacgcecattctigtittaaaaaacactaagtttictttta gttataccttccectecttattctctccaaagtaaatattgtagcaagtgttggttgatceattgtgaatcttattatcetatttaacatgeaggt gaaactgtctggatcagttagcagtcaatacttgactgctttgcttatggcagetectttagetctiggtgatgtggaaattgagattgttgat aaactgatttctgticcatatgttgaaatgactctgaagttgatggagegttttggagtttctgtggaacacagtggtaattgggataggttce ttggtccatggaggtcaaaagtacaagtaggtitctatgtittagtgttacatcactittagtatccaaaatgcaatgaaattaaaactcatgtt tcctattaggtctectggeaatgettttgtigaaggtgatgettcaagtgecagttatttactagetggtgcagceaattactggtggpgactat cactgttaatggctgtggcacaagcagtttacaggtattcatgaatgacactatcttctattatcttttattttatagcttacactatcattcctaa ttcaacccccttettttctetttcececteactcccaaaatagagettatcattgtatecttaatagetcettttatgtgetgttteatetettgageag attctacatgattatcctttttagtgaacttittigtcttitaaataattgatatcatcatitgaacttgcacatcatctctatecttccteattttattat atttcattaagagtgataaaattacattgtcaagtaaagcaagttagegtatcagataatgatgcticgattgcagaattggtgaaagcttg cacaattcattagcttagtgacaattgtgatgtagatagccataatcttccatgcaacttattatgctttttgtctaaaacttcttttgcacttaaa catgaattagagagttaggatgaacaatagtaacagacacaaagcttatttctagaccacccagtggtgaagacgaagcagceatgagt gagattaatggcagcatctgattgaagcttctittggtattattggagatgaaatcttgagecaaattagggettttgectectcaatageca ttggttcaaaattgcittcaataaaatgattacagaatcaaattcttaagaaagaccttcaagaacaacatcaagatgtticctgtgcaaaac aggctcacctacaaaagagtgtctacaagceacctttacacttgcaaaaaattecttaactgaacaattgecaagagteatgttgcaaactt gagattggagttgattagatttggtotgtetgagatictggaaatgagcatgaagttitttgcaaagctcataaaatgaatgcagecaaga : atcctagataggattgaatttgagagagaggcttgaagtcaagataaccgcaactgatcttgetgttcecatgetgeataggactegtts : attctaccaagataacaatctictgtggtgagaatatgagtgggaattgtcaggcaacaaagaaaatgaaggctatgagcctttgttaag gtgcagagagaaaacagaaaatgaagaacttgtgtattgaaggaattgaaaagccaattacaattgtgttgcagagagatatttatagtt ctgaagtgtataactaactaaacagaatgctaccaacctagaggceagttgagaattgetcccttattacaatactctcacagecttgatgat : aggcttgatttgctgccaccgaagaagaacattattgtiggagagtttticagtgattgcatcagagaaagttacaagtgtgattggagat gaaggacttgcggtegtcgaaggttaagtgtiaagtggtggaatgtetatcggaggtggttgectageecaagaagetggttgeagty gaagcggatgcggcagaagccatgggttcagatcagaactatgttctagataccatattagggttagctitcaagagaaaacttatgaa actgaactgtaaactgttgtattattgattagctgatctagtagtgatggaagcttgetigegaagcttctatggaggctggatcattgaget tcaatgaggtccttcaatggtgatttttcaccatggagatgcageggaagataaatgaagaggtgagaggaggegtcatccactagga aataaactatggaagaaggagcticaccaccaagagagtgtcttggataagaagcttagagaggaagcticaatggaggaatagaaa gagagagggggaacaaaaaattgaaggaggaaaagagggagagaagttgaactttgaagtgtgtctcacaagactcattcattaaag ttacaacaagtgttacacatgcttctatttatagtctaggtaacttccttgagaagctagaacttaactacacacacctctctaataactaaga taacctccttgagaaatticetigagaagettcctiaagaagattcctagagaagctaaagcttagttacacacacctctctaataactaagt fcacctcctigagatgagangctagageetiagetacacacaceetiataatagetaaacteactetaticeanaatacatgasaatacaa aaaagttcctactacaaagattactcaaaatgtcctgaaatacaagactaaaactctatactactagaatggtcaaaatacaaggtccaaa agaaggaaaaacctattctaatatttacaaagagagtggacccaaccttagtccatgggetcagaaatctaccetgaggttcatgggaat cctagggtcttctttagtagcictagtccaattttcttggagtcttctatccaatatcctigggggtaggattgeatcatgtagtacaagagag gggaatatatatacagttgtaagttgtaactacctaatcaaacccaactgactcaccatacacagaaaaacaatgtacaaaggataatag anaaactgaaactgagatatactcattacatagaagaattacatgatgaatetgaaaatittaatiggganactgaggacaataacaagg ctttcagagttcattttgacaataggtaaattatggacttcaacttagacctcaagggtatgcttgggagtggpgttttagaggaaaaggg gaaggagggaaattttttaattctagtaaatattctctattttgattaatttitaaaataaaacaaataaacttatagattagcattcacttaatgt cctgatcttttatttgtttcatgaagttttttatagectttctgtitctgttaaaagaaattggagggtgticataatctatatgcceatatatatgta ttgtcctgttgtetgtgtttctgtttictitctitagtgtctcgectttccttaattecttatcaacaccttgtitatitttgaaaacttaaatgtccteat ttittttacctgtactataactticcaaacaaatagtagaaaatgtttcaaatattccccagaactgtttcagtgaacaaagttcaagccagaa aaaaagcaagcagaggctaaagaagtatatcttattgtgaagagtaatctcaattggttaattatcgaattgtatcattttacaatagaaaat tagaagtgggttgattagtttatacgaacaattatttaaatagggttgatg gtgtggttaattactgatcatatgttaagactatgagtcgatg accagcctcagtgceagtcattttaagttccattattttttaattgtgcttatgtitaactttgtectictittaaagggagatgtaaaatttgetgaa gttcttgaaaagatgggagctaaggttacatggtcagagaacagtgtcactgttictggaccaccacgagattitttctggtegaaaagtct tgcgaggcattgatgtcaatatgaacaagatgecagatgttgecatgacactigetgtigtigeactatttgetaatggteccactgetata agagatggtatggtitagetgtitgtititgctcaagagettgttticacatattigtggicaagageggtitagetgttttititittaaattgtog ttaatgaaattattataattatactaatattgaaattggatcactaaccatgtgaaatgcttgaatttttagcttgaaaacttcttttgtggatgatt ’ titcttttatctatgtagtgtggggcatctatgttgttcctttaagetttgtgtcatagttgtacaacctggtetgtgggetggtecagtictiact . catgactgtcttttgcagcaaactggttaaacttgggtgacctgttgacccacccagattggectgticttitttaaataaaactccaaaagg ctacttataagatttcaacatgatacttgaatgaccacccttactttaaaggtcattatgccatcagaccecttgattctetgttcagttatgtic fttattcttattattttttaatttatattattatccaacgatctgatctttgtacatgatgctggacaatcatcaaagcetagtttggttacatcatataa taccttttttticataaatiattitticceataatatatitatatetattittttaatacaatattctggggaaattitititttctgttitctittitctggtity aatactatttcaatgactgggccttattattttctggtitgggttatacaactgtecttigatgtacttttgaatgcettcaatagtatttttcataate atggaaggcactagagtgcagtgcatattgcacaaggtictttaatggcatctigaatttgttagaacatggagttatgatatacaaccatt cctatgtcttcatctaatagctaaagcttttggegtagtiggttaacatggtattggaatcttattitaaaggtccatctiaticgcaagtacaa ggcaggtggacctgegcattattcacgtgeccaggetcaaagggattitgtatgaggpgpaatttttggaatataatatatagaatcattca .tgtggttcacctatcatgtgtcaactcaagttitigtcctagttgtattattgcagtgtctaaactaggeatgatcttctgtggaaggaaattta acctaaggaacttgaatgcttcttgttctgagatctttatttttttictccaatctttttaatacttgaaaggttttagttgtatctataaagggtge agaattagggggtcagctittctgtigtaagegtgaattaagtgcattttatgttgttcectattitatacatttgaactatcaaccatatcattta gcaaacttctttgttgctcagattcccatitattcttgtticetctattttttagtggeaagttggagagttaaagagactgagaggatgatage aatctgcacagaactcagaaaggtcitgctaattcctitatggtttctatattactggactttttacatctcactgacctactactgtcttggtat ttcagctaggagcaacagttgaagaaggtcctgattactgtgtgattactccacctgagaaattgaatgtcacagcetatagacacatatga tgaccacagaatggccatggcattctctettgetgettgtggggatgticcagtaaccatcaaggatectggttgecaccaggaagacatt tcctgactactttgaagtccttgagaggttaacaaageactaageattttgtacatigagtagggaagagagagagatatatataaatact cacaaagcagtgagtatatggcttgctttigttictaaacaticctitataaggacttgagataatttgtattgtitaaaagagcecattggtict gttgtatcaaagtaatttaattttcagtaccgacttggctctactcatatgtggtggtgtacatigeatetttgeatitgaticcatatctattgg gatgggaccatacattttttgtttattatttaagtcaaacatatcagataatatgtggtgaccagaaaagtgtctagcaatcaaatgggtetgt gattgcatgtttgagttcaggacatttattaatgagtgacagaattttaaaaagctcgccaataggagttgccacatctgatcgagtctietg taaacactaactgtaacttgagtttgataatcagattccececcgttggtaggtaatatgtaaatttcactatagaticttactgaggatgatgg tcttgacttcgaagtggtgagtgtaatictctaatctaaactttatatatatataaaaaaagaatgttaaaaactigagtgacatacagcaaat agcaatgaaagcatgaccatggccttgggggeccaaatggecatgtaccactittccacctactigagagecatggtectgaatgaggt ’ ccttttgtticattttttttacaataaagaaagttcatattcttggcaatagcaaggcaaatcatitgtggaagtcacatgaaattcaccatagg cttcattgttcaaatcctttagtcactaaggecagggectatgtaagaattttgactactctigtaaatgetgtgeggtaaagactacgggaa aatataaattattgcatatctagaggtgagottcatttctcegatccattictccaagtaataaaaatatatataaattattaatatggtatgata tggttatttgtcctitaaatatgegattataggttcaatctttggttaatctatcaaatgeatcteaatattitgagagaatagtttttagetettga ctgagagatactitgagttaaaaaaatgtatitataaactattgtctattgaatttttatttttittgtaacaccacatgtgagtattttactaaatcc atgttacaatgtactgaatgttttacaatacagtctgtitgataatanaatatgeacaaagtccagettatgtaactetticaatteatggaaa atgatgatatgcgaatiganagaaagasaaccataatgtaagtgtatititttttictitotcttetttaatatiactcaatatcagattgeacatg ggaagggtactggctcatgtgggatattaatttttatcecttacctaaaaagagagaaagagaaaataactatttaaaaagagtaccacc accacctttttcgettttaagttitgtictgtittcactactctttcatgegttgtttgttggettccgatagtgacgaatatgataatgattttacgt tgagaaanaaaatgtgccatgtaaattccagagattgaaattitagcttcaaattaatatttattitattatcttttcanattggttgcatgtgaa agaatttgaagticttcaacaaggaaataaacacttcaatgctcaatccttagagtcagteactagatcccaaaagaatgtgatgtttacac acattagtatatatatatatataaacacagcttatattatattaatgagtgatgcgegaggacggtggtgacactacatggccaaaacaag aaatgtaatttaatttttttttctttaagtattactctatccttgaatattagtcttaaatcticaaagaccttgegaacgaagcaatettgtcctga tcctgtgattgttetacactagtecttacgtgtacctaageacatgatactttgetgeectaacataaattgtaccataaggattettgggga gatpcttttgccttcattttcaagtttgtitacactttcaagtegtttittcaatgeattetetttcetitctgggaccectigtetitaacacgege gcacacaaaaactagtagacaataattagtactacttgggttccattaaattgtaactacatatacatgtgtttttittttcttggatcaactge atatacatatgttttatgagtttcattgaatttatatttacacaaacagttattaaaacataatgtagagccttgtcattaacctgatgttaggatt ataatttcatgctttgattttgattgtacgttttitgttittattgtaaagtgtitattitattaaaattigtcttggagtgetgtgatctttagggigea ccgttcaaaagagagacgacaaggataatactaatactagtagattccacgcattcaaccetagttagtttagctatgacaaattaageat gotasgasaaggggaggagaaaagtaagaatgaanacatatancaaatigtgattgaacttttccatgacgtaatgaaaacattaattit aagataagcticaactcctaagaagagatatgtcaaagaaacttaggattttticictatttataacggtaaattactcatcetittaaatgatt aatttgcgttgttgaaticgttgtaaagggaaaatcaagaagtcteticacgggaaagttatatcaaagtatcatatactagacttcatgget agcttttactttgattataagtaatgcatgcaattaatgggcaaataaattatttgaaaccaactaaagtacaaataattttcctccaaaacct ctcaagttcgeattgaaattaaataaaccaatgeatattaaggegtaaatctaaaccatgtitgtitcatctigtatigtataicatagtattaat aaggtactitgaatttagttgttatigaccgttaaatttaggggtgagttgtttactatctcttactcaattgetittattcaacgcaaattetagt aggatittcagcccaaattaaaagaagttttacggtttgatictctacaaacttgaattgagattictaatticagaaatcaataattgeggtet taattaactctataatcaaaccttttaacccaatcttttictcaatictctgaattaagacaatcaaaatttaaactcacacgaatctcacacge cttcccacggtagagaaatatagggagtcecttaatagcaaaagectcaaaattcagaaaatctcatceattgeatitgeacattcaacaa accacccattattatgttcccttaataaatctcacacttaaaaaccetectecacecataattaacccaaaaggaagtticctccacacaaaa aatatccttaaacaaagagcctctataaatctattttaaaaaaacccccaaatttaagga
SEQ ID No. 32 with double mutation (SEQ ID No. 36) aaaagtctgaatgaagtgaagtigtigtgttagggggatgctgaatttgattitaatitaatttaaataaattacctgtgtaaaggatttttgta cogectittaatcacaaattgtegtgtatcgaaagtitgitgaattitatagtaactatcttggaggtiatacctagtaggattictgattagtta accatgtaaatttttttaatgggtttgigttigtittaactgatgitgtttttgatatgtacgtggtaagtgtgatgagtitgtgcatatctigatca aagactgaagtgaagtigttgtgtitogggggttgactcttitaggaagaggatttgagggaatticgccaatgggggageagaactce gggacaccctgagaattitgagactccgggaattgaagttacaacaggtttgatatgagttagagttigtataatagaatagtaattctittt attttttatttttattgtttatttatccattattgctatttttgtaggtcctettggtcaggggattgecaatgetgtiggttiggeecttgeagagaa geacttggetgcaagatacaacaagectgacaatgagattgttgaccattacacgtaaaaataactaaatcatacacaacttgcaagact ttagttgttgtottttgctaatggegtitgttitatgcaggtatgctattctgggtgatgptigtcaaatggagggaattgeaaatgaageat getcacttgctggecactggggactggggaagetgatagcattttatgatgacaatcatattictattgatggtaacacagagatigegtt caccgagagtgttgatagtcgtttigagggacttgggtggcatgttatttgggtaaagaatggaaataatggetatgatgatattegtget occattaaggaageanaagetgieanagacasacceacattaatcaaggiiagtitactaatigtggeaatgatatgeatagatitctgge ttgtagttaccataacaatcataatctgtcatgatttatagggattcttitaaactaaggttataaacatgatatgttactaaagactgcattge attgtagtacctcatttgagasactggaagtiataggtgggaaatcaaaatagtaaattatgggteagtttattaagtgtagetggtttgtott ttgctaactctatcatttcacaggtcacaacaaccattggttatggtictcctaacaaggetaactectacagtgtgeatggaagtgeactg gotgccaaagaagttgatgecaccaggeagaaccitggatggteacatgagecaticeacgtgectgaggatgtcaaaaagtatggat gatgggtttagagattictittttcctgtgacactgetgatgtitataatgatactgaataagaattgettgtetgtecccaggeattggagte gceacacceetgagggtgctgeacttgaagetgagtggaatgetaagtttgetgagtatgaaaagaaatacaaggaggaagetgeag aattgaaatctattatcaatggtgaattccetgetggtigggagaaageacttceggtgagtaaatictaaactcacaggittticttacatgt ttgtaacttitcaaggtttggattacatactatccaaagttgatcatgatttcagtitgattiggtagtatggggcticaaaaagtattccaaat attaaaacctggcttccaatttgatttcagacatacactccagagageccageggatgecaccagaaacctgictcaaacaaaccttaat geectigeaaaggticticeeggtetgettggtggeagtgeagatcttgeticticcaacatgaccttgetcaaaatgticggggacttcea aaaggatactccagcagagegtaatgitagaticpgtgttagagaacacggaatgggagetatctgcaacggeattgetcticacagee ctggactgattccatattgtgeaaccitcttigtaticactgactacatgagaggtgecataaggettictgegetgtetgaggetggggtta tttatgtcatgacccatgattcaataggacttggagaagatgggecaacceaccagectatigageacctageaageticegggeaatg ccaaacattttgatgcttcgtectgcegacggtaacsgaaacagecsgageatacaaagtggeegtgetcaacaggaaagagaccet ccattcttgecctatccaggeaaaaactgecccageticecggaactthcattgaaggagttgaaaagggtggttacaccatttcggga caactccactggeaacaagcectgatgteattttgatcggaactggticggaattggaaategetgecaaagetgetgatgacctaagga aggaagggaaggctgttagagtigtticectigttictiggggaactitttgatgagcaatcagaagestacaaggagagtgtittecetg ctoctgtttcagecagagttageattgaggcaggatcaacatttgggtgggagaaaatigitggagcaaagggaaaageaataggeat tgatcgtittggagcetagtgetecagetggaagaatatacaaagaatttggtatcactaaggaagetgitgtigetgeagetaaagagett
: atctagaactittgatttitttitgectictggititggtigagageaticeatgteatgaataagaaaaggtiaaatatecticgattgggaat ttgggattctaagtgaagaagcaacatagatcaaagaattitgtgaacitgtaataactatttgacaatttagtittgcactgecacatggtta BE aattcaatgtttgatcatatcaaccatagatgctagtitatactacttgtataattigtttcacttgeagattcactcttageatttgagtgtiigg Le atggccgtgtittgttcattaagaaatgttgacatggatagtttgttgeatggtaaatiggteattaatacctitttaagettettttggeaagtt gttaaaaagtgttttgttitaatctetagttaatctaaaaatgectacttattttattttgactticaaaacttgtctatatgeccgagtataaaaaaa acttgtctatataagttccttatggaaaaaggacctacaaaataatitaaaaatgctgaattigttaggaagtitgacaactttagacattaat anttgtttttitttcatatatataatigactitcasaactigtctatatattatanaticgttatgganagggogaccacacgtaaaacgtaacat gccaatctetecctagtgaactgttattetcatteagttittgtaagticaccttcaaattttcaatttttittttgacaaaaatatctttgatggaac acgttaggggtetaaaticaccattcatcatttcattcattatacacaatagtctitcataatccaatgaaaactigtittgtigtiatitittictg aaaaatctttatanaataaataaaaacatittittgttataaattcagttgaaatacataaccattaattotacagagtgttaatgttgatgtaaa ataaaaanatattggatatcaaacttaatgaacagaacaaaaattacaaaattgtacaatttaaatgataaaaaaccaaattcacaaaaata aaaattaaggacgaaatttgagaaatgataattaaaaacgattaaaaatataattaaactaaaatttattatgtaattctitaatatatatatata tatatatatatatatatatatatatatatatataataaaagttttacattataattttgaaatgaagtatttgataaacgaacaacccacccttggg sttegtgagagtganacggagaacagtgtcteecteactiggtettetgagtegagicctattcatcaccaacceeactegteaaaattgtt gtatgctatgtaaccatitigttttitaataaataaaagtglittgitctgctatgeactccecatcaaataccatttacttitttitigtctictatca , atttctatttagttcctagttgctacaacttccagetggtgaaaaatagtcaacagagactacaatattctaataaaatagaataacaaaatc anatataticatttaatatgattttatittiatttaatitaaaacatgaattattigtitcttatttaattaccgtitcgttcactictcaattaataaaata aaaaatttctacaattatagaaaaagtttagttttgtagattgttaacataaagattiticctattaactaattaattaaaagtcatctiatatataa gtittanagtaattatcitatatatgtacccaaaagtittaaagcaatiattataaaaaagtaaaattttatcatatacaataatctataattacat gaaagtataatttttaaattattaatacgttaaaattattittttaaaatttgaatgatcatatagtaattitattitataccaagtcccaacatttect attttattccacttttaccaataaatttcctcataaacacttataagaaaaaaagtaagtaaagaataaaataagcttttctataaactataaac aaatitgtataaactttcttatattagtttttctgaaaactaattttaaattatacataaattgaatttactgataatttitattitctttttgtataagty ttttttaagaaatttgttcaaacatatttttatgacatgtcaatgcttgagagatataaggtgagttaaatcataaatgatiaaagaaaaataaa agaagaaaaagataattaatttaattttttattaacatictaacaaattaacattatataaataaanataatatitcaataatiggatcaataatac tattgttcttaaacaccaaaccaaccttcctaaagtectaatctaatccaaaagecatcattcatittcettggtaggtaaagticeaaaacet ttaccaaccttitcactcaattattttggtgtaagcaattcgacatgtgttagtgtiagttggcaaccaaaaaccectttatgtgactcactcaa tccaacaacctctcacaccaccaacceccccataactcataaggecaaaaccattictcacaaaacceticattacacacattattateatt atcacacacacaaaaaacctctcatttcaaagagagagagagatttcacagaccaaattgcagaggacgacaaagttcacaacttcaa opanaatcganatggoccaagigageagagigeacaatetigeicaaageacteaaatittyggycatteticcaayyceaacaaacy caaatcggygaattcggtttcattgaggecacgecetttggggkscetcaaaatctegeatcyygrigmayaaaamtggaagceyttat gggaaattttaatgyggggaagggaaaticeggertgtitaaggttictgeatesgicgeegeegeegeagagaagecgicaacgteg ccggagatcgtgttggaacceatcaaagacttctegggtaccatcacattgecagggtceyaagtctetgtecaatcgaattttgettcttg - ctgcetetetetgaggtaaagtttatitatttatttatttctgtatccaaaaatgtaaattgttagtttgttaatitttgttagcagtgagagtcgaact acttggctictttcttagtcatccaaccaaccttatatctccaaaatttatttattggttttttttggg gttatgt ggttaggaataggagtttgatg oo cgtggagtggattttgaatatttgattitttittitittgiattaticagtgaaaatgaageatctigtcccatgaaagaaatg gacacgaaatta agtggcgtatgatttagaatgatgatagaaatgtgtataggtggttttaatgtgtagcaataagcatattcaatatctggattgatttggacg tttctgtataaaggagtatgctagceaatgtgttaataatgtcttgttaaaagtatggatggctaaaataatcataaaaatcgagtgggagta gtatacatatctacaggaaatgtattaggtgaggcatttggctictctattgegagtaaggaacaagtaatctcagttaatgtgaaaatcaa tggttgatattccaatacattcatgatgtgttatttacgggaacgcaatattgactgttgattttatctgecagetgagattatatactatatectt ccaaagaaatctttgactcttgattatccaagtatggttgtattaccaattttagctctagaagataatcectcecccaaaacacaaattaga atggtgctgcaagttccgtgttactttcattctattatitttataacttttaattatttaatagatgtcttgtttgg cataaactataatttattctgtttt titttattcttatitagggaacaactgtigtagacaacttgytgtayagygaggatattcattacatgetiggtgcattaaggaccettggact gegtgtggaagay gacmaaacaaccaaacaagcaattgtkgaaggetgtgggggattgtticccactaktaargaatctaaagatga aatcaatttattcctiggaaatgctggtactgeratgegtectitgacageagotgtrgtgetgcaggtgganatgcaaggtotgttttttgt titgtitettcatcatgateteigaattgticetcgtataactaatcacatcagactatgtgticttectecatcctgttataatetaaaaateteat ccagattagtcatccttetttaaatgaaccttiaattatatctatgtatttatitaacatgtaaattagctigtcaagtcaaagtctageatataga tatactgattacactctgaggaatgcacctgagggtcttaatcatgatctatttcaaccttgecactttcticttttattattagatcacctatcat gattactggtttgagtctctaaatagaccatcttgatgticaaaatatttcagcetacgtacttgatggrgtgececgaatgagagagaggee aattgggpatttggtigetggtettaagcarcty ggtgcagatgtigattgetttctiggeacaaactgiccacctgiicgtgtaaatggga agggaggacttcctggeggaaaggtatggtttgpatticcattagaataaggtggactaactticctggageaaaattctaatttataccct gtttccecctetitagaataagacactaagggtatgtttaggagttgggttitggecgagaaagggaagggagggcaattttititctaataa atattctttaatttgataaattttttaaacgaaggaatatgaagatagattagcataacttaatgttttaatctittatttatttttataaatattatata cctctatttaaaaacaagatatttttcctecattcectttecctitaaaacctcagttccaaatatacegtacttgaattatattttggaaggtota ttggttggagacctttccttttcagaggttatceeteaccetttattatagecttictactctettaatgagttcatigtgeattgagtcattgaactt cctgtgaaaagaaattgtttactittctttatitgttacctacatcettattcetgttttaaaaaatactaagttttcttttagttatgecttecectee ttattctctccaaagaaaatataatagcgaatgttggtttatccattgtgaatcttattatcctatttcacatgcaggtgaaactgtctggatea gttagcagtcaatacytractgcetttgettatggeagetcctitagetetiggygatgtggaaattgagatigtigataaactgatttctgttc catatgttgaaatgactctgaagttgatggagegttttggagtttctgtggaacacagtggtaattgggatargticttggtccatggaggt
. canangtacaagtaggtttctatgtittagcattacateactttttagtatccanaatgcaatgaaatcaaaacteatgtttictatcaggtote ctggcaatgettttgtigaaggtgatgeticaagtgecagttayttmetagetggtgeagearttactggtgggactatcactgttaatgg ctgtggcacaagcagtttacaggtattcatgettgacactattttctattatctittattttatggtetatactgtatcattcctaattcaacceect tetttictetttccectcacttccaaaaaaatagagcttatcattgtattcttaatagetettgtatgtectttttegtetettgageagattctace gtgattatcctttitagtaaacttttttittgtgtgtctittaaataattgatatcatcatatgaattcacacatcatctctatcecttecteattttatta tatticattaacagtgataaagatasaaataaatigtcangtasagcaagtiageatgteagataatgatgcticaatigcaanatiggtgaa agcttgcacagtacattagctttggtgacaattgtgatgtagatagcecataacctcecatgeaacttattatgttgtttgettaaacttettttg cacttaaacacggattagagagagtgaggatgaacaataataacagacacaaagctiagtttiataccacceggeacecagiggtgaa gaccaagcagtatgagtgagatcaatggcagcatctgattgaagcttcttgtggtattttiggagatgaaatccgaggegaattagggcea tctggctcaacaatagecattggticaaacttgcttttaataaaattgattacagaatcaaattcttgaggaagcecttcaagaactacatcat gatgttccctgtgcaaaacaggttcaccgacaaaagagaacatctacaagttcetttacacatgecaaaaattcctcaactgaacaattg ccaagagtcatgttgcgaacttcaggttggagttgacgaaatttggtgcatgtatgattctggaaatgagcatgaagtttittcctaagete ataaaagtgaatgcagccaagaaccctagataggattgaatcggagagaggcttgaagecaagataacagceaactgatcttgetgtic ccatgctgegtaggactcattgattctaccaagatcacaatctictgtggtgagaaaatgagggtgaattgtcaaccaataaagaaaatg gtgaaggctgagtcttgatgataggetigatttgettgcgetgaagaagaacgttatigttgtagagttictcagtgattgtatgagagtaa gitacaggtgcgattggagatgacggacttgtggtoggaggaggptaagtgttaagtggtggaatgcgtatcagaggtggttgccea gccaaagaagetggttgcggtegaggaggtggtaptecagtggaagecatgggttttgatgctittgagagaaaacatacgaaactg aactgtaaacttttgtattattgattagctgattiggtagtacaagagaggaatatatatacagttttaatgtaactacctaaccaaacatgag gaactctccatacacagaaagacgtatacaaaggataacagacaaacagaaacttagatatactcatacagagaagaattacaggatg aatctgagaattttaattgggaaactgaggaaaatagcaagggtticagaattcattttgacgataggcaaatcatggacttaacttagac ctcaagggtacgcttgggagtggggotttttagaggpaaaagggaaggagggcaaacttitaaticctaataaatattctcttttitgattit tttttaaataaaacaaataaacttatagattagcatacacttaatgtcctaatcttttatttatttgcatgagttttittcttttatattctttctgtitct gttttctitcttcagtgtctettgtctticettaaticcttatcaataccttgtttatttitgaaaacttaattttcctcatttttttaacttataggetata ctatagtatgtataactattcaaataaatagtagaaaatgtttcaaatattccccagaactgtiicagtgaacaaagticaagccagaaaaa agaagtatatcttcttgtgaagagtagtctcaagtggttaattgtcaaattgtatcattttagaatacaaaattagaagtggtttgattagtttat acgaacgattatttaaatagggttgatgatgtggttaattactgatcatatgtgaagactgtgagtcgatgaccageecagtgeagtcatit taaattccattattttitaatttgtgcttatgttaaactttgtcctictttcaaagggagatgtaaaatttgctgaagticttgaaaagatgggage taaggttacatggtcagagaacagtgtcacygttwetggaccrceacragattyttctggteraaaagtcttgeraggeatigatgteaat atgaacaagatgccagatgtigccatgacwettgeygtigtygeactatttgetaatggtcmmactrcyatmagagatggtatggttt agctgtttgtitgtgticaagagctigttitaacaaattgtittttttaattatggttaatgaaattattataattacactaatatigaaattggatca ctaaccatgtgaaatgctigaatttttagcttgaaaacttcttttgtggacaattittcttttatctatggattgtggggcatctatgttgticctit aagcttcgtacaacctggtetgtgggetggtecagtecttcttactcatgacagtcttttgcagtaaactggttaaacttgggtgacctgttg acccacccagattggcctgticttittaaataaaacttggctacttataagatttcaacatgatacttgaatgatcaccettactctaaaggec attatctgticagttatgtictictictictiattatititaatitatattattatccaacgatetgatctttgaacatgatectggacaateatcanag ctagtttggttacatcatataatacctttitittcatatattatitticccatagtatatttttgtgtitttttitcatacaatattatictgaaaaaaactt gtttcgittttttcctggettgaatgctatttcaatgactgggecttattatittctggtitaggttatacaactgtectccaattgactttigaatg cttcaatagttttcttcttaatcatggaaggcactagagtgcatatigaatatgttagaacatggaaggcttaaatatctttttagtetttgeaat ttaacgtttttttgctittagtccttgcaaaattataattittitttagtcctgactaattatgtttgttttgttittgagggcgagecctggtgeage ggtaaagttgtgecttggtgactigttggteatgggticgaatccggaaacagcectetttgeatatgcaagggtaaggctgcgtacaatat cectececcataccttcgcatagegaagagectetgggeaatggggtagaaaaagaagaatgctttagataacacttttittgttactgtt caaagcactatctaaagtgctttgaggactaaacacaaaacaaacataatttgcaaggactgaaaaacaaaaaaataattitgcaagga caaaaaaacaaaaaaaaaaaacaaaatigcaaggaccaaaaatatatttaaaccaacatgaaattatggtataaaaccattcatatgtett catctaatagcttaagcttitgggatagttggttaacaatatggtattagagtcttatgatttttaggtggtetttgagttcaatccttgetgete ccagttctagttaatttcttittggtccacticanataaanagtigaatttaagggtaaggeagetggacctgcgeattaatcatgtgteagg ctcaaagggcttttgtatggggggcatgtttggaatataatatagaatcattcatgtggtttcacctatcaaggacaactctagtttitgtcat acttgtattattacagtgtctaaactagacatgatctttttccggaaggaaatttaacttaaaaggaacttagatgcttcttgttctgtgatettt atttgtttattttticcaatctttitaacaattgaaaggttttagtigtatccaatctttitatacatitggactatctaccatatcatttagcaaactig tttgctgctcagattctectitggactatctaccatatcatttagcaaacctgttcactgetcagattctcatttattctttgtttcctetatttitca gtggcaagttggagagttaaagagactgagaggatgatagcaatctgcacagaactcagaaaggtgagtgtcttgctaattectttatg gtttcgatattactggactttttacatctcactgacctactctgtettggtatticagctaggageaacagttgaagaaggtectgattactgt gtgattactccacctgagaaattgaatgtcacagetatagacacatatgatgaccacagaatggecatggcattetctctigetgettgtg gggatgticcagtaaccatcaaggatcetggttgcaccaggaagacatttccygactactttgaagtecttgagaggttmacaaagcea ctaagcattttgtacatigagtaggaagagagagagagataaatactcacaaaacagtgagtatatgcatggcttgcttitgtttcttaaca ttcccttgtaagaacttgagataatttgtattgttggaaagagctattgattctgttgtatcaaagtaatttaatttccagtacagacttggcetet aftcctcatatgtggtggtgtacattgcatcttigeatttgatcecatttctattgggataggaccatacctttttttgtitattattcaagtcaaac ttagcagataatatgtggtgaccagaaaatagtctagctagcaaatagacctgtgattgeatgtttgaattcaggacttcaggacatttaat taatgagtgacaatgttaaaaagctcgccaacaggagttgacacatctgatigagtctictattaacactaactgtaacttgagtttgattat cagattcctectgttggtaggtaatatgtaaatttcactatatatttaccgaggttggtoptcttacttgactttgaagaggtgagtgtaattta aacttttatatcaaaaaaagattgctaaaagettgagtpggcatgcaacaaatagcaatgaaagaatgactatggecttgggaaccaaatg gccacgtaccacttttccaccaacttgagagccctggtceetggatgatgeccctttttttttttcatttctitgacaataaagaaagttcttatte ttggcaattgcaagtcgtttgtggaagtcacatgaaattcaccataggctteattgttcaaatcctitagtcactaactaaaggetggaccta tgcaagaattttggctactcttataaatgetgtgecggeaaagactacggaaaaatataaattattgeatatctagaggtgaggttcattgct cccatccatttttccaagaactaaaatatatataaattattaatatgatattacatigaaaaataatatitttcttttaaatatgtoatcataagttta attttaagtctattcatacgaaaaaaatatitattagaaaagattaatttattaaatggatctcaatattttaagaaattaacttttagctetcaac caacagatgatttgagttaaaaaaatgtatatataaactattgcatatctgetgatttttgtttgtaacaccaataagtgggcattttactaaat ccatgtgacaatgtactgaatgttttagaatacagtctggtttgataataaaacgtgcataaagtccagcttatgttaactcttaattcatgga aaatgatgatatgcgaattgaaagaaagaaaaccataatgtaagtgcagtittctetetcttttitaatattattcaatatcagattgeacatg ggaaggggtattggctcatgtggpatattagtttttgtcecttacctaaaaagagagaaagagaaaaataacaatttaaaaagagtacca : ccgctaccacctttttcgcttttaaatttitgtictgttticactactetttcatgegttgtttgttggetictgatagtgacgaatatgatataatga ttttatgttgggaaaaaagtgccatgtaaattctagagattgaaattttagcatcaaattatttattttatcaccttttaaaatttgtigcatgtga 5S aagaatttgaagctctccaacaaggaaataacacttcaatccttagagtcatcetctagatcccaaaagaatgtgatgtttatacacattag tatatatatatatatatatatatatatatatatatatatatatatatatatatatatatatatagggtttatattatattaatgagtgatgtacgaggac ggtggtgacactatatggccaaaacaagtgtaatataattatttttttttctcaagtattactctatccttgaatattattagtcttaaatcticaa gcaccttgtgaacgaagcaatcttgicc :
FMV S35S90 enhancer (SEQ ID No.37) aagcttccegggecggecgeagetggetigtggggaccagacaaaaaaggaatggtgcagaattgttaggegeacctaccaaaage atctttgcctttattgcaaagataaagcagattcctctagtacaagtggggaacaaaataacgtggaaaagagetgtectgacageecac tcactaatgcgtatgacgaacgceagtgacgaccacaaaactcgagacttticaacaaagggtaatatccggaaacctcetcggattcea ttgcccagctatctgtcactttattgtgaagatagtggaaaaggaaggtggetcctacaaatgecatcattgegataaaggaaaggecat cgttgaagatgcctctgccgacagtggtcccaaagatggacceccacccacgaggageatcgtggaaaaagaagacgttccaacca cgtcttcaaagcaagtggattgatgtgatatctccactgacgtaagggatgacgcacaatcccactatecttcttaattaa
FMV 35846 enhancer (SEQ ID No38) aagcttcccgggecggeegeagetggetigtggggaccagacaaaaaaggaatggtgcagaattgttaggegeacctaccaaaage atctttgcctttattgcaaagataaagcagattcetctagtacaagtggggaacaaaataacgtggaaaagagetgtcectgacageccac tcactaatgcgtatgacgaacgcagtgacgaccacaaaactcgagaacatggtggageacgacacacttgtctactccaagaatatea . aagatacagtctcagaagaccagagggctattgagacttitcaacaaagggtaatatcgggaaacctcctcggattccatigeecaget atctgtcacttcatcgaaaggacagtagaaaaggaagatggctictacaaatgccatcattgegataaaggaaaggcetategticaaga tgcctctaccgacagtggtcccaaagatggacceccacecacgaggaacatcgtggaaaaagaagacgttccaaccacgtettcaaa gcaagtggattgatgttaattaa
GmTerm Bam (SEQ ID No.39) ctgcagggatcctggtigcaccaggaag
GmTermEco (SEQ ID No.40) gaattcccgggtatggtgaatttcatgtg
BnMUT2PST (SEQ ID No.41) gactictcgggtaccatcacattge
BnMUTkpn (SEQ ID No.42) cacctgcagcaaccacagcetgcetgtcaaagaacgeattgcaataccageatttce
] -6] - oo
GmRubPac (SEQ ID No.43) aatttaattaattcataaatatgttac
GmRubbot (SEQ ID No.44) ggtcttetecttettagttctcaactacttgttctictgetgecagatttcaattttcctiaaagtigtgaac
GmRubtop (SEQ ID No.45) atctggcagcagaagaacaagtagttgagaactaagaaggagaagaccatggeccaagtgageagagigeac ’
GmRubKpn (SEQ ID No.46) ggcaatgtgatggatcccgagaag
ZMPPDK1 (SEQ ID No. 47) gcgccatggeggeatcggtitccaggg
ZMPPDK?2 (SEQ ID No. 48) gegggtacctcagacaagcacctgagcetgeage
ECPPS1 (SEQ ID No. 49) geggceatgeccaacaatggetegtc }
ECPS2 (SEQ ID No. 50) : gcggatccttatttcttcagttcageca :
EPSPS motif (SEQ ID No. 51)
ALLMZAPLA, wherein Z isnot Sor T
EPSPS motif (SEQ ID No. 52)
EIEIZDKL, wherein Z is not V
EPSPS motif (SEQ ID No. 53)
FG(VM)XK/S)ZEH, wherein Z isnot V
EPSPS motif (SEQ ID No. 54)
AL(K/R)ZLGL, wherein Z is-not R
EPSPS motif (SEQ ID No. 55)
GLXVEZ,DXZ,XXXA/V)V, wherein Z, is not T and/or Z, is not E
EPSPS motif (SEQ ID No. 56)
ITPPZ K(L/V)YK/N)Z, wherein Z, is not K and/or Z, isnot T
EPSPS motif (SEQ ID No. 57)
TIZ(D/N)PGCT, wherein Z isnot N or L
EPSPS motif (SEQ ID No. 58)
(D/N)YFXVLXZXX(K/R)H, wherein Z is not R
EPSPS motif (SEQ ID No. 59) (I/V)VEGCGG(I/L/Q)FP(V/AITY(S/G)
EPSPS motif (SEQ ID No. 60) (I/IV)VVGCGG(/L/Q)FP(V/A/T)E
EPSPS motif (SEQ ID No. 61)
UV)VVGCGGULIQFP(V/ATYS/G)
EPSPS motif (SEQ ID No. 62) (I/V)VVGCGGKFP(V/A/T)(S/G)
EPSPS motif (SEQ ID No. 63) (/V)VEGCGGKFP(V/A/T)E
EPSPS motif (SEQ ID No. 64) (I/V)VEGCGG(U/L/Q)FP(V/A/T)E;
EPSPS motif (SEQ ID No. 65) (/V)VEGCGGKFP(V/A/T)S/G).
Claims (64)
1. A glyphosate resistant EPSPS enzyme wherein in comparison with the wild type EPSPS the protein sequence is modified in that a first position is mutated so that the residue at this position is Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into "EPSPS sequences which comprise the conserved region GNAGTAMRPL in the wild type enzyme such that the modified sequence reads GNAGIAMRSL, wherein the enzyme does not comprise the sequence K(A/V)AKRAVVVGCGGKFPVE, characterised in that the enzyme is stable and possesses at least one of the following sequence motifs (i) to (viii) in which X is any amino acid and Z, Z, and Z, are any amino acid other than those specified:- ®) ALLMZAPLA, wherein Z isnot S or T; (ii) EIEIZDKL, wherein Z is not V; (iii) FG(VA)K/S)ZEH, wherein Z is not V;. (iv) AL(K/R)ZLGL, wherein Z is not R; (v) GLXVEZ,DXZ,XXXAUV)V, wherein Z, is not T and/or Z, is not E; (vi) ITPPZ,K(L/V)(K/N)Z, wherein Z, is not K and/or Z, is not T; (vii) TIZ(D/N)PGCT, wherein Z isnot N or L; (viii) (D/N)YFXVLXZXX(K/R)H, wherein Z is not R.
2. An enzyme according to claim 1, which comprises at least two of the motifs (i), (ii), (iii), (v) and (vi).
3. An enzyme according to either of claims 1 or 2, wherein in motif (i) Z is A; in motif (ii) Z is I; in motif (iii) Z is A; in motif (iv) ZisK, T or A; in motif (v) Z, isR or A or less preferably D or E and Z, is preferably V or A or less preferably T; in sequence motif (vi) Z, is E or A and Z, is P, I or V; in motif (vii) ZisR or K; and in motif (viii) Z is T or S or less preferably Q.
4, An enzyme according to claim 1, which comprises one or more sequences selected from the group consiting of: ® (I/V)VEGCGG(/L/Q)FP(V/A/T)(S/G) Gi) @/V)VVGCGGI/L/QFP(V/A/T)E; (iii) (A/V)VVGCGGI/L/Q)FP(V/A/T)(S/G); (iv) (I/V)VVGCGGKFP(V/A/T)(S/G); (v) (I/V)VEGCGGKFP(V/A/T)E; (vi) (/V)VEGCGG/L/Q)FP(V/A/T)E; (vii) (UV)VEGCGGKFP(V/A/T)(S/G).
5. An isolated polynucleotide comprising a region which encodes an EPSPS according to any one of claims 1 to 4.
6. A polynucleotide according to claim 5, having a sequence depicted in SEQ ID Nos. 4 or 5.
7. A polynucleotide encoding an EPSPS, which polynucleotide is obtainable by screening plant genomic DNA libraries with a polynucleotide constituting an intron located within SEQ ID Nos. 4 or 5.
8. A polynucleotide according to any one of claims 5-7, comprising the following components in the 5' to 3' direction of transcription:- 6) At least one transcriptional enhancer being that enhancing region which is upstream from the transcriptional start of the sequence from which the enhancer is obtained and which enhancer per se does not function as a promoter either in the sequence in which it is endogenously comprised or when present heterologously as part of a construct; (ii) The promoter from the soybean EPSPS gene; (iii) The soybean genomic sequence which encodes the soybean EPSPS chloroplast transit peptide; (iv) The genomic sequence which encodes the soybean EPSPS;
(v) A transcriptiohal terminator; wherein the soybean EPSPS coding sequence is modified in comparison with the wild type sequence ir that a first position is mutated so that the residue at this position is Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into EPSPS sequences which comprise the conserved region GNAGTAMRPLTAAYV in the wild type enzyme such that modified sequence reads GNAGIAMRSLTAAV.
9. A polynucleotide according to claim 1, comprising the following components in the 5' to 3' direction of transcription:- 6) At least one transcriptional enhancer being that enhancing region which is upstream from the transcriptional start of the sequence from which the enhancer is obtained and which enhancer per se does not function as a promoter either in the sequence in which it is endogenously comprised or when present heterologously as part of a construct; (ii) The promoter|from the Brasicca napus EPSPS gene; (iti) The Brasicca napus genomic sequence which encodes the Brasicca napus EPSPS chloroplast transit peptide; (iv) The genomic sequence which encodes the Brasicca napus EPSPS; (v) A transcriptional terminator; wherein the Brasiccalnapus EPSPS coding sequence is modified in comparison with the wild type sequence, in that a first position is mutated so that the residue at this position is Ile rather than Thr and a second position is mutated so that the residue at this position is Ser rather than Pro, the mutations being introduced into EPSPS sequences which conintise the conserved region GNAGTAMRPLTAAYV in the wild type enzyme such that modified sequence reads GNAGIAMRSLTAAV.
10. A polynucleotide according to any one of claims 5-9, further comprising a sequence which encodes a chloroplast transit peptide/phosphoenolpyruvate synthase (CTP/PPS) or a chloroplast transit peptide/pyruvate orthophosphate di-kinase
(CTP/PPDK), which sequence is under expression control of a plant operable promoter.
11. A polynucleotide according to the preceding claim, wherein the CTP and PPDK encoding sequences are non-heterologous with respect to each other.
12. A polynucleotide according to any one of claims 5-11, wherein the said enhancing region constitutes a sequence, the 3’ end of which is at least 40 nucleotides upstream of the closest transcriptional start of the sequence from which the enhancer is obtained.
13. A polynucleotide according to claim 12, wherein the enhancing region constitutes a region the 3’ end of which is at least 60 nucleotides upstream of the said closest start.
14. A polynucleotide according to claim 12, wherein the said enhancing region constitutes a sequence the 3’ end of which is at least 10 nucleotides upstream from the first nucleotide of the TATA consensus of the sequence from which the enhancer is obtained.
15. A polynucleotide according to any one of claims 5-14, comprising first and second transcriptional enhancers which are tandemly present in the polynucleotide.
16. A polynucleotide according to any one of claims 5-15, wherein the 3’ end of the enhancer, or first enhancer, is between about 100 to about 1000 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
17. A polynucleotide according to any one of claims 5-16, wherein the 3’ end of the enhancer, or first enhancer, is between about 150 to about 1000 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
-67 - oo
18. A polynucleotide according to any one of claims 5-17, wherein the 3’ end of the enhancer, or first enhancer, is between about 300 to about 950 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
19. A polynucleotide according to any one of claims 5-18, wherein the 3’ end of the enhancer, or first enhancer, is between about 770 and about 790 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
20. A polynucleotide according to any one of claims 5-19, wherein the 3’ end of the enhancer, or first enhancer, is between about 300 and about 380 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region. :
21. A polynucleotide according to any one of claims 5-18 and 20, wherein the 3’ end of the enhancer, or first enhancer, is between about 320 and about 350 nucleotides upstream of the codon corresponding to the translational start of the EPSPS transit peptide, or the first nucleotide of an intron in the 5' untranslated region.
22. A polynucleotide according to any one of claims 5-21, wherein the region upstream of the promoter from the EPSPS gene comprises at least one enhancer derived from a sequence which is upstream from the transcriptional start of either the CaMV35S or FMV35S promoters.
23. A polynucleotide according to any one of claims 5 -21, wherein the region upstream of the promoter from the EPSPS coding sequence comprises at least one enhancer derived from a sequence which is upstream from the transcriptional start of a promoter selected from the group consisting of those of the actin, rolDFd, S-adenosyl
O3/zt6 & homocysteinase, histone, tubulin, polyubiquitin and plastocyasnin genes and the CaMV35S and FMV35S genes.
24. A polynucleotide according to claim 23, comprising in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of either the CaMV35S or FMV358 promoters, and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of an actin gene. !
25. A polynucleotide according to claim 23, comprising in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of either the CaMV35S or FMV35S promoters, and a%econd enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the rolDfd gene.
26. A polynucleotide according to claim 23, comprising in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of either the CaMV358 or FMV358 promoters, and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of a histone gene.
27. | A polynucleotide according to claim 23, comprising in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of either the CaMV358S or FMV35S promoters, and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of a tubulin gene.
28. A polynucleotide according to claim 23, comprising in the 5' to 3' direction a first enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the FMV35S promoter and a second enhancer comprising a transcriptional enhancing region derived from a sequence which is upstream from the transcriptional start of the CaMV35S promoter.
29. A polynucleotide according to any one of claims 5-28, wherein the nucleotides 5' of the codon which constitutes the translational start of the soybean EPSPS chloroplast transit peptide are Kozack preferred.
30. A polynucleotide according to any one of claims 8 to 29, wherein 5' of the genomic sequence which encodes the EPSPS CTP there is located a 5' untranslated leader sequence derived from a relatively highly expressed gene 1s
31. A polynucleotide accérding to the preceding claim, wherein the said highly expressed gene is selected from the group consisting of those which encode glucanase, chalcone synthase and Rubisco.
32. A polynucleotide according to any one of claims 8-31, which comprises a virally derived translational enhancer or non-viral translational enhancer located within the non translated region 5' of the genomic sequence which encodes the EPSPS chloroplast transit peptide.
33. A polynucleotide according to any one of claims 5-32, further comprising regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, dessication, and herbicides.
34. A polynucleotide according to claim 33, wherein the herbicide is other than glyphosate.
35. A polynucleotide according to the preceding claim wherein the herbicide is a protoporphyrinogen oxidase (PPGO) inhibitor, in particular butefenicil, and the corresponding resistance protein is a PPGO or inhibitor resistant variant thereof.
36. A polynucleotide according to either of claims 33 to 35, wherein the insect resistance conferring regions encode crystal toxins derived from Bt, including secreted Bt toxins; protease inhibitors, lectins, Xenhorabdus/Photorhabdus toxins; the fungus resistance conferring regions are selected from the group consisting of those encoding known AFPs, defensins, chitinases, glucanases, Avr-Cf9; the bacterial resistance conferring regions are selected from the group consisting of those encoding cecropins and techyplesin and analogues thereof; the virus resistance regions are selected from the group consisting of genes encoding virus coat proteins, movement proteins, viral replicases, and antisense and ribozyme sequences which are known to provide for virus resistance; the stress, salt, and drought resistance conferring regions are selected from those that encode Glutathione-S-transferase and peroxidase, the sequence which constitutes the known CBF1 regulatory sequence and genes which are known to provide for accumulation of trehalose.
37. A polynucleotide according to claim 36, wherein the insect resistance conferring regions are selected from the group consisting of those that encode crylAc, crylAb, cry3A, cry1BC, ViplA, ViplB, Vip3A, Vip3B, cystein protease inhibitor, and snowdrop lectin.
38. A polynucleotide according to any preceding claim, which is modified in that mRNA instability motifs and/or unwanted splice regions are removed, or crop preferred codons are used so that expression of the thus modified polynucleotide in a plant yields substantially similar protein having a substantially similar activity/function to that obtained by expression of the protein encoding regions of the unmodified polynucleotide in the organism in which they are endogenous.
39. A polynucleotide according to the preceding claim, wherein the degree of identity between the modified polynucleotide and a polynucleotide endogenously contained within the said plant and encoding substantially the same protein is such as to prevent co-suppression between the modified and endogenous sequences.
40. A polynucleotide according to the preceding claim, wherein the said degree is less than about 70%.
41. A vector comprising the polynucleotide of any preceding claim.
42. Plant material which has been transformed with the polynucleotide of any one of claims 5-40, or the vector of claim 41.
43. Plant material which has been transformed with the polynucleotide of any one of claims 5-40 or the vector of claim 41, and which has been, or is, further transformed with a polynucleotide comprising regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, desiccation, and herbicides.
44. Morphologically normal, fertile whole plants which have been regenerated from the material according to either of claims 42 or 43, their progeny seeds and parts.
45. Morphologically normal fertile whole plants which result from the crossing of pints which have been regenerated from material which has been transformed with the polynucleotide of any one of claims 5-40 and plants which result from regeneration of material transformed with a polyncleotide which comprises a sequence which encodes a protein capable of providing for elevated levels of phosphoenolpyruvate in the chloroplast.
46. Plants according to the preceding claim, wherein the said capable protein is a fusion of a CTP and PPS or a fusion of a CTP and a PPDK.
47. Morphologically normal fertile whole plants which comprise the polynucleotide of any one of claims 5-40 and which result from the crossing of plants which have been regenerated from material transformed with the polynucleotide of any one of claims 5 - 40 or the vector of claim 41, and plants which have been transformed with a polynucleotide comprising regions encoding a CTP/PPS or CTPPPDK, and/or regions encoding proteins capable of conferring upon plant material containing it at least one of the following agronomically desirable traits: resistance to insects, fungi, viruses, bacteria, nematodes, stress, desiccation, and herbicides, the progeny of the resultant plants, their seeds and parts.
48. Plants according to any one of claims 44 to 47, selected from the group consisting of field crops, fruits and vegetables such as canola, sunflower, tobacco, sugar beet, cotton, maize, wheat, barley, rice, sorghum, tomato, mango, peach, apple, mangel worzel, pear, strawberry, banana, melon, potato, carrot, lettuce, cabbage, onion, soya spp, sugar cane, pea, field beans, poplar, grape, citrus, alfalfa, rye, oats, turf and forage grasses, flax and oilseed rape, and nut producing plants insofar as they are not already specifically mentioned, their progeny, seeds and parts.
49, Soybean, canola, brassica, cotton, sugar beet, sunflower, peas, potatoes and mangel worzels according to any one of claims 44-48.
50. A method of selectively controlling weeds in a field, the field comprising weeds and plants or progeny according to any one of claims 44-49, the method comprising application to the field of a glyphosate type herbicide in an amount sufficient to control the weeds without substantially affecting the plants.
Sl. A method according to the preceding claim, further comprising application to the field either before or after application of the glyphosate herbicide of one or more of the following: a herbicide, insecticide, fungicide, nematicide, bacteriocide and an anti-viral.
52. A method of producing plants which are substantially tolerant or substantially resistant to glyphosate herbicide, comprising the steps of: ®) transforming plant material with the polynucleotide of any one of claims 5 to 40 or the vector of claim 41; ; (ii) selecting the thus transformed material; and (ili) regenerating the thus selected material into morphologically normal fertile whole plants.
53. A method according to the preceding claim, wherein the transformation involves the introduction of the polynucleotide into the material by: (i) biolistic bombardment of the material with particles coated with the polynucleotide; or (ii) impalement of the material on silicon carbide fibres which are coated with a solution comprising the polynucleotide; or (iii) introduction of the polynucleotide or vector into Agrobacterium and co-cultivation of the thus transformed Agrobacterium with plant material which is thereby transformed and is subsequently regenerated.
54. A method according to the preceding claim, wherein the transformed material is selected by its resistance to glyphosate.
55. Use of the polynucleotide of any one of claims 5 to 40, or the vector of claim 41, in the production of plant tissues and/or morphologically normal fertile whole plants which are substantially tolerant or substantially resistant to glyphosate herbicide.
56. Use of the polynucleotide of any one of claims 5 to 40, or the vector of claim 41, in the production of a herbicidal target for the high throughput in vitro screening of potential herbicides.
57. A method of selecting biological material transformed so as to express a gene of interest, wherein the transformed material comprises the polynucleotide of any one of claims 5 to 40 or the vector of claim 41 and wherein the selection comprises exposing the transformed material to glyphosate or a salt thereof, and selecting surviving material.
58. A method according to the preceding claim, wherein the biological material is of plant origin.
59. A method according to the preceding claim, wherein the plant is a dicot.
60. A method according to the preceding claim, wherein the dicot is selected from group consisting of soybean, cotton, sugar beet, Brassica napus, campestris or oleraceae.
61. A method for regenerating a fertile transformed plant to contain foreign DNA comprising the steps of: (2) producing regenerable tissue from said plant to be transformed; (b) transforming said regenerable tissue with said foreign DNA, wherein said : foreign DNA comprises a selectable DNA sequence, wherein said sequence functions in a regenerable tissue as a selection device; (©) between about one day to about 60 days after step (b), placing said regenerable tissue from step (b) in a medium capable of producing shoots from said tissue, wherein said medium may further contain a compound used to select regenerable tissue containing said selectable DNA sequence to allow identification or selection of the transformed regenerated tissue; (d) after at least one shoot has formed from the selected tissue of step (c) transferring said shoot to a second medium capable of producing roots from said shoot to produce a plantlet, wherein the second medium optionally contains the said compound; and (e) growing said plantlet into a fertile transgenic plant wherein the foreign DNA is transmitted to progeny plants in Mendelian fashion, wherein between step (b) and step (c) there is an optional step of placing the transformed material onto callus inducing medium, characterised in that the foreign DNA is, or the selectable DNA sequence comprised by the foreign DNA comprises, the polynucleotide according to any one of claims 5 to 40, and the said compound is glyphosate or a salt thereof.
62. A method according to the preceding claim, wherein the plant is a dicot selected from the group consisting soybean, cotton, sugar beet, Brassica napus, campestris or oleraceae.
63. A method according to either of claims 61 or 62, wherein the said regenerable tissue is selected from the group consisting of embryogenic calli, somatic embryos, immature embryos etc.
64. A diagnostic kit comprising means for detecting the enzyme of any one of claims 1-4 or that encoded by the polynucleotide of any one of claims 5 to 40 or the polynucleotide or vector of any one of claims 5 to 41.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0023911A GB0023911D0 (en) | 2000-09-29 | 2000-09-29 | Improvements in or relating to organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200302168B true ZA200302168B (en) | 2004-02-16 |
Family
ID=9900391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200302168A ZA200302168B (en) | 2000-09-29 | 2003-03-18 | Herbicide resistant plants. |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0023911D0 (en) |
ZA (1) | ZA200302168B (en) |
-
2000
- 2000-09-29 GB GB0023911A patent/GB0023911D0/en not_active Ceased
-
2003
- 2003-03-18 ZA ZA200302168A patent/ZA200302168B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB0023911D0 (en) | 2000-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7169970B2 (en) | Herbicide resistant plants | |
AU2001287862A1 (en) | Herbicide resistant plants | |
EP1173582B1 (en) | Herbicide resistant plants | |
EP1341903B1 (en) | Plant derived hydroxy phenyl pyruvate dioxygneases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases | |
CZ20013859A3 (en) | Plants resistant to herbicides | |
US20030079246A1 (en) | Herbicide resistant plants | |
JP2003528571A6 (en) | Herbicide resistant plants | |
BRPI0407592B1 (en) | Glyphosate resistant class i 5-enolpyruvilshikimato-3-phosphate synthase (epsps), dna molecule encoding it, dna construct and processes for preparing a glyphosate tolerant plant and weed control | |
AU2005267423B2 (en) | Microbial glyphosate resistant 5-enolpyruvylshikimate-3-phosphate synthases | |
US7056715B1 (en) | GST sequences from soybean and their use in the production of herbicide resistant plants | |
ZA200302168B (en) | Herbicide resistant plants. | |
RU2235778C2 (en) | Isolated polynucleotide able to confer to plant resistance or tolerance to glyfosate herbicide, vector, method for preparing plants with tolerance or resistance to glyfosate herbicide, method for regeneration of transformed plant and method for selective control of weeds | |
ZA200108766B (en) | Herbicide resistant plants. | |
ZA200108769B (en) | Herbicide resistant plants. | |
ZA200108768B (en) | Herbicide resistant plants. |